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Thesis Abstract 
Aim: Diabetes is an important barometer of health system performance. This chronic 
condition is a source of significant morbidity, premature mortality and a major 
contributor to health care costs. There is an increasing focus internationally, and more 
recently nationally, on system, practice and professional-level initiatives to improve the 
quality of care. The aim of this thesis was to investigate the „quality chasm‟ around the 
organisation and delivery of diabetes care in general practice, to explore  attitudes to 
engaging in quality improvement activities in general practice and to examine efforts to 
improve the quality of diabetes care in Ireland from practice to policy. 
Methods: Quantitative and qualitative methods were used. A postal survey of 600 GPs 
was conducted to assess the organisation of care. This was followed by an in-depth 
qualitative study using semi-structured interviews with a purposive sample of 31 GPs. 
The qualitative methodology was also used to examine GPs‟ attitudes to engaging in 
quality improvement. Data were analysed using a Framework approach. A 2nd 
observational study was used to assess the quality of care in 63 practices with a special 
interest in diabetes. Data on 3010 adults with Type 2 diabetes from 3 primary care 
initiatives were analysed and the results were benchmarked against national guidelines 
and standards of care in the UK. The final study, an instrumental case study of policy 
formulation, involved semi-structured interviews with 15 members of the Expert 
Advisory Group (EAG) for Diabetes. Thematic analysis was applied to the data using 3 
theories of the policy process as analytical tools.  
Results: The survey response rate was 44% (n=262). Results suggested care delivery 
was largely unstructured; 45% of GPs had a diabetes register (n=157), 53% reported 
using guidelines (n=140), 30% had formal call recall system (n=78) and 24% employed 
none of these organisational features (n=62). The lack of coordination between settings 
was identified as a major barrier to providing optimal care leading to waiting times, 
“overburdened” hospitals and avoidable duplication. The lack of remuneration for chronic 
disease management had a ripple effect also creating costs for patients and apathy 
among GPs. There was also a sense of inertia around quality improvement activities 
particularly at a national level. This attitude was strongly influenced by previous 
experiences of change in the health system. In contrast GP‟s spoke positively about 
change at a local level which was facilitated by a practice “ethos”, leadership and special 
interest in diabetes.  
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The 2nd quantitative study found that practices with a special interest in diabetes 
achieved a standard of care comparable to the UK in terms of the recording of clinical 
processes of care and the achievement of clinical targets; 35% of patients reached the 
HbA1c target of <6.5% compared to 25% in England. With regard to diabetes policy 
formulation, the evolving process of action and inaction was best described by the 
Multiple Streams Theory. The formulation of recommendations by the EAG was 
facilitated by overarching agreement on the “obvious” priorities although the details of 
proposals were influenced by personal preferences and local capacity. In contrast the 
national decision-making process was protracted and ambiguous. The lack of impetus 
from senior management coupled with the lack of power conferred on the EAG 
impeded progress.  
Conclusions: The findings highlight the inconsistency of diabetes care in Ireland. The 
main barriers to optimal diabetes management centre on the organisation and 
coordination of care at the systems level with consequences for practice, providers and 
patients. Quality improvement initiatives need to stimulate a sense of ownership and 
interest among frontline service providers to address the local sense of inertia to 
national change. To date quality improvement in diabetes care has been largely 
dependent the „special interest‟ of professionals. The challenge for the Irish health 
system is to embed this activity as part of routine practice, professional responsibility 
and the underlying health care culture. 
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1.1 Introduction 
This thesis documents a series of studies examining the quality of diabetes care in 
Ireland from a practice, professional and policy perspective. Focusing on the general 
practice setting, each study relates to the organisation of care, which has been suggested 
as a cause of and solution to the „quality chasm‟ in health care. The first study examined 
the level and organisation of diabetes care in general practice including access to 
support services and links with secondary care. The results informed the follow-up 
qualitative study which explored experiences of providing diabetes care in general 
practice in more detail, and identified the barriers and facilitators to delivering high 
quality care in Ireland. The third study examined GPs‟ attitudes to engaging in quality 
improvement activities at local and national level. The final two studies concentrated on 
bottom-up and top-down efforts to improve the quality of diabetes care in Ireland. A 
cross-sectional study, combining audit data from three primary care-led diabetes 
initiatives, demonstrated the quality of care achieved by proactive health care 
professionals adopting a structured approach to diabetes management. The final study, 
an example of a top-down effort to improve diabetes care in the policy arena, 
investigated the formulation of recommendations by the Expert Advisory Group for 
Diabetes (EAG) as an instrumental case study of policy formulation in the Irish health 
system.  
This chapter briefly outlines why diabetes is a condition of choice for modelling change 
in health care and the increasing focus on system, practice and professional level 
interventions to improve the quality of care. The origins of this thesis are summarised, 
followed by an overview of the context and terminology which provide a backdrop to 
the research. Finally, the aims and objectives of the research are presented with an 
outline of the thesis structure. 
1.2 Background 
Diabetes has become the chronic condition of choice for modelling quality 
improvement for a number of reasons (2). First and foremost diabetes is a leading cause 
of death worldwide (3) and a source of significant morbidity and disability for 
individuals living with the condition. The rising prevalence and cost of diabetes places a 
substantial burden on health systems (4, 5). Secondly, despite progress in the 
therapeutic management of diabetes, a gap persists between the ideal standard of care 
set out in guidelines and the reality in everyday practice (6-9). The traditional orientation 
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of health systems towards acute episodic care is frequently cited as one of the original 
causes of the „quality chasm‟ in health care (10) and it is now accepted that this model 
of care will not cope with the future burden of chronic conditions such as diabetes (11, 
12). As a result greater attention has been paid to ways of reorganising services, 
including the reorientation of care towards the primary care setting (13). 
Since the term „quality chasm‟ was coined by the Institute of Medicine in 2001(10), there 
has been a growing focus both nationally and internationally on system, practice and 
professional-level initiatives to improve the quality of chronic disease management. 
Evidence from quality improvement research has demonstrated the positive impact of 
organisational and professional interventions on the quality of diabetes care {Renders, 
2000 #62;Shojania, 2006 #9;Weingarten, 2002 #451}. The focus on reorganisation can 
also be seen in policy as the national guidelines for diabetes care in Ireland promote care 
which is planned, structured and integrated (17). In particular, patient registration, 
regular recall and review are considered the three key organisational components of 
effective diabetes management.  
However the science of quality improvement is not only about examining the 
effectiveness of quality improvement interventions. Many experts now contend that 
understanding the context in which quality improvement flourishes or fails is as 
important as generating evidence on the statistical significance of different strategies 
(18, 19). Indeed a review of organisational and professional strategies for diabetes care 
found that effectiveness was dependent partly on clinical context but also other 
contextual factors such as the beliefs and attitudes of professionals (8). This thesis looks 
at the organisational, professional and cultural context of delivering and improving 
diabetes care in Ireland. 
1.3 Building on Earlier Research and Established Networks 
Over the past decade both the Department of Epidemiology and Public Health and the 
Department of General Practice in University College Cork, have become more active 
in diabetes research in Ireland. Consequently a number of previous projects and new 
opportunities informed the development of this thesis.  
1.3.1 Building on previous doctoral research 
This thesis builds on another doctoral thesis conducted in the Department of 
Epidemiology and Public Health by Dr Margaret Collins. Examining the determinants 
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of quality of life in patients with diabetes, Dr Collins investigated the impact of three 
models of care on the quality of care and quality of life. Using a patient report card to 
measure quality, the findings indicated that less than half the patients were receiving 
more than seven out of ten processes of care. Structured care in general practice was 
significantly associated with higher quality of care and quality of life scores compared to 
traditional and shared care models (20). From this starting point of three models of 
care, the present thesis explores the understanding and experience of diabetes care 
arrangements from the GP perspective (Chapter 4). The qualitative study seeks to 
disentangle the concepts of shared and structured care in Ireland. In the cross-sectional 
study presented in Chapter 6, the standard of primary care-led structured diabetes 
management is compared to audit results from a shared model of care in Ireland Quality 
is assessed using process and outcome measures extracted from GP records, advancing 
from patient-reported quality of care in the previous doctoral research. 
1.3.2 Working with Local Initiatives 
In 2003 the Department of Epidemiology and Public Health was commissioned to 
compile an audit report on the Midland Area Diabetes Structured Care Programme. A 
resulting publication stated that a quality chasm existed in Ireland between current 
routine practice and optimal standards in chronic disease management (21). That 
statement became the focus of this thesis as the PhD student endeavoured to examine 
the „quality chasm‟ in greater depth and explore why it existed. The student went on to 
establish links with the team in the Midlands and contributed to the most recent audit 
of care in 2009. As part of a national research placement under the Health Research 
Board PhD Scholars Programme (Appendix I), the student also worked on an audit of 
practices participating in the Diabetes Interest Group (DIG) in Cork in 2008. The links 
with diabetes initiatives led to the opportunity to collate audit data across three schemes 
to examine the quality of primary care-led diabetes management, the results of which 
are presented in Chapter 6. 
1.3.3 The National Diabetes Register Project (NDRP) 
In 2007, the National Diabetes Register Project (NDRP) was established to conduct a 
programme of research into the feasibility of a national diabetes register. Funded by the 
Irish Health Research Board, the project was a collaboration between UCC 
(Department of General Practice, Department of Epidemiology), NUI Galway 
(Department of Medicine) and the Midland Diabetes Structured Care Programme. Two 
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of the supervisors of this thesis were lead investigators on the project (CB & IP). 
Another of the principle investigators, Dr Velma Harkins, was involved in the 
aforementioned Collaborative Primary Care Diabetes Project (Chapter 6). 
There were four areas of research in the NDRP plan; survey of care provision in Ireland 
including GPs & hospital consultants, qualitative follow-up studies with both groups as 
well as with people with diabetes, multisite audit of 3 models of care and finally an 
economic evaluation of three models of care. The PhD student was involved in the 
general practice components of the project, namely the survey and qualitative follow-up, 
which were led by the UCC team. The student was responsible for inputting, analysing 
and interpreting the results of the GP survey and was lead author of the subsequent 
publication. Together with a postdoctoral researcher Dr Monica O‟Mullane, the PhD 
student conducted the qualitative follow-up study with GPs. When Dr O‟Mullane left 
the team in March 2010, the student became the lead researcher on this arm of the 
project. She was also involved in the literature review which informed the review 
included in this thesis and led to two published papers (Appendix I). The National 
Diabetes Register Project came to a close in the summer of 2010 however the findings 
continue to inform the design and development of services nationally under the 
direction of the National Working Group for Diabetes, part of the Clinical Care 
Programme in the HSE. The design and results from the first phase of research by the 
NDRP are reflected in the first three studies presented in this thesis and the story of the 
feasibility of the national diabetes register is weaved through this thesis.  
1.4 Context and Terminology 
The following section provides a summary of the context which underpinned the 
research methodology and an introduction to the terminology used in the thesis.  
1.4.1 Epistemology 
This thesis is a collection of quantitative and qualitative studies. In line with the 
problem-orientated nature of Health Services Research (HSR), the choice of research 
design and methodology was guided by the aims and objectives of the thesis (22, 23). 
The use of both quantitative and qualitative methods is reflective of the pragmatic 
paradigm underlying this thesis, which refers to the selecting the method or 
philosophical approach which best suits the issue under scrutiny (24). 
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Pragmatism rejects the forced choice between quantitative and qualitative 
methodologies, advocating that decisions about methods should be informed by the 
research question (24). Any proposal to improve the quality of diabetes care in Ireland 
will be grafted onto an existing health care structure and integrated into an established 
professional and organisational context. Hence, a mixed method study with a 
quantitative and qualitative phase was undertaken to assess and understand the level and 
organisation of diabetes care in general practice (25). The survey results provided 
baseline data on the organisation of diabetes care nationally and informed the design of 
the qualitative study. The qualitative analysis explored GPs‟ experiences of delivering 
care in more detail unearthing nuances in the Irish health system which were not 
captured by the questionnaire, for example the perceived role of luck in accessing 
auxiliary services. The study also identified the barriers and facilitators to optimal 
delivery from the GP perspective rather than assuming to know the challenges of 
providing care in this setting. 
Pragmatism acknowledges the influence of values in conducting research, seeking 
explanations and drawing conclusions. In this vein, the student‟s values as a Health 
Services Researcher influenced the topic under scrutiny: the quality of diabetes care. A 
background in health psychology increased the student‟s awareness of the influence of 
beliefs and attitudes on behaviour. This influence is the focus of Chapter 5 which 
examines attitudes and openness to quality improvement in general practice. Some of 
the themes which emerge from qualitative research in this thesis, such as the enabling 
role of local leadership in quality improvement, were rooted in context and present 
significant challenges in terms of quantitative measurement(26). Interpretation of the 
results draws on theory from health psychology, sociology and change management to 
move analysis from face-value description to understanding why attitudes and 
perspectives emerged (27).  
Quality is considered a dimension amenable to measurement through assessment of the 
structures, processes and outcomes of care (28). The quality of diabetes care is typically 
measured along these dimensions and benchmarked against national and international 
best practice. This quantitative approach to evaluating quality was adopted in Chapter 6 
to examine the performance of three initiatives which are pioneering quality 
improvement at the practice level. In contrast qualitative methodology was used to 
examine efforts to enhance diabetes care in the national policy arena. Policy analysis 
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typically employs a case study design to investigate how and why questions(29), such as 
those posed about the process and outcome of the Expert Advisory Group for 
Diabetes in Chapter 7. 
The practical and applied research philosophy of pragmatism should not be interpreted 
as an „anything goes‟ approach to research (30). Seale et al (2004) stress the need to 
contextualise the principles of qualitative methodology in practice which involves 
turning to everyday life to understand human nature and social order. This thesis 
focuses on the everyday experience of organising and coordinating diabetes care in 
general practice. The researcher does not seek to ascribe value to the opinions, 
emotions and attitudes contained in results of this thesis but rather focuses on 
investigating the how they are brought to bear on participants‟ understandings, actions 
and interactions surrounding the provision and improvement of diabetes care (30). 
1.4.2 General Practice in Ireland 
This thesis focuses on the organisation and coordination of diabetes care from the 
general practice perspective. General Practitioner (GP) services are at the centre of 
primary care in Ireland. There is no national register of General Practitioners in Ireland, 
however it is estimated that there are more than 2,500 GPs in the country (31). GPs are 
independent self-employed health care professionals contracted to provide certain 
services within the national health system, the Health Service Executive (HSE). Other 
members of primary care such as Public Health Nurses and Community Diabetes Nurse 
Specialists are employed directly by the HSE.  
Some people have free access to GP services under the General Medical Scheme (GMS) 
while others are considered „private patients‟ and must pay per visit. Individuals and 
families below a certain income threshold are eligible for a medical card under the GMS 
and approximately one third of the population qualify (32). The HSE reimburses GPs 
for care provided to individuals and families with a medical card. The annual capitation 
fee per patient is based on demographic information (e.g. age) and geographic 
information (e.g. distance from the GP). People with diabetes who do not have a 
medical care qualify for the Long Term Illness Scheme which entitles them to 
medication for the treatment of diabetes free of charge. It does not cover the costs of 
doctor visits or medicines not related to the treatment of diabetes. Other primary care 
health care professionals (e.g. community dietician) are part of the HSE therefore 
private patients (non-GMS) may not have free access to those services and may have to 
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pay privately (33). GMS patients are registered with a specified doctor but private 
patients are not registered as universal patient registration is not compulsory in Ireland. 
1.4.3 Terminology for Quality Improvement 
There are two activities synonymous with achieving quality; quality improvement and 
quality assurance. The terms are used interchangeable as they form part of the 
continuous cycle of identifying areas for attention, establishing the criteria for judging 
quality, assessing quality and implementing change (34). This thesis uses the term 
„quality improvement‟ as an umbrella term to describe these activities. The following 
definition of quality improvement has been adopted: 
“the combined and unceasing efforts by all involved (healthcare professionals, patients and their 
families, researchers, planners and policy makers) to make changes that will lead to better 
patient outcomes, better system performance and better professional development” (35). 
1.4.4 Terminology for Health Policy Analysis 
The study of the policy process involves analysis of how policy decisions are made and 
how these decisions are shaped into action (36). In this thesis the Expert Advisory 
Group for Diabetes (EAG) is examined as an example of the policy process, with a 
focus on how and why decisions to improve diabetes care were made and whether these 
decisions led to action or inaction. This thesis adopts the definition of health policy a 
„web of decisions‟ (36) but also „courses of action and inaction that affect the set of institutions, 
organisations, services and funding arrangements of the health system‟ (p6) (37) . This definition 
embraces the interaction between state and non-state actors as health policy can be 
formulated within and outside government, by non-governmental actors and by 
organisations external to the health system (29). The conceptualisation corresponds to 
the Expert Advisory Group, a multidisciplinary body of health care professionals, health 
service management and government representatives.  
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1.5 Aims and Objectives 
There were three broad aims to this research; to investigate the „quality chasm‟ around 
the organisation and delivery of diabetes care in general practice, to explore attitudes to 
engaging in quality improvement activities in general practice and to investigate efforts 
to improve the quality of diabetes care in Ireland from practice to policy. Each aim had 
a number of specific objectives: 
1. To investigate the „quality chasm‟ around the organisation of diabetes care in general 
practice in Ireland. 
I. To describe the level and organisation of diabetes care in General Practice in 
Ireland. 
II. To elaborate on GPs‟ experiences of delivering care and elucidate the 
models of care functioning in Ireland. 
III. To explore GPs‟ perceptions of the barriers and facilitators to providing 
diabetes care in everyday practice. 
2. To explore GPs‟ attitudes and openness to engaging with quality improvement. 
I. To elicit attitudes to the development of a national diabetes register and the 
use of audit as mechanisms for quality improvement. 
3. To examine efforts to bridge the quality gap around diabetes care in Ireland from 
practice to policy. 
I. To assess the quality of structured Type 2 diabetes management in practices 
with a special interest in diabetes, a bottom-up primary care-led approach to 
improvement.  
II. To analyse the formulation of the recommendations from Expert Advisory 
Group for Diabetes, a top-down approach to improve the quality of 
diabetes care.  
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1.6 Thesis Outline 
The thesis comprises of five studies which address the aforementioned aims and 
objectives. Figure 1 illustrates each aim and objective and the corresponding chapter.  
The literature review presented in Chapter 2, outlines the case for diabetes as a model 
for quality improvement and the gap between evidence-based standards of care and the 
reality for patients. The chapter charts the emergence of a quality agenda in healthcare 
and summarises the body of evidence from system, practice and professional level 
interventions which seek to improve the quality of diabetes care. This is followed by an 
overview of the models of diabetes care and their defining characteristics. Finally the 
organisation of diabetes care in Ireland is outlined including established models of care 
and the policy framework underpinning efforts to improve care  
A descriptive study of the organisation and delivery of diabetes care in general practice 
is presented in Chapter 3. The results of the survey describe the organisation of care 
within practices and access to services outside practices. It also examines links with 
secondary care providers. Chapter 4 presents the qualitative follow-up study examining 
GPs‟ experiences of providing and organising diabetes care in more depth. This study 
explores GPs‟ understanding of models of care and explores the barriers and facilitators 
to providing care in every-day general practice. Chapter 5 outlines results from a further 
objective within the qualitative analysis; that is to explore GPs‟ attitudes and openness 
to engaging in quality improvement. The results focus specifically on attitudes to a 
national diabetes register and audit as mechanisms for quality improvement at local and 
national level. 
Chapter 6 examines the quality of care delivered by practices with a special interest in 
diabetes as part of primary care-led initiatives in 3 regions of Ireland. The study 
involved practices which had adopted a structured approach to diabetes management 
including regular audit and feedback. Data on processes and intermediate outcomes for 
over 3000 patients with Type 2 diabetes were benchmarked against national guidelines, 
audit results from a shared care initiative and standards of care achieved in the UK. The 
study highlights some of the challenges facing such initiatives in the absence of a 
national infrastructure for diabetes care.  
The final study presented in Chapter 7 is an analysis of a top-down initiative to improve 
the quality of diabetes care. This study examines the Expert Advisory Group for 
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Diabetes and the development of its recommendations as an instrumental case study of 
policy formulation within the Irish health service. The thesis is summarised with a 
discussion of the implications for diabetes care and areas for future research. 
The final chapter in the thesis summarises and integrates the results from the 
aforementioned five studies. The discussion in Chapter 8 reflects on the need to 
consider quality improvement in context and the absence of a quality improvement 
culture around diabetes care in Ireland. 
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Figure 1 Thesis overview of the aims and objectives of each study and the corresponding chapter.
The Quality of  Diabets Care in 
the Community: Practice, 
Policy & Culture. 
1. To investigate the 
„quality chasm‟ in 
diabetes care in general 
practice 
To describe the 
organisation of diabetes 
care in general practice 
Quantitative Survey 
Chapter 3 
Paper 1 
To elaborate on 
experiences providing 
care & the barriers and 
facilitators to optimal 
care 
Qualitative follow-up using 
semi-structured interviews 
Chapter 4 
Paper 2 
2. To explore GPs' 
attitudes to engaging in 
quality improvement 
activites 
Chapter 5 
Paper 3 
3. To examine efforts to 
improve the quality of  
diabetes care in Ireland   
from practice to policy  
To assess the quality of 
Type 2 diabetes 
management in practices 
with a special interest in 
diabetes care  
Crossectional 
analysis using routine 
audit data 
Chapter 6 
Paper 4 
To analyse the establishment 
of the Expert Advisory Group 
for Diabetes and formulation 
of its recommendations 
Policy Analysis using 
semi-structured 
interviews 
Chapter 7 
Paper 5 
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2.1  Introduction  
This chapter presents existing knowledge regarding quality improvement in diabetes 
care, establishing the evidence-base and context which subsequent studies in this thesis 
will build upon. The first section sets out the rationale behind the choice of diabetes as 
a model for quality improvement initiatives. Contributory factors include the burden of 
disease on the health system and the patient, and the demonstrable gap between the 
ideal standard of care and reality. The second section charts the emergence of the 
quality agenda in health care and the conceptual frameworks underlining quality 
improvement including the Chronic Care Model which conceptualises the components 
of optimal chronic illness care. The third section focuses on one of the proposed 
solutions to the „quality chasm‟; the reorganisation and reorientation of chronic illness 
care. A critical synthesis of the evidence documenting the impact of changes in the 
organisation and coordination of services on the quality of diabetes care is outlined. 
This body of literature is also used to explore the similarities and differences between 
various models of diabetes care and the types of improvement strategies they include. 
The final section of this chapter introduces the organisation and delivery of diabetes 
care in Ireland as well as summarising efforts of „local champions‟ to improve the 
quality of diabetes care within the health system. 
2.1.1 Diabetes as a Model for Quality Improvement 
Diabetes has become the chronic condition of choice for modelling health care reform 
(2). This chronic illness embodies many of challenges facing health systems today 
including increasing chronic disease prevalence and burgeoning healthcare costs. In 
addition people with diabetes are cared for by multiple health care professionals across 
several settings, presenting significant challenges in terms of the organisation and 
coordination of services within the system. This costly illness highlights the need for 
health systems to reorganise healthcare from acute reactionary services to systematic 
planned diabetes management.  
2.1.2 Burden of Diabetes on Health and the Health System 
The World Health Organisation (WHO) estimated an increase in the worldwide 
prevalence of diabetes from 2.8% in 2000 to 4.4% by 2030 which equates to an increase 
from 171 million people to 366 million people in thirty years (4). A study of prevalence 
estimates from 27 EU countries projected an increase in population prevalence from 
7.5% in 2003 to 8.6% of the population by 2008 (38). This European estimation is 
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slightly higher than prevalence estimates in Ireland. The Institute of Public Health 
(IPH) estimated that 4.7% of the population had diabetes in 2005 (140,000 adults) with 
an expected increase to 5.6% of the population by 2015 (190,000 adults) (39). The 
figures were based on the most realistic forecast whereby obesity increases in a linear 
fashion. However the figures are likely to underestimate the true prevalence of diabetes 
as the proportion of undiagnosed cases was not determined due to inadequate primary 
care data. The Diabetes Federation of Ireland (DFI) suggests that almost half as many 
people may have undiagnosed diabetes as are currently diagnosed (40). 
2.1.1.1. Diabetes-Morbidity and Mortality 
Diabetes Mellitus is a group of chronic metabolic disorders characterised by 
hyperglycaemia as a result of defects in insulin secretion, insulin action or both (41). 
The main categories of diabetes are Type 1 diabetes and Type 2 diabetes. Type 1 
diabetes is attributable to the destruction of insulin secreting cells in the pancreas 
leading to absolute insulin deficiency. Type 2 diabetes is characterised by defective 
insulin secretion and contributing insulin resistance. Type 2 diabetes typically has a 
more gradual onset and people often present with evidence of complications at the time 
of diagnosis (42). Unlike people with Type 1 diabetes, initially people with Type 2 
diabetes do not require insulin therapy to survive but may require insulin into the 
future. There are „other specific types‟ of diabetes including gestational diabetes and 
diabetes due to genetic defects. Pre-diabetes has also emerged as a potential future 
health concern. This umbrella term for Impaired Fasting Glucose (IFG) and Impaired 
Glucose Tolerance (IGT) represents intermediate stages of elevated glucose levels 
between normal glucose regulation and diabetes. People with pre-diabetes are at 
increased risk of developing Type 2 diabetes and are vulnerable to developing 
complications associated with the disease (43). 
Diabetes is a significant source of morbidity and mortality due to the severe micro- and 
macrovascular complications associated with the illness. Microvascular complications 
include diabetic kidney disease (nephropathy), diabetic eye disease (retinopathy) and 
diabetic nerve disease (neuropathy). Up to 50% of people with diabetes develop nerve 
damage leading to foot ulcers and in severe cases, limb amputation (44). Diabetes is one 
of the leading causes of blindness among adults aged 20-74 years (45). Furthermore 
diabetes has become the most common cause of end-stage renal disease. The WHO 
estimate that between 10 and 20% of people with diabetes die of kidney failure (44). 
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Macrovascular complications include cerebrovascular disease, ischaemic heart disease 
and peripheral heart disease. Cardiovascular disease is the leading cause of death among 
people with Type 2 diabetes (46). It is difficult to assess the true burden of diabetes 
mortality from death certificates as people with diabetes typically die of cardiovascular 
disease or renal disease rather than causes uniquely related to diabetes (47, 48). Taking 
into account deaths in which diabetes was a contributory condition, a study in 2000 
attributed 5.2% of all cause mortality to diabetes worldwide. This estimate represents an 
excess global mortality of 2.9 million deaths due to diabetes (3). The risk of mortality is 
at least double among people with diabetes compared to those without diabetes (44).  
2.1.1.2. Cost of Diabetes Care 
The management of diabetes and treatment of complications places a significant 
financial burden on the health system. Global health expenditure on diabetes was 
projected to cost at least 376 billion US Dollars in 2010 rising to 490 billion USD by 
2030 (49). The CODE-2 study (Cost of Diabetes in Europe – Type 2), which assessed 
the cost of managing Type 2 diabetes in eight European countries, estimated a total 
direct medical cost of €29 billion a year (1999 values), an average of €2834 per person 
per year (50). The cost of care was largely attributable to the management of 
complications as the total cost of managing patients with both microvascular and 
macrovascular complications increased by up to 250% compared to those without 
complications (51). A more recent cost analysis conducted in Scotland, examined the in-
patient cost of Type 1 and Type 2 diabetes separately. The estimated total annual cost 
of admissions for people with Type 1 diabetes was £26 million while the cost of 
admissions for Type 2 diabetes was £275 million. This equated to 12% of the total 
inpatient expenditure in the country (5). In Ireland the most recent study of the cost of 
diabetes, based on data from 1999/2000, estimated that €580million was spent on Type 
2 diabetes care (52). A substantial proportion of the cost of was attributable to 
hospitalisations as over half the sample had developed complications. The cost of 
treating patients with both micro- and macrovascular complications was 3.8 times the 
cost of treating those without complications (53). This study did not take into account 
the indirect economic cost of diabetes due to loss of productivity and workdays. In 
addition, a growing number of people with Type 2 diabetes are being cared for outside 
the hospital setting however there are no studies to date on the cost of managing 
diabetes in primary care.  
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2.1.3 Diabetes Care & the Quality Chasm 
Another factor which has contributed to the choice of diabetes as a model for reform is 
the broad consensus on what constitutes good quality diabetes care (2, 54). A 
substantial body of research has demonstrated the effectiveness of treatments and 
therapies in managing diabetes and slowing the progression of complications (42, 55-59) 
which have informed both national and international guidelines on optimal 
management (17, 60-62). Despite this progress, a measurable gap has been highlighted 
between the ideal standard of care set out in guidelines and the reality of everyday care 
received by patients with diabetes (6, 8, 63, 64).  
The quality of diabetes care emerged as an international concern in the late 1980s. In 
1989 health departments from across Europe including Ireland signed the St Vincent 
Declaration, a set of standards and goals to improve diabetes care (65). The onus was 
placed on individual governments to develop strategies to meet the agreed targets. Over 
the next two decades a number of countries developed coordinated national 
programmes for diabetes management. In the UK for example, a National Service 
Framework for Diabetes was established to improve the care and health of people with 
diabetes in 1999 (66). Each country in the UK has a separate service framework with 
established minimum standards of care in each region and an implementation strategy, 
the progress of which is monitored and ongoing (67).  
The gap in the quality of health care is not unique to diabetes. It has been described as 
“one of the most consistent findings in health services research” (p57) (68). Concerns about the 
quality of health care led the Institute of Medicine (IOM) to coin the term „quality 
chasm‟ to describe system deficiencies in the U.S (10). Among the contributory factors 
identified by the IOM, was the inability of health systems, which were traditionally 
orientated towards acute episodic care, to meet the changing needs of patients with 
chronic illnesses. This orientation towards acute care permeated the whole system 
including the primary care setting, leaving little scope for planned, proactive care (69). 
Another related factor was the poor organisation and lack of coordination within health 
systems to deliver multidisciplinary integrated care necessary to manage complex 
chronic conditions. Over the past decade, the American concept of a „quality chasm‟ 
has become a worldwide concern and health system redesign has been proposed as a 
solution. The following section outlines the emergence of a quality agenda in healthcare 
and the influence of industrial style principles on quality improvement. 
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2.1.4 The Quality Agenda in Healthcare 
In 1996 articles in the New England Journal of Medicine heralded the „comeback‟ of 
quality of care (70). In 2011 the concept has established itself as a key consideration for 
health care professionals and health system management. According to Blumenthal the 
emergence of a quality agenda in health care was the result of a number of factors(71). 
Firstly the increasing complexity of conditions requiring input from multiple disciplines 
and specialties, demand greater coordination at a health system level. Secondly 
healthcare became a sector of the economy and therefore is open to the logic and 
demands of the free-market, competition and customer service. Thirdly quality 
improvement has become a field of inquiry in itself, driving the quality agenda with 
advances in knowledge dissemination and research methods. Sciences such as clinical 
epidemiology and health services research have highlighted how variation in practice 
can be a learning opportunity and several advances have been made in the measurement 
of outcomes including patient experience. Finally one of the most common drivers 
behind quality improvement is the need to contain healthcare costs, a driver that often 
causes scepticism towards quality improvement among health care professionals (71). 
2.1.5 Defining Quality in Health Care 
The term „quality‟ is scattered throughout research articles and policy documents on 
organising and delivering healthcare. Its omnipresence often implies that the concept is 
well defined, however the definition of quality in health care depends on the perspective 
of the definer (71-74). One of the original writers on this topic, Avedis Donabedian, 
accepted that “several formulations are possible and legitimate depending on where we are located in 
the system of care and on what the nature and extent of our responsibilities are” (75). A number of 
definitions centre on delineating the individual components of quality, reflecting its 
complex and multidimensional nature (73). Donabedian proposed seven pillars of 
quality emphasising the need for balance between dimensions (76): 
 Efficacy - the ability of care to improve health.  
 Effectiveness - the degree to which attainable health improvements are realised 
through care received. 
 Efficiency- ability to obtain improvements at the lowest possible cost 
 Optimality- most advantageous balance of costs and benefits 
 Acceptability- meeting patients preferences in terms of cost, access, effects of 
care and relationship with health care providers 
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 Legitimacy- meeting social expectations and norms within society 
 Equity – fairness in the distribution of health care and its effects. 
The seven dimensions suggest quality is a judgment based on science (efficacy and 
effectiveness) but also individual preferences and expectations (acceptability) and social 
values and norms (legitimacy) (76). Campbell et al (2000) propose two all-encompassing 
dimensions of quality in health care: access and effectiveness (73). All individual 
dimensions fall under this dichotomy. The authors do however make a distinction 
between quality of care at an individual level and quality of care at a population level. At 
an individual level quality is defined according to whether individuals can access the care 
they need and whether that care is effective when they receive it. At a population level 
quality is defined according to whether populations can access effective care on an 
efficient and equitable basis. The distinction highlights the importance of considering 
the opportunity costs of health care as improving care for the whole population may 
conflict with care for individuals, particularly in systems with limited resources. Again 
the definition of improvement depends on balancing dimensions of quality. 
There are two activities inherent in efforts to achieving quality; quality improvement 
and quality assurance. The terms are used interchangeable as they form part of the 
continuous quality cycle of identifying areas in need of attention, establishing the criteria 
for quality, assessing quality and implementing change (34). Quality improvement has 
been defined as “combined and unceasing efforts by all involved (healthcare professionals, patients 
and their families, researchers, planners and policy makers) to make changes that will lead to better 
patient outcomes, better system performance and better professional development” (35). This 
definition captures the proactive nature of quality improvement. However efforts to 
implement improvement originally began as passive diffusion of publications to health 
care professionals, moving on to the dissemination of guidelines and systematic reviews 
to inform care (77). It was the influence of industrial style change on healthcare which 
introduced the more active inclusive approach to quality improvement promoted today. 
2.1.6 Quality Frameworks: from industry to healthcare models 
Since the 1980s there has been a greater emphasis on continuous monitoring and 
improvement across the whole health system, reflective of the principles of Total 
Quality Management (TQM) (78). TQM is a systematic approach to quality 
improvement in which poor performance is the responsibility of the organisation and 
not the individual. This approach, also known as Continuous Quality Improvement 
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(CQI), focuses on improving quality at every level of an organisation thereby creating an 
organisational culture in which people take responsibility for and commit to improving 
quality (78). 
The principles of TQM originated in the manufacturing and services industry (34) 
stemming from the work of two „quality gurus‟, Deming and Juran (79). Both experts 
developed their quality control techniques and theories working with manufacturers and 
corporations in post World War 2 Japan which was struggling to produce high quality 
goods and services (80). The key message conveyed to senior executives was that 
improving quality reduced waste and inefficiency, and ultimately saved money. Deming 
emphasised the need for commitment to quality across the entire organisation, a 
principle reflected in Total Quality Management. One of his most popular techniques 
was the systematic approach to problem solving known as the Plan, Do, Study, Action 
cycle (PDSA) which has transferred to quality improvement innovations in other 
settings including health care (81). Juran emphasised the need to plan improvement as 
part of a trilogy of management processes which also included quality control and 
quality improvement. He recognised the contribution of people to this process, 
promoting education and training for managers who should assume responsibility for 
quality (80). There is ongoing debate as to whether frameworks from industry, such as 
Total Quality Management, are applicable to healthcare delivery (79) and there are few 
rigorous evaluations of this approach in healthcare (82). However mistakes, inefficiency 
and poor performance are costly in all organisations including health systems, and a 
number of the principles from this framework are applicable to quality improvement in 
health care including leadership and commitment to quality (78). 
The phase of quality improvement which followed the industrial style approach was a 
response to the perceived shortcomings of Total Quality Management. System 
reengineering proposed more radical change in contrast to the incremental approach 
promoted by TQM (83). Current thinking emphasises the merits of both approaches: 
continuous gradual improvement with lateral leadership to produce organisation-wide 
change (83). This phase is known as system redesign or transformational change. One 
framework from healthcare which combines transformational change with an emphasis 
on multi-level involvement is the Chronic Care Model. It is one of the few conceptual 
frameworks developed specifically to guide change in chronic illness care. 
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2.1.7 Chronic Care Model: Framework for Improvement in Healthcare 
Like TQM, the Chronic Care Model (CCM) focuses on the organisational context of 
chronic illness care while also adopting a system-wide perspective of quality. This 
framework proposes profound changes to the organisation and delivery of health care 
(84). The Chronic Care Model, developed in the United States during the 1990s, is not 
an abstract theory but rather “like an evidence-based guideline: a synthesis of system changes to be 
used to guide quality improvement” (p76) (81). 
The model outlines the components necessary for high quality chronic disease 
management. Firstly there are three overlapping spheres in which chronic illness care 
takes place; the practice is embedded in a health system which is embedded within a 
wider community of resources and policies. There are 6 „pillars‟ of effective chronic 
illness care; community resources and policies, health care organisation, self-
management support, delivery system design, decision support and clinical information 
systems (69). Community resources include policies and negotiated relationships or 
links with other care providers to enhance the continuity of care (81). Health system 
organisation relates to the structure, values and goals of a system including the 
promotion and prioritisation of chronic care and payment structures to support service 
delivery. The remaining four components, self management support, delivery system 
design, decision support and clinical information systems, exist within the practice 
setting (69). Figure 2, which illustrates the Chronic Care Model, has been supplemented 
with examples of interventions in each area. The ultimate goal according to this model 
is a „productive interaction‟ between an informed active patient and a prepared 
proactive primary care team with the relevant expertise, information and resources to 
assist patients (69, 81). Each element in the model is interdependent. The prepared 
proactive care team organise and coordinate patient care facilitated by delivery system 
design and clinical information systems. Equally these components in the practice could 
not be sustained without leadership and financing within the health system (69). 
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Figure 2 The Chronic Care Model with examples of interventions in each area 
The CCM has yet to be implemented in its entirety. Intervention studies tend to 
concentrate on the 4 elements within the practice, which are more amenable to change 
by health care professionals than community resources for example (84). Consequently 
the health care system and community resource components have received less 
empirical attention and their impact on the quality of care has yet to be tested. 
Since the 1990s research on the model has progressed from case studies (84) to a meta-
analysis of interventions implementing components of the CCM across numerous 
chronic illnesses (85), strengthening its claim as an „evidence based‟ model. The model 
is also widely used at a national level in the US by collaborative programmes involving 
health plans and provider organisations seeking to improve the quality of care (81, 84). 
At an international level, the Chronic Care Model is recognised as a framework for 
quality improvement in chronic illness care and as such has informed the health care 
policies and directives of several countries such as Germany (86) and Canada as well as 
developing countries (87). The national Framework for Chronic Disease Management 
in Ireland also refers to the Chronic Care Model as a guide to quality improvement (11). 
As one of the most widely applied frameworks in the field of quality improvement 
research, the effectiveness of CCM-based interventions will be addressed within a wider 
review of quality improvement interventions outlined in the following section. 
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2.1.8 Improving the Quality of Diabetes Care 
Since the term quality chasm emerged in 2001 there has been a steady stream of 
interventions seeking to reorganise chronic illness care as a means of quality 
improvement, a number of which have focused on diabetes care. This section presents a 
critical synthesis of the evidence examining whether changes in the organisation and 
coordination of care improves the quality of diabetes care. Particular attention was paid 
to the type of strategies included as part of quality improvement interventions. Given 
the proliferation of articles on this topic the synthesis of the literature focused on 
systematic reviews and recent trials examining: 
1) Changes within the practice setting including organisational and professional 
interventions. 
2) Changes to enhance the coordination of care between providers and settings. 
Interventions were categorised as changes to the organisation care, the coordination 
care or a mixture of both approaches (Table 1). This classification was informed by 
previous taxonomies of organisational change (15, 88), including the classification used 
by Renders et al in their seminal review of interventions in primary care, community 
and out-patient settings (14). 
Table 1 Changes to organisation & coordination of care to improve quality 
TYPE  DEFINITION 
Organisational/Professional interventions within the practice 
Knowledge 
management  
Organisation of knowledge within a setting including use of information and 
communication technology, electronic medical records, electronic patient 
registers. 
Professional 
interventions 
Education, clinician reminders, audit & feedback 
Quality 
management 
Continuous efforts to improve, measure and analyse performance including 
explicit CQI interventions also referred to as TQM.  
Coordination between providers & settings 
Team Changes  Changes to structure and organisation of care team including; adding a team 
member or “shared care” e.g. routine visits by professionals other than 
physician (e.g. Diabetes Nurse Specialist);Use of multidisciplinary teams; 
Revision of professional roles (e.g. increasing role of the nurse). 
Mixed organisation & coordination 
Integrated care 
programme  
Organisational process of coordination to achieve continuous care for 
patients with specific diseases including organisational and/or professional 
interventions. This encompasses chronic disease management programmes 
and case management which overlap.  
The classification and definition of improvement strategies was based on the taxonomies developed by Wensing et 
al (88), Shojania et al (15) and Renders et al (14), which define organisational, professional and coordination 
strategies and were originally informed by the list of interventions used by the Cochrane Effective Practice and 
Organisation of Care (EPOC) group. 
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Search Methodology 
The review was restricted to evaluating structural, organisational and professional-level 
interventions which targeted the setting and/or provider of care rather than the patient. 
Only articles which focused on diabetes or diabetes as one of a number of chronic 
conditions were included. Articles were identified by electronic searches of MEDLINE, 
EMBASE, Cochrane Database of Systematic Reviews and the Clinical Trials Register, 
CINAHL and ERIC. Review articles were restricted to English-language publications 
issued between January 2000 and July 2011. A supplementary search was conducted for 
individual studies published since the most recent systematic review (2008-2011). 
Combinations of the following search terms were used: “diabetes”, “chronic disease”, 
“quality of health care”, “quality assurance”, “delivery of health care” and “disease 
management”. Reference lists of relevant studies were reviewed to identify further 
articles (Appendix II for outline of review methods). 
Description of Studies 
Initially the literature search yielded 1948 potential articles across five databases. Of 
these 139 were selected based on the title and abstract. A total of 28 articles met the 
inclusion criteria (see Appendix II). Of the 28 studies 17 were systematic reviews (Table 
2) and 11 were individual trials published since 2008 (Table 3). The results of the 
systematic reviews will be outlined first followed by recent evidence from randomised 
trials of quality improvement interventions.  
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Table 2 Overview of systematic reviews of interventions to improve the organisation or coordination of diabetes care 
STUDY FOCUS AIM 
Organisational changes within the practice (organisational/professional) 
Gulburg et al 
(2009)(89) 
Feedback Assess the effect of feedback to GPs on the quality of care for patients with Type 2 diabetes 
Dorr et al (2007) (90) Information Systems To examine the function of health care information systems in chronic illness care and improvements in processes and 
outcomes attributable to such systems. 
 
Coordination changes between providers & settings 
Loveman et al (2003) 
(91) 
Specialist Nurses To assess the impact of diabetes specialist nurses/nurse case manager in diabetes on metabolic control of patients with 
Type 1 or Type 2 diabetes. 
Smith et al (2007) (92) Shared Care To examine the effectiveness of shared care interventions designed to improve the management of chronic diseases 
van Bruggen et al 
(2007) (93) 
Shared care To examine the impact of sharing care and allocating care tasks on the quality in diabetes care and cardiovascular risk 
among patients with diabetes.  
 
Mixed organisational & coordination strategies 
Ouwens et al (2005) Integrated care  To investigate the effectiveness, definitions & components of integrated care programmes for  chronic illness 
Bodenheimer et al 
(2002) (69)  
Chronic Care Model To examine the extent to which interventions based on the Chronic Care Model improves the management of chronic 
illness using diabetes as an example. 
Norris et al (2002) (94) Disease Management To determine the effectiveness & economic efficiency of disease and case management for people with diabetes.  
Weingarten et al 
(2002) (16) 
Disease Management To assess the effectiveness of disease management programmes for peoples with chronic illness (meta-analysis). 
Knight et al (2005)(95) Disease Management To evaluate the impact of disease management for patients with diabetes on processes and outcomes of care. 
Krause (2005) (96) Disease Management To examine the economic effectiveness of disease management programmes for patients with chronic illnesses 
Tsai et al (2005) (85) Chronic Care Model To examine whether interventions incorporating elements of the Chronic Care Model improve care and outcomes for 
patients with chronic illness and determine which elements are essential for improvement.  
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STUDY FOCUS AIM 
Scott (2008) (97) Chronic Disease 
Management 
To provide an overview of the evidence for chronic disease management including; the effectiveness , the most 
successful elements and economic efficiency of such programmes.  
Glazier et al (2006) 
(98) 
Patient, provider & 
health system 
intervention 
To review evidence on the effectiveness of patient, provider and health system interventions to improve diabetes care 
among socially disadvantaged populations 
Renders et al (2000) 
(14) 
Organisational & 
Professional 
intervention 
To assess the impact of interventions targeting health care professionals or the structure of care for patients with 
diabetes in primary care, outpatient and community settings.  
Seitz et al (2011) Interventions in 
primary care  
To assess the impact of interventions in primary care on cardiovascular risk factors and HbA1c levels in patients with 
diabetes. Interventions included organisational and professional interventions. 
Shojania et al (2006) 
(15) 
Quality 
Improvement 
strategies 
To assess the impact of 11 improvement strategies for Type 2 diabetes on glycaemic control (meta-analysis) 
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2.1.9 Reviews of organisational changes within the practice 
Two systematic reviews concentrated solely on organisational changes within the 
practice setting (89, 90). The first review examined the effect of providing feedback to 
GPs on the quality of diabetes care. There was a positive impact on processes of care 
including foot exams, eye exams and HbA1c measurement however the impact on 
patient outcomes was less definitive. There were significant positive changes in HbA1c, 
blood pressure and cholesterol levels however such indicators were less frequently 
measured. Only one of ten studies included in the review examined long-term outcomes 
including complication rates and mortality, however no significant difference was 
detected (89). 
The focus of the second review was less well defined, examining the impact of 
information systems on the quality of care across a number of chronic diseases 
including diabetes. Although a wide range of study types were included, the evaluation 
of effectiveness was based on evidence from experimental studies due to a publication 
bias detected in non-experimental studies. Overall information systems had a positive 
impact on guideline adherence and documentation of care but an inconsistent effect on 
referral rates and visit frequency across all chronic diseases. Clinical outcomes were not 
broken-down by type of disease and were categorised as laboratory values and 
standardized instruments. There was no consistent evidence of a positive effect. The 
review also examined the impact of information systems across a number of different 
health care settings (out-patients, primary care, hospitals etc) but again did not separate 
the impact on processes and outcomes in terms of setting (90). Hence it is difficult to 
draw any definitive conclusions regarding the impact of information systems on 
diabetes care in primary care from such an all-encompassing evaluation.  
2.1.10 Reviews of changes to the coordination of care 
Three reviews examined interventions involving team changes (91, 93, 99). Loveman 
and colleagues investigated the role of the diabetes specialist nurse in improving care 
(91). Four of the six trials dealt with adult patients however only one of these studies 
found a significant short-term benefit in terms of HbA1c. The review used a limited 
number of indicators to evaluate the effectiveness of the diabetes nurse specialist role. 
Notably absent from the battery of indicators were process of care measures and 
intermediate outcome measures such as blood pressure and cholesterol levels. However 
unlike other reviews, this study examined the impact of team changes on long-term 
28 
 
outcomes although there was no evidence of a significant effect. There were 
inconsistent findings in relation to the occurrence of short-term complications 
(hypoglycaemic and hyperglycaemic episodes). Few studies in the review evaluated the 
impact of the nurse specialist role on quality of life, BMI or mortality.  
A systematic review of shared care interventions for chronic disease management found 
little consistent improvement in most outcomes assessed (99). Although „shared care‟ 
falls under the category of team changes according to Shojania et al (15), the 
interventions included in this study also involved organisational and professional 
strategies (e.g. clinical protocols, continuing education, audit and feedback) blurring the 
distinction between types of quality improvement strategies. Three of twenty studies in 
the review focused on shared care for patients with diabetes and similar to the overall 
findings there was inconsistent improvements on processes of care, no significant 
improvements in physical health outcomes and inconsistent findings for psychosocial 
outcomes. The final article, a review of reviews, which focused specifically on shared 
care and task delegation for diabetes care, found a positive improvement in terms of 
processes of care where this indicator was used (93). A number of reviews of delegated 
care and/or shared care interventions demonstrated a positive impact on HbA1c. There 
was insufficient evidence of the impact on the cardiovascular of patients with Type 1 or 
Type 2 diabetes. Given the quality of this review and the level of detail provided, a 
number of the systematic reviews included in the article are dealt with separately in this 
synthesis to unpick the findings in more detail (14, 91, 94, 95). 
2.1.11 Reviews combining organisation and coordination strategies 
Most reviews synthesized evidence on the effectiveness of multifaceted interventions to 
improve both the organisation and coordination of care. Five articles focused explicitly 
disease management programmes for chronic illnesses including diabetes (16, 94, 95) 
one of which examined the cost effectiveness of such programmes (96). Two reviews 
examined the effectiveness of interventions based on the Chronic Care Model (69, 85). 
Multifaceted quality improvement interventions 
One of the earliest reviews by Renders et al (2000) looked at the impact of professional 
and organisational interventions on diabetes care in primary care, outpatient and 
community settings (14). Of the 41 studies identified, 20 studies combined both 
professional and organisation change strategies. Patient education was added to 
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professional and organisational interventions in 15 studies. Professional interventions 
had a positive impact on process measures as did organisational interventions which 
facilitated the structured follow-up of patients. A similar trend emerged from 
interventions combining professional and organisational strategies. Computerised 
reminders and/or audit and feedback had a positive effect on processes of care however 
the impact on patient outcomes was rarely assessed. Similarly centrally organised 
systems for tracking patients and arranging follow-up were beneficial in terms of 
process but not outcomes. Generally those studies which reported a positive impact on 
patient outcomes tended to have greater involvement from a nurse and/or included 
patient education.  
In an effort to distinguish between the impact of various strategies Shojania et al (2006) 
assessed the impact of 11 QI strategies on glycaemic control in patients with Type 2 
diabetes using meta-analysis techniques (15). Across all 66 trials there was a mean 
reduction of 0.4% in HbA1c levels (95% CI 0.29-0.54%). However after adjustment for 
relevant confounders only two strategies were associated with incremental reductions in 
HbA1c: team changes (0.33%) and case management (0.22%). In particular, 
interventions in which nurse or pharmacist case managers could adjust medication 
without awaiting physician approval showed significant reductions in HbA1c levels.  
A review conducted by Seitz et al (2011) expanded the research question investigated by 
Shojania et al to examine the impact of quality improvement on cardiovascular risk 
factors as well as glycaemic control (100). A similar taxonomy of interventions was used 
to classify studies: professional, organisational, patient-centred, financial and regulatory 
(100). Less than half the studies evaluating single professional interventions (e.g. 
professional education) found significant improvements in HbA1c or any of the 
cardiovascular risk outcomes. Processes of care such as foot exams improved but there 
was no significant impact on recording of blood pressure, HbA1c or the assessment of 
complications. Only two studies examined single organisational interventions, (e.g. 
shared care, case management) with no significant impact on HbA1c detected. There 
was no reference to the measurement of cardiovascular risk outcomes in either study. 
Most studies included in the review were categorised as combined interventions with 
mixed results. A number of multidimensional studies found improvements in clinical 
outcomes such as HbA1c levels, cholesterol and blood pressure levels however no 
improvement emerged consistently from the body of literature.  
30 
 
The effectiveness of multidimensional interventions rather than single strategies was 
highlighted by Glazier et al in a review of interventions in socially disadvantaged areas 
(98). Only one intervention targeted the “provider-level” which seemed to involve 
educational reminders to enhance processes of care. Seven studies focused on system-
level changes which ranged from nurse-led case management to treatment algorithms. 
Interventions involving system-level changes demonstrated a positive impact on 
HbA1c, lipid concentrations and blood pressure in disadvantaged populations. Changes 
in processes of care were less well defined in the review beyond highlighting that eye 
examinations improved in two system-level studies.  
Finally a review by Ouwens et al examined the effectiveness of integrated care 
programmes explicitly, defined as an organisational process of coordination with the 
aim of achieving continuous care (101). Integrated care interventions consisted of 
patient (e.g. education), professional (e.g. education), organisational (case management) 
and coordination strategies (e.g. multidisciplinary teams). There was a positive impact 
on processes of care for patients with diabetes however there was no significant impact 
on outcomes. Two of the thirteen reviews included in the article pertained to diabetes, 
both of which are dealt with separately in this section (14, 94). 
Disease Management Programmes 
Five reviews examined interventions described as disease management programmes (16, 
94-97). A meta-analysis of the effectiveness of chronic disease management suggested 
that programmes targeting provider behaviour were associated with improvements in 
terms of provider adherence to guidelines (process measure) and disease control 
(outcome measure) across a number of chronic conditions. The provider interventions 
examined were restricted to education, feedback and reminders (16). However, the 
impact of diabetes-specific programmes on the quality of care was variable (26/102 
studies). None of the studies involving provider feedback led to a statistically significant 
impact on diabetes process (fundoscopy performed, retinal screening, renal screening, 
foot exam and HbA1c testing) or outcome measures (HbA1c). A number of studies 
involving provider education and provider reminders conferred a significant benefit in 
terms of HbA1c and provider adherence. 
Another broad review of chronic disease management programmes highlighted the lack 
of consistent evidence to single out one crucial element of such interventions (97). 
Focusing on the 7 diabetes-specific reviews included in the study, there was no evidence 
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of a significant reduction in mortality, hospitalisation or cardiovascular events. There 
were significant improvements in intermediate outcomes such as disease control 
(HbA1c), blood pressure control, screening processes and patient self-care. A number 
of the reviews included in the article are discussed individually given the lack of 
diabetes-specific information in the article (14-16, 85, 91). Cost savings from chronic 
disease management were evident in the small number of studies which included this 
indicator however this finding pertained to only one diabetes-specific study.  
A review which focused solely on the economic effectiveness of chronic disease 
management programmes included 11 articles on diabetes out of a total of 67 (96). Very 
little detail was given on the type of interventions included beyond classifying strategies 
as team management, nurse management or patient management interventions. Overall 
the results demonstrated that chronic disease management programmes were cost 
effective with statistically significant average effect size of 0.3 (95% CI=0.27-0.35). 
Disease type did not have a significant influence on effect size however the type of 
disease management programme (team, nurse, and patient) did have a significant impact 
on economic effectiveness. 
Looking specifically at chronic disease management for diabetes, a systematic review of 
disease management and case management for people with Type 1 or Type 2 diabetes 
demonstrated a positive impact on the processes of care (monitoring glycaemic control 
and retinal screening) and metabolic control (94). Other outcomes were not typically 
assessed. A similar pattern was evident for case management interventions which also 
had a positive impact on glycaemic control. When case management was combined with 
disease management it also had a positive impact on the monitoring of glycaemic 
control. However there were too few studies to accurately assess the impact of disease 
or case management on a number of outcomes including lipid concentrations, BMI and 
psychosocial indicators.  
A similar positive impact on glycaemic control was found by another review of chronic 
disease management programmes for diabetes conducted in 2005 (95). There were 
consistent improvements in retinopathy screening however inconsistent evidence of 
improvements in terms of foot examination, HbA1c measurement and referral to 
podiatry. There was no consistent impact on other outcomes including cholesterol 
concentration levels, blood pressure levels and the monitoring of glycaemic control. 
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Reviews of the Chronic Care Model 
Two reviews examined the impact of components of the Chronic Care Model (CCM) 
on the quality of chronic illness care. One article looked broadly at the impact of the 
CCM elements on the quality of chronic illness care by choosing a disease-specific 
clinical outcome (HbA1c), quality of life measure (unspecified) and process of care 
measure (number tested for HbA1c level) to evaluate the studies (85). Of 112 studies 
identified 31 related to diabetes care. Looking at the pooled estimates for diabetes 
specifically, 25 studies contributing continuous data on HbA1c found a pooled effect of 
-0.19 in favour of the intervention (CI 95% = -0.29, -.10). There was no significant 
impact on quality of life detected. Nine studies examined the number of times HbA1c 
was measured (1.10; 95% CI= 1.01, 1.19). While no single element of the CCM was 
sufficient to improve outcomes, a number of components were associated with better 
outcomes and processes overall. Delivery system design and self-management elements 
conferred a statistically significant benefit on continuous clinical outcomes and 
processes. However in both cases there were a greater number of studies included and 
larger estimated effects. There was no statistically significant impact from interventions 
involving clinical information studies however only a small number of studies were 
included.  
The other review of elements of the Chronic Care Model focused on diabetes 
specifically (69). Thirty-nine studies addressed elements of the CCM which incorporated 
professional and organisational strategies such as reminder systems, performance 
feedback and planned follow-up as well as coordination strategies such as 
multidisciplinary care teams. Overall interventions demonstrated improvements in at 
least one process or outcome measure however the exact indicators to improve were 
not specified in the review. The majority of studies included in this article were based 
on those included in the Renders review (14) published the previous year suggesting an 
independent search strategy was not developed.  
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2.1.12 Individual studies of Quality Improvement Interventions 
Moving on to individual evaluations of quality improvement interventions, eleven trials 
met the inclusion criteria (Table 3). Five studies examined organisational changes within 
the practice setting (102-106). Three studies were classified as interventions involving 
changes to the coordination of care between providers (107-109). Finally three studies 
involved a combination of strategies to improve the organisation and coordination of 
diabetes care (110-112).  
Effectiveness of Organisational Changes 
Most of the studies evaluating organisational changes within the practice utilised IT and 
electronic communication systems to enhance the delivery of care. One RCT examined 
the impact of electronic decision support and reminders for providers and patients, 
based on information from a web-based diabetes tracker monitoring disease risk factors 
(104). There was a significant difference between the intervention and control group in 
terms of the composite score of process measures (mean difference= 1.27; 95% 
CI=0.79-1.75; p<0.001) and a significant difference in the composite score of clinical 
measures (mean difference=0.55; 95% CI=0.04-1.07; p=0.036). There was no evidence 
of an effect on patients‟ quality of life.  
In contrast another study of decision support found no significant improvements in 
clinical outcomes (HbA1c, BMI, BP, Cholesterol) although processes of care improved 
(113). The intervention group were more likely to received guideline appropriate care 
for testing lipids (OR=1.39, p=0.01) and creatinine (OR=0.40, p=0.02) but not HbA1c 
testing (OR=1.17, p=0.43). The intervention, known as the Vermont Diabetes 
Information System, also involved other improvement strategies including the 
implementation of an electronic patient registry and audit and feedback for physicians. 
The multifaceted nature of the intervention means it is not possible to isolate or directly 
compare the effect of decision support in this study relative to the previous findings.  
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Table 3 Overview of individual trials investigating the impact of quality improvement interventions on diabetes care (published 2008-2011). 
STUDY FOCUS AIM 
Organisational changes within the practice (organisational/professional) 
Holbrook et al 
(2009) (104) 
Electronic decision 
support & reminders 
To evaluate whether shared electron decision support (between doctor and patient) with reminders improves the 
quality of diabetes care in the community. 
MacLean et al (2009) 
(105) 
 Information System To evaluate the impact of registry and decision support on the quality of diabetes care 
O‟Connor et al 
(2009) (102) 
Physician Education To assess physician learning interventions designed to improve the quality and safety of care 
Gulberg et al 
(2011)(103) 
Feedback To evaluate the effectiveness of providing electronic feedback on treatment status for patients with Type 2 diabetes to 
general practitioners 
Goderis et al (2010) 
(106) 
GP Support 
Programme 
To assess the effectiveness of a support programme for GPs including education and annual benchmarking on Type 2 
diabetes outcomes. 
Coordination changes between providers & settings 
Peikes et al 
(2009)(108) 
Coordination To determine the effectiveness of care coordination programmes on hospitalisations, cost and the quality of care for 
patients with chronic illnesses 
Simpson et al (2011) 
(107) 
Team Changes To evaluate the impact of adding pharmacists to primary care teams on blood pressure control in patients with Type 2 
diabetes 
Van Bruggen et al 
(2008) (109) 
Guidelines To evaluate the impact of a facilitator-enhanced intervention to implement local guidelines on shared care for Type 2 
diabetes. 
Mixed organisational & coordination strategies 
Chan et al (110) Structured care To assess the impact of structured care on renal complications in Type 2 diabetes compared to usual care 
Peterson (111) Organisational 
intervention 
To examine the impact of a multidimensional organisational intervention on diabetes processes and outcomes in 
primary care 
Cleveringa et al 
(2010) (112) 
Protocol To determine the effectiveness of a diabetes care protocol in terms of patient-important outcomes 
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O‟Connor et al examined the impact of simulated physician learning on care processes 
and clinical outcomes (HbA1c and LDL cholesterol) (102). The intervention involved 
simulated case management with electronic feedback to primary care physicians on their 
prescribing behaviour. The intervention was also combined with opinion leader 
feedback and compared to a control group and intervention-only arm. At 12 months 
both intervention groups showed significant improvements in risky prescribing 
behaviour (p=0.03) however there was no significant difference between groups in 
terms of LDL cholesterol testing (p=0.30) or LDL cholesterol levels (p=0.67). There 
was also no significant difference detected in the rate of treatment intensification for 
patients not reaching target (p=0.41). Patients whose physicians received simulated 
learning only had significantly better glycaemic control compared to the other 2 groups 
(p=0.04) hence there appeared to be no additional benefit from adding opinion leader 
feedback to the intervention. 
In a similar study, Gulberg et al (2011) examined the impact of real-time electronic 
patient feedback provided to GPs during their daily clinical work (103). The primary 
measure of effectiveness was patients‟ retrieval of prescriptions according to guidelines 
on diabetes treatment. More people in the intervention group redeemed prescriptions in 
accordance with guidelines for oral antidiabetic medicine (p=0.002), insulin (p<0.001), 
lipid-lowering medication (p=0.004) and blood pressure medication (p=0.03). There 
were no significant differences between the groups in terms of secondary clinical 
outcomes, HbA1c and cholesterol levels, at fifteen months follow-up.  
The final clustered RCT evaluating organisational changes in general practice compared 
a usual quality improvement programme to an „advanced‟ quality improvement 
programme in Belgium (106). There was no control group included in the trial. The 
usual quality improvement programme involved following an evidence-based protocol 
for monitoring patients, professional education, case coaching from an endocrinologist 
in the event of problems, annual benchmarking and feedback, and patient education. 
The „advanced‟ quality improvement intervention represented an intensification of these 
elements, e.g. intensified education, three monthly benchmarking and feedback, joint 
meetings with specialists, organised group education for patients and families. Both 
interventions demonstrated a significant improvement in HbA1c, LDL cholesterol and 
systolic blood pressure levels. However there were no statistically significant differences 
between the two interventions in terms of the three primary outcomes. Only physical 
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exercise and anti-platelet therapy were significantly higher in the advanced improvement 
group. Also addition elements of the advanced QI interventions were only used by a 
minority of participants. Hence the findings suggest intensified support for GPs and 
patients, beyond usual interventions to improve care in Belgium, were not fully utilised 
and did not have additional benefit in terms of improving patient outcomes. 
Interventions to improve the coordination of care  
Peikes et al (2009) examined the impact of care coordination plans on hospitalisations, 
Medicare expenditure and the quality of chronic illness care in the U.S (108). Care 
coordination plans included enhanced communication and case discussion and changes 
in medical records systems. Overall there was no significant reduction in 
hospitalisations and there were no net savings generated as a result of the intervention. 
One diabetes-specific study found a significant impact on hospitalisations and four 
studies found significant monthly cost savings for those in the intervention group. 
Additional quality of care measures measured using a patient survey (e.g. self 
management skills) improved as a result of the intervention. 
Another trial targeting care for patients with Type 2 diabetes looked at the impact of a 
facilitator-enhanced intervention to implement local shared care guidelines in general 
practice in the Netherlands (109). The visiting nurse-facilitator had a central role in 
improving care by providing training for GPs and practice staff in the use of guidelines, 
encouraging structured care and providing performance feedback. There were 
significant differences between the groups in terms of measurement of patient 
outcomes (p<0.001). A larger proportion of patients in the intervention group reached 
HbA1c targets compared to the control group however this was not significant after 
adjustment for relevant factors such as clustering (70% vs. 58%, p>0.05). There were 
also small but non-significant changes in other clinical outcomes (mean HbA1c, BP, 
BMI or treatment satisfaction).  
Simpson et al looked at the addition of pharmacists to the primary care team and the 
impact on blood pressure control of patients with Type 2 diabetes. As part of the 
intervention pharmacists performed medication assessments and limited history and 
physical exams as well as providing recommendations to optimise medication 
management based on guidelines. A significantly higher proportion of patients in the 
intervention group achieved a ≥10% decrease in systolic blood pressure compared to 
the control group (OR=1.9, 95% CI 1.1-3.3, p=0.02). Concentrating on those with 
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poorly controlled hypertension at baseline, those in the intervention group were more 
likely to achieve the target than patients in the control group (OR=2.6, CI 95% 1.3-5.0, 
p=0.007). 
Multifaceted interventions to improve diabetes care  
One of the few studies to use long-term outcome measures as its primary outcome was 
examined the effect of structured care on renal endpoints in patients with Type 2 
diabetes (110). Structured care which incorporated guideline driven care and 
multidisciplinary teams had no significant effect on the composite primary outcomes of 
end stage renal disease, dialysis and mortality. The composite end point of all three 
outcomes was equal in both groups (RR=0.96, 95% CI 0.50-1.84). A higher proportion 
of patients in the structured care group achieved ≥3 clinical targets compared to the 
control group (61% vs. 28%, p<0.01). Patients who achieved ≥3 clinical targets had a 
60% risk reduction in reaching the primary end point compared to those who did not 
achieve ≥3 targets (RR=0.43, 95% CI 0.21-0.86, p=0.04).  
The TRANSLATE Trial was conducted in 24 practices to investigate whether a 
multidimensional intervention would improve clinical outcomes and processes of care 
(111). The intervention, which was aimed at patients with Type 2 diabetes, incorporated 
an electronic diabetes registry, reminders, a coordinator to plan patient visits and 
monthly review meetings with a local champion. All practices showed significant 
improvements in process measures however there were significantly greater net 
improvements for the intervention group in foot examinations (p<0.001), annual eye 
exams (p<0.001), renal testing (p<0.001), HbA1c testing (p<0.001), blood pressure 
monitoring (p<0.05) and LDL testing (p<0.001). Only the intervention group showed 
significant improvements in clinical outcomes. Using a composite score of outcomes 
the intervention group had significantly greater net improvements in terms of targets 
for blood pressure, HbA1c and LDL cholesterol compared to the control group 
(p=0.002). 
Finally the Diabetes Care Protocol (DCP) trial focused on the impact of a 
multidimensional intervention on patient-important outcomes (112). The primary 
outcome was diabetes-related health status while secondary outcomes included 
measures of quality of life. The intervention combined task delegation to the practice 
nurse, computerised decision support system providing feedback and intensification of 
diabetes treatment. The results of this trial were inconsistent. The intervention was 
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deemed to be non-inferior to usual care in terms of diabetes related health status 
however comparison between the groups on secondary outcomes were inconclusive. 
Within group analysis showed a worsening of scores on some health profile and health 
status subscales for both the intervention and control group. 
2.1.13 Summary of the Evidence 
The preceding section synthesised evidence of the effectiveness of interventions to 
improve the organisation and coordination of diabetes care from systematic reviews and 
individual trials. As suggested by the Agency for Healthcare Research and Quality 
(AHRQ) everything seems to work for diabetes in some instances for some outcomes 
(8). Similar types of interventions can produce inconsistent results depending on the 
indicators chosen to evaluate improvement and the lines drawn between different types 
of strategies. For example a Cochrane review of shared care for chronic illness found no 
consistent benefit in terms of process or clinical outcomes (99). In contrast a diabetes-
specific review of shared care and task delegation found improvements in process 
measures and a number of studies demonstrated a positive impact on HbA1c (93). 
Interestingly there were different studies of shared care included in both reviews despite 
an overlap in their search timeline. It is important to note that while the Cochrane 
review only included three diabetes studies, the quality and rigour of literature search 
was higher.  
There are a number of ways of categorising quality improvement. As Norris and 
colleagues point out, case management can be implemented as part of a broader disease 
management programme, as a single intervention or in combination with other 
interventions (94). This is true of most strategies. The various lenses for viewing 
strategies are reflected in the substantial overlap between the studies included in 
different reviews. For example the review of professional and organisational 
interventions by Renders et al (14) was included in four other reviews (69, 93, 97, 101). 
Categorisation is even more challenging given the lack of detail provided in many 
articles (16, 69, 85, 96). Lack of descriptive detail can lead to problems identifying or 
recreating the necessary conditions for effectiveness (114). Guidelines have been 
proposed to enhance the writing, reviewing and interpretation of quality improvement 
research in the hope of bringing more structure and rigour to the field (115). 
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Indicators of Quality Improvement 
The results of this synthesis highlight the attention given to process measures over 
clinical and patient-reported outcomes beyond glycaemic control. Some researchers 
favour the use of process measures suggesting they are more sensitive as an error in care 
delivery does not always lead to a poor outcome (116). Processes are common, under 
the control of the health professional and can be changed more readily (73). Davies & 
Crombie suggest the while clinical outcomes have intuitive appeal they are influenced by 
several factors beyond the health care professionals control (117). 
While a number of articles found significant improvements in glycaemic control as a 
result of the intervention (16, 94, 95, 97) there was inconsistent evidence of an effect on 
cardiovascular risk factors such as blood pressure, cholesterol and BMI (94, 95, 100). 
Outcomes beyond glycaemic control are often neglected in evaluations of quality 
improvement interventions. Mortality among people with diabetes tends to be as a 
result of cardiovascular disease or renal disease rather than causes uniquely related to 
diabetes (47), and yet we continue to measure HbA1c while ignoring cardiovascular and 
other risk factors.  
The follow-up periods of the trials included here rarely extended beyond twelve 
months. The overemphasis on intermediate outcomes measured in the short-term may 
underestimate the true effect of QI interventions which has yet to be realised (118). 
Quality improvement interventions should include long-term outcomes in their battery 
of indicators such as cardiovascular events, visual impairment and mortality. Chan et al 
was one of the few researchers to assess change in long-term outcomes (110). The 
selection of quality indicators should be guided by theory, the objectives of the program 
or previous research (114). Most studies do not outline the mechanisms by which 
interventions are expected to change the quality of care hence there is often a 
nonexistent link between the components of an intervention and the indicators used to 
evaluate improvement (119, 120).  
Patient reported outcomes were also neglected in the studies within systematic reviews 
(14, 94, 98) and indeed by the reviews themselves, making it difficult to draw 
conclusions regarding effectiveness. For example Knight et al (2005) alluded to the 
assessment of patient-reported outcomes in their review of disease management 
programmes however they grouped health status, physical functioning and patient 
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satisfaction under the term quality of life (95). Multifaceted interventions generally 
incorporate a patient-focused component; therefore patient-important outcomes should 
be assessed. In their review of over 100 chronic disease management programmes 
Weingarten et al found that patient education was the most common interventions used 
in over 70% of programmes (16).  
Isolating the success factor 
One of the main challenges when evaluating complex multidimensional interventions is 
disentangling the impact of the various components to identify which are most 
effective. Ovretveit & Gustafson (2002) suggest the activities of quality improvement 
interventions “may be mutually reinforcing and have a synergistic effect” (114). This point is 
particularly relevant in the case of diabetes registries. The authors of the TRANSLATE 
trial stress the central role of the disease registry in supporting other improvement 
strategies such as enhancing the work flow through patient-specific provider alerts, 
decision support and facilitating monthly progress reviews (111).  
The confusion is multiplied when no significant improvements are detected by a study; 
are all similar interventions ineffective or did the problem lie with the design and 
methodology of the trial (121). In 2000 the Medical Research Council developed a 
framework to guide the design and implementation of complex interventions (122) and 
this has since been updated. The revised version recognises that the phases of 
development and implementation may not always be linear and while randomised 
controlled trials are the favoured design these are not always possible (123).  
Translating Research in Practice 
Questions have been raised about the external validity of RCTs in evaluating 
multidimensional quality improvement initiatives which require significant time and 
resources to run effectively in a research setting. Such interventions are less likely to 
translate to a real health care setting (124). One study of an advanced quality 
improvement programme found that additional more intensive elements of the 
intervention were only used by a minority of participants (106). Norris et al (2002) 
highlight that health care professionals who are selected by researchers or volunteer 
themselves to such interventions may be more committed to change and more adept at 
the processes involved (94). These are just some of the issues affecting the translation 
of quality improvement research into real world change. Understanding the context in 
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interventions succeed and fail is as important as determining the effectiveness of 
various QI strategies (18). 
2.1.14 Untangling Models of Diabetes Care 
The body of literature outlined above illuminates some of the distinctions and 
similarities between „models‟ of diabetes care. A model of care relates to the way 
diabetes management is arranged across settings and organised within a setting. Models 
of care exist in under several terms which are often ill-defined: „integrated care‟, shared 
care (Europe), „managed care‟ and chronic disease management programme (USA) and 
„structured care‟ (7). The literature on models of care is embedded within the wider field 
of quality improvement research as different multidimensional models target the 
practice, provider and setting to improve the quality of care. For this reason a number 
of the aforementioned studies will be reiterated here in an attempt to untangle the 
terminology around models of care.  
2.1.14.1 Shared Care 
Shared care was one of the first demonstrations of efforts to improve diabetes care 
delivery. The concept was a consequence of the shift from an acute response to chronic 
disease management to increased responsibility in primary care for the management of 
diabetes (125). The Netherlands has been a pioneer of the shared care approach with 
health care providers working together in regional networks under the term „transmural 
care‟ (126, 127). When introduced in the Maastrict region, shared care comprised of a 
change to the care setting and the health care provider. Care for patients with Type 2 
diabetes shifted from the outpatient clinic delivered by the endocrinologist to the 
general practice setting where care was provided by a nurse specialist. The 
endocrinologist continued to review patients annually while the GP was ultimately 
responsible for patient care and took on a greater role with patients and other care 
providers. The nurse specialist had an interfacing role, co-coordinating care between the 
two settings, which had a positive impact on HbA1c levels and was as good as the 
traditional model on other clinical outcomes (128). The establishment of shared care in 
Maastricht led the way for a more formal disease management model in the region. This 
disease management model was proposed as an integration of shared and traditional 
care models that had been operating in the hope of providing structured and integrated 
care for all patients (129). Thus concepts of sharing and structuring care were combined 
in an effort to provide more comprehensive disease management. The blend of 
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structured and shared care concepts is also reflected in a recent systematic review of 
shared care interventions which included organisational and professional components 
such as “pre-specified clinical protocols, referral guidelines, continuing education of participating 
clinicians, specifically designed information systems and ongoing audit and evaluation of services 
delivered” (p2)(99).  
2.1.14.2 Chronic Disease Management 
The experience in the Netherlands suggests the concept of shared care was regarded as 
a precursor for fully developed chronic disease management programmes (7). Chronic 
disease management programmes are designed to deliver structured, proactive, 
integrated care and are often based on the Chronic Care Model (CCM) (130). The 
systematic review by Norris et al defined disease management according to 4 key 
elements; 1) identification of the population with diabetes, 2) implementing guidelines 
or standards of care, 3) regular management of identified people 4) use of information 
systems for tracking and monitoring patients. Additional interventions can be patient-
orientated (e.g. education), provider-orientated (e.g. education also, reminders) or 
system-orientated (e.g. practice redesign) (94). In the US there is a distinction among 
chronic disease management programmes between those based on primary care and 
integrated within the health system and commercial plans developed by companies to 
which employers and health care plans contract out disease management (130). The 
latter format of disease management is a for-profit service marketed to customers as a 
cost containment strategy. The focus is often on patient education and self management 
employing e-health technology and telemedicine without having to engage the physician 
in behaviour change or reorganisation (131).  
2.1.14.3 Structured Care: an organised approach to delivery 
Chronic disease management programmes, particularly those based on the Chronic Care 
Model, deliver structured care to patients in an effort to improve the quality of care. 
However the term structured care is often used by itself in interventions and in Ireland 
it has particular connotations with primary care management, therefore it warrants 
clarification.  
In the literature, structured care is largely defined by the strategies it incorporates to 
improve care delivery. Hence structured care can be thought of as an approach to care 
delivery applicable in many care settings. For example, a systematic review by Griffin 
and Kinmonth (1998) differentiated between structured and unstructured care by the 
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presence or absence of an organised system for recall and prompting for patients and 
doctors (132). In the more recent TRANSLATE Trial a structured care intervention 
involved the use of guidelines and prompts for GPs, continuing education, regular 
patient follow-up, individualised patient goal setting and feedback for both patients and 
GPs. Hence the model of structured care was characterised by a series of  “multifaceted 
disease management strategies” (p8) (133). Finally, a study examining the impact of a nurse 
facilitator-enhanced intervention on Type 2 diabetes included training for GPs and 
practice staff in the use of guidelines, encouraging structured care and providing 
performance feedback (109). This intervention was conducted in the Netherlands using 
locally adapted shared care guidelines. This interchangeable use of terminology muddies 
the waters in terms of a distinction between shared and structured care and definitions 
proposed by the studies outlined above suggest a substantial overlap between terms. 
2.1.15 Diabetes Care in Ireland 
The traditional approach to diabetes care in Ireland was to refer patients to specialist 
hospital-based care upon a diagnosis of diabetes where patients were managed 
indefinitely (134). However for more than a decade there has been a shift towards 
greater primary care involvement. A survey of diabetes care in general practice in 
Ireland, conducted prior to the establishment of the Health Service Executive (HSE), 
found that up to 60% of Type 2 diabetes care was being provided by the GP as well as 
up to 24% of Type 1 diabetes care (135). However the balance of care between general 
practice and the hospital setting is not always straight-forward and there are a variety of 
diabetes care arrangements in Ireland including traditional hospital-based management, 
shared care between GPs and hospitals and primary care-led management.  
2.1.15.1 Quality of Diabetes Care in Ireland  
In line with international evidence, the provision of structured diabetes care in the 
general practice has also produced favourable results in Ireland in terms of processes 
and outcomes of care (20, 136-138). However this model of care is not common-place 
and there is a dearth of information on the quality of routine diabetes management at a 
national level. In the 1990s it was observed that quality improvement initiatives were 
“sporadic and individually driven” (79) and this has remained the case in diabetes care. There 
are currently 10 local diabetes initiatives across the country, illustrated in Figure 3, 
ranging from shared care schemes to structured care initiatives set up by GPs, to more 
recent initiatives which are mainly characterised by the appointment of a Diabetes 
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Nurse Specialist. A number of schemes were initiated and pioneered by groups of 
interested health care professionals, „local champions‟ of diabetes care. Some initiatives 
independently monitor and assure the quality of care through routine audit and 
feedback (136, 137, 139, 140). However the quality assurance of diabetes care in Ireland 
is largely limited to these initiatives and the 2003 survey of diabetes care in general 
practice found that only 14% of GPs participated in a formal diabetes care scheme 
(135). Outside such groups, participation in quality improvement is largely unknown.  
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Figure 3 Diabetes Initiatives in Ireland  
-Map reproduced with permission from the Health Service Executive 
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2.1.15.2 Models of Care in Ireland 
The terminology used to describe models of care in Ireland is context-specific and 
based on participation in local quality improvement initiatives. Shared care is defined as 
the “joint participation between hospital consultants and general practitioners in the planned delivery of 
care for patients with a chronic condition, informed by an enhanced information exchange over and 
above routine discharge and referral notices” (141). This model is currently formally provided 
by the East Coast Area Diabetes Shared Care Programme (ECAD), which was 
established jointly by a GP and an endocrinologist. There are number of primary care 
initiatives in Ireland providing a structured approach to diabetes care in the general 
practice setting (137, 140). Providing structured care in this context encompasses a 
systematic approach to management including maintaining patient registers, regular 
audit, continuing professional education, and the routine review and management of 
patients in general practice. Notably in an Irish context use of the term „structured care‟ 
has connotations with primary care-led management, traditionally used to distinguish 
this model from shared care schemes, however this is not to imply that shared care or 
hospital-led care is unstructured in its delivery.  
Recent developments in policy have led to the promotion of an integrated model of 
diabetes care in Ireland. This model of care, endorsed in the national guidelines for 
diabetes management, refers to the joint responsibility of primary and secondary care 
for the care of patients with diabetes (17). The working definition of integrated care 
proposes that the majority of patient visits take place in general practice with review in 
diabetes centres. Depending on patient need, this interval could be agreed locally by 
integrated partners between primary and secondary levels, depending on circumstances 
and resources (142). This model was also endorsed in the recommendations from the 
Expert Advisory Group for Diabetes (1). It is the first time a model of care has been 
agreed at a national level, the implementation of which is part of the Clinical Care 
Programme for Diabetes under the auspices of the Quality and Clinical Care 
Directorate in the HSE.  
2.1.15.3 Improving Diabetes Care at a National Level  
The report by the Expert Advisory Group for Diabetes represents the most recent 
attempt to develop a cohesive strategy for the provision and improvement of diabetes 
care in Ireland. The recommendations follow on from a series of reports on the 
deficiencies of diabetes care and the need for change. In 2000 the government was 
urged to form a policy planning group dedicated to the development of a national 
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diabetes care programme, in response to the internationally agree St Vincent 
Declaration (143). This call has since been reiterated by a number of multidisciplinary 
groups including the Diabetes Services Development Group (144), a working group 
established by the Department of Health (145) and most recently the Expert Advisory 
Group set up by the Health Service Executive (146). 
Each report has prioritised similar areas included the development of national 
retinopathy screening, information technology and communication (ITC) requirements, 
improving paediatric services and the integration of providers and settings. However at 
the time of writing the provision and coordination of diabetes care was not the subject 
of a dedicated national strategy document akin to those for cardiovascular disease (147) 
and cancer care (148) in Ireland, an absence which has been highlighted at European 
level. A report from the International Diabetes Federation European Region and the 
Federation of European Nurses in Diabetes in 2005 documented the absence of a 
national diabetes plan in Ireland although one was expected that year according to the 
DOHC. At the time eleven out of twenty-five countries in Europe (44%) had national 
framework or plan for diabetes. By 2008, thirteen out of twenty-seven member states 
(48%) had a national plan in place for the management of diabetes including newly 
developed plans in countries such as Romania, Poland and Lithuania. Ireland, along 
with Germany and Luxembourg, was one of the countries reiterating the promise of a 
national diabetes framework. Responsibility for the development of a national diabetes 
programme has since been assumed by the newly established Clinical Care Programme 
for Diabetes (CCP) set up by the HSE in 2009 under the Quality and Clinical Care 
Directorate to improve access to and quality of services in a number of areas. The 
outcome of this latest national-level effort to improve the organisation and coordination 
of diabetes care is awaited.  
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2.1.16 Summary 
This chapter outlined the case for diabetes as a model for quality improvement (2) due 
to its rising prevalence, mounting financial and human costs and the gap between the 
evidence-based standards of care and reality. Diabetes represents many of the challenges 
facing health systems seeking to reorganise services and orientate care away from the 
traditional acute model of episodic disease management.  
This chapter summarises the emergence of a quality agenda in healthcare which was 
influenced by the principles of industrial quality frameworks. The Chronic Care Model, 
a framework for optimal chronic disease management, reflects the profound change 
proposed by system redesign while emphasising the inclusive proactive approach to 
change endorsed by Total Quality Management. The „quality chasm‟ has become an 
international concern with increasing attention paid to structural, organisational and 
professional interventions to improve the quality of care. The synthesis of evidence 
from systematic reviews and recent randomised trials suggests multidimensional quality 
improvement interventions improve the processes of care although their impact on 
clinical outcomes is less consistent. A review of quality improvement strategies targeting 
organisation and provider behaviour in diabetes found that effectiveness was dependent 
partly on clinical context but also other contextual factors such as the beliefs and 
attitudes of professionals (8). In the field of quality improvement research 
understanding the context in which quality improvement flourishes or fails is as 
important as generating evidence of the effectiveness of different strategies (18, 19). 
This thesis will examine the organisational, professional and cultural context of diabetes 
care in Ireland.  
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2.1.17 Overview of Research 
Chapter 3: Diabetes Care in Ireland: a Survey of General Practitioners. 
This chapter reports on the survey of the organisation and delivery of diabetes care in 
general practice. The results describe access to services outside the practice and links 
with secondary care providers. The relationship between maintaining a diabetes register 
and the level of organisation in the practice is examined. 
Chapter 4: Providing Diabetes Care in Ireland; Everyday Experiences and the Barriers 
and Facilitators to Optimal Delivery. 
This qualitative study, informed by results of the GP survey, is outlined in Chapter 4. It 
examines experiences of providing diabetes care in more depth and explores GPs‟ 
understanding of the various models of diabetes care. This chapter also explores the 
barriers and facilitators to providing diabetes care in general practice. 
Chapter 5: Attitudes to engaging in Quality Improvement in General Practice.  
This chapter presents results from the second objective within the qualitative study; to 
explore GPs‟ attitudes and openness to engaging in quality improvement activities. The 
results focus in particular on attitudes to a national diabetes register and audit as 
mechanisms for quality improvement at local and national level. 
Chapter 6:  The Quality of Primary Care-Led Diabetes Management: a Bottom-Up 
Approach to Improvement 
This study examines the quality of care delivered by 3 primary care initiatives which 
have adopted a structured approach to diabetes management. Data on processes and 
intermediate outcomes for over 3000 patients with Type 2 diabetes are compared to 
national and international standards.  
Chapter 7: Improving Diabetes Care through Policy Formulation; a Case Study of the 
Expert Advisory Group for Diabetes. 
The final study examines the Expert Advisory Group for Diabetes and its 
recommendations as an instrumental case study of policy formulation within the Irish 
health service.  
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Abstract 
Background: In Ireland an increasing proportion of diabetes care is being provided in 
general practice. The aim of this study was to examine the organisation and delivery of 
care to patients with diabetes in this care setting.  
Methods: A postal questionnaire was administered through the Irish College of 
General Practitioners to a random sample of 600 GPs. The survey addressed four key 
topics; characteristics of the practice, diabetes care delivery, the use of services and 
opportunities for developing diabetes care. The questionnaire was developed was based 
on an instrument previously used in the UK to assess diabetes service provision. 
Results: The response rate was 44% (N=262). There were an additional 86 responses 
to a follow-up shortened version of the survey resulting in a 58% response rate for 9 
key questions. Most respondents were from an urban (43%, n=112) or a mixed area 
(39%, n=101) and 19% of practices were single-handed (n=66). Forty-six percent of 
GPs maintained a diabetes register (n=157) and 55% reported using guidelines 
(n=140).While 30% had a formal call/recall system for review (n=78), a further 20% 
indicated that an informal yet regular approach was in place (n=54). Almost one quarter 
of GPs did not employ any of these components in the practice (24%, n=62). There was 
a significant association between maintaining a diabetes register and other aspects of 
care delivery such as engaging in formal recall (p<0.001), using guidelines (p<0.001) and 
a declared special interest in diabetes (p=0.001). Just over 60% of respondents had 
direct access to a dietician (63%, n=165) and 57% direct access to chiropody services 
(n=149). Most GPs were in favour of a mixture of capitation and fee for patient as 
remuneration for providing diabetes care (54%, n=136). Training for GPs and nurses 
was cited as the main opportunity for developing diabetes care (76%, n=196). 
Conclusions: The results of this survey suggest a substantial proportion of diabetes 
care in general practice is unstructured with limited adoption of diabetes registers, 
routine recall and guidelines. Maintaining a register is likely to be a marker of 
enthusiasm and investment in quality improvement in the practice. Despite the policy 
emphasis on the transfer of chronic illness care to the community, considerable 
organisational gaps and resource deficiencies remain in general practice. 
  This paper has been published in Primary Care Diabetes (2009) (Appendix II) 
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3.1. Introduction 
Diabetes Mellitus is emerging as one of the most significant problems facing health 
systems around the world with an estimated increase in the worldwide prevalence of 
diabetes from 2.8% in 2000 to 4.4% in 2030 (4). In Ireland the prevalence is expected to 
increase from 4.7% of the population in 2005 to 5.6% by 2015 (39). The rising 
prevalence and the ever increasing cost of chronic diseases such as diabetes have led to 
health services examining ways to reconfigure services with growing emphasis on the 
development of primary care services (13).  
Consequently General Practitioners (GP) are assuming greater responsibility in the 
delivery of diabetes care (149). Care in the community has been found to be as effective 
as hospital-based care when it is structured and supported by specialist input (132). It 
has also been shown that care provided in the primary care setting can enhance diabetes 
quality of life without compromising quality of care (20). The first national survey of 
diabetes care in Ireland in 2003 found that while a significant amount of diabetes care 
was delivered in general practice, particularly for Type 2 patients, this care was largely 
unstructured. Less than half of the GPs surveyed reported using a register while just 
over half engaged in routine recall (135). Other countries such as the US which have 
examine the use of „diabetes care management processes‟ such as the use of registers 
and guidelines have also found limited adoption (150). 
The level of organisation in general practice is associated with processes and clinical 
outcomes of care(151). Hence there is increasing interest in professional and 
organisational interventions which enhance the structure of diabetes care delivery as an 
avenue for improving outcomes. In particular centrally organised systems for tracking 
patients and arranging follow-up improved the process of diabetes care in primary care, 
out-patient and community settings. Computerised reminders and/or audit and 
feedback were found to have a similarly positive effect on the process of care (14). 
Quality improvement strategies have also been shown to improve patient outcomes in 
general practice. The TRANSLATE Trial, which incorporated an electronic diabetes 
registry, reminders, a coordinator to plan patient visits and monthly review meetings 
with a local champion, led to significant improvements in clinical outcomes (111). As 
reflected in the aforementioned trial, patient registration is one of a variety of quality 
improvement strategies typically incorporated as part of a multidimensional 
intervention, making it difficult to demonstrate its independent contribution to quality. 
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A review of the literature conducted by this PhD student and colleagues found that 
registers are assumed to be a central and underlying feature of diabetes management 
(152).  
The organisation and delivery of diabetes services is complex and differs between 
countries involving secondary care, primary care or shared care systems integrating 
services from both settings (138). This study examines the organisation and delivery of 
diabetes care in the Irish general practice setting including the use of diabetes registers 
in the practice. Before quality improvement strategies such as a patient register can be 
developed on a national scale, the current level of diabetes care needs to be assessed. 
3.1.1 Aims and Objectives 
As part of the overall aim of this thesis to investigate the „quality chasm‟ around 
diabetes care in Ireland, a sequential mixed methods design was used to examine the 
organisation of diabetes care in general practice, beginning with a quantitative GP 
survey which is the focus of this chapter. The objectives of this study were: 
1. To describe the organisation of diabetes care in general practice in Ireland.  
2. To look at the relationship between maintaining a diabetes register and other 
organisational features of the practice.  
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3.2 Methodology 
3.2.1 Design 
A cross-sectional postal survey of a random sample of GPs practicing in the Republic 
of Ireland was conducted in collaboration with the Irish College of General 
Practitioners (ICGP). This study represents the first phase of a sequential mixed 
methods design (153). As such the results of this survey were used to inform the design 
of a qualitative follow-up study. 
3.2.2 Instrument 
A questionnaire was developed from a survey instrument used to assess diabetes care in 
general practices in the Galway region (154). The instrument had previously been 
adapted for an Irish context from a survey used in the UK to assess diabetes service 
provision (155). To ensure content validity for the purpose of this national study, the 
questionnaire was piloted among a convenience sample of thirteen GPs. Seven of the 
thirteen GPs responded to the pilot phase and minor adjustments were made to the 
layout and wording of the questionnaire. The survey addressed four key topics: the 
characteristics of the practice, the organisation of diabetes care delivery, the use of 
services and opportunities for developing diabetes care (Appendix IV). In addition the 
questionnaire was used to establish GPs willingness to be involved in a qualitative 
follow-up study, the second phase of the mixed methods research design. 
3.2.3 Sample 
The sample was recruited through the Irish College of General Practitioners database. 
Approximately 2500 GPs are registered with ICGP representing 90% of practicing GPs 
in Ireland (31). A random sample of 600 GPs was selected from the ICGP database by 
an ICGP researcher to maintain members‟ anonymity. The sample size was calculated to 
provide a representative sample of GPs based on previous research carried out by the 
ICGP. 
3.2.4 Procedure 
The questionnaire was circulated in June 2008 with a cover letter outlining the purpose 
of the study and a stamped addressed envelope to return the survey. On the back page 
of the questionnaire GPs were given an „opt-in‟ option to participate in a qualitative 
follow-up study by providing their name and contact details. In addition participants 
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were provided with a postcard to return separately from the questionnaire to 
discriminate between the proportion of responders and non-responders. 
Follow-up 
Due to ICGP regulations precluding telephone contact with members it was not 
possible to conduct follow-up phone calls to further increase the response rate or 
characterise non-responders to the survey. However, a second round of questionnaires 
was sent out two weeks after the first mailing to all those who had not returned a 
responder postcard in an attempt to increase the response rate. This questionnaire was a 
shorter version of the original survey, containing nine key questions (See Appendix V). 
Figure 4 illustrates the survey administration process. 
 
Figure 4 Flowchart of administration of survey
Random sample 
of 600 GPs 
Reminder to those 
who hadn‟t 
returned postcard 
Response:  
262 (44%) 
Short survey 
mailed  
to 338  
non-responders 
86 respondents  
(25% of non-
responders) 
No significant differences 
between responders to 1st & 2nd 
surveys with exception of special 
interest in diabetes 
Therefore for 9 key 
questions there is a total 
sample of 348 GPs. 
252 GPs  
did not respond  
to either survey 
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3.2.5 Data Management 
The questionnaire was produced in a scannable format for automatic data capture and 
entry using TeleForm scanning software (156). Firstly the Teleform Designer was used to 
create the questionnaire and generate a unique ID number for each form. Once 
completed the questionnaires were scanned and recognised by the TeleForm Reader. 
Unknown fields and participant hand-writing were highlighted by the Reader which 
were checked and verified in the Teleform Verifier. The data were transferred directly to 
an Excel file and imported into SPSS (Version 15) for analysis. A number of 
questionnaires were randomly checked to ensure complete and accurate data transfer.  
3.2.6 Analysis 
3.2.6.1 Quantitative 
Standard descriptive statistics are used throughout the results section. Categorical data 
are presented as number and percentage. The percentage is based on the number who 
answered the question unless otherwise stated. Continuous data are described using 
median and interquartile range (IQR) as data were highly skewed. Data were compared 
using non-parametric analysis, the Mann-Whitney test and Kruskal-Wallis test for 
differences between groups. Chi-squared tests were used to examine the statistical 
significance of associations between categorical data. The difference between 
proportions and 95% confidence intervals (95% CI) are reported when appropriate as 
tests of statistical significance have been argued to be of limited value (157). Bonferonni 
adjustment was applied to the alpha value 0.05 where multiple comparisons were 
conducted.  
3.2.6.2 Qualitative 
There were opportunities throughout the survey for respondents to expand on their 
answers using open-ended fields. Responses were coded in NVIVO 8 software. 
Thematic analysis was applied to responses. Inter-coder reliability was carried out on the 
most common 25% of themes on the main open-ended responses (158). For example 
where 20 themes emerged, the top 5 themes were subject to inter-coder reliability. For 
the purpose of this chapter only the main themes are highlighted (see Appendix VI for 
emergent themes). 
3.2.7 Ethical Approval 
Ethical approval for this study was granted by the Irish College for General 
Practitioners (ICGP) (Appendix VII). 
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3.3 Results 
This section begins with an outline of the final response rate and the practice profile of 
the sample including the level of computerisation. The organisation and delivery of 
diabetes care in general practice is then presented including the use of a diabetes register 
and call/recall system as well as links with hospital-based specialist teams and access to 
services (e.g. dietician). The relationship between maintaining a register and other 
organisational features are explored followed by analysis of the relationship between 
having a special interest and the organisation of care in the practice.  
3.3.1 Response Rate 
The final overall response rate was 44% (N=262). A follow-up mailing of a shorter 
version of the survey to increase the response rate resulted in an additional 86 
respondents for 9 key questions (N=348, 58%). Respondents to the initial questionnaire 
were compared to those who responded to the shorter questionnaire on nine common 
questions to identify any differences between the two groups. 
3.3.1.1 Comparing responders & initial non-responders 
A Mann-Whitney test indicated no significant difference between the groups in terms of 
number of doctors employed (U=10058; p=0.3); total patient population (U=8323; 
p=0.5) or total diabetes patient population (U=5663; p=0.6). There was no significant 
difference between length of survey completed and key features of practice organisation 
as illustrated in Table 4. The length of the survey was significantly associated with 
whether practices reported having a special interest in diabetes (χ²= 6.372; p=0.009) 
however following Bonferonni adjustment this association was no longer significant. As 
there was no difference between GPs who responded to the initial survey and those 
who responded to the follow-up survey, the latter group were included in the analysis of 
9 key variables to produce a response rate of 58% for those questions (n=348).  
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Table 4. Association between the lengths of survey completed & care delivery 
Characteristic 
Long 
Qn. 
N (%) 
Short Qn. 
 
N (%) 
% Difference 95% CI p 
Practice Characteristics 
Practice Nurse 220 (84) 66 (77) 7% -2 to 18% p=0.13 
Computer System 244 (94) 77 (90) 4% -3 to 12% p=0.5 
Diabetes Module 117 (66) 30 (53) 13% -2 to 27% p=0.13 
Diabetes Care Delivery 
Diabetes Register 121 (46) 36 (43) 3% -9 to 15% p=0.7 
Specific Clinics 58 (22) 20 (23) 1% -12 to 9% p=0.96 
Special Interest 84 (81) 54 (63) 18% 5 to 31% p=0.009* 
*Not significant after adjustment 
3.3.2 Practice Profile 
This section outlines the profile of participating GP practices in terms of location, staff 
levels and practice population including the prevalence and incidence of diabetes.  
3.3.2.1 Practice Location 
The majority of practices were in urban (43%, n=112) or mixed locations (39%, 
n=101). Less than 20% of practices were in a rural location (18%, n=47) (Table 5).  
Table 5 Practice location compared to national profile 
 Urban 
N (%) 
Rural 
N (%) 
Mixed 
N (%) 
Total 
N 
Current survey (2008) 112 (43) 47 (18) 101 (39) 260 
National Profile (2006)(159) 205 (43) 100 (21) 171 (36) 476 
3.3.2.2 Staff 
Doctors 
The median number of doctors per practice was 3 (IQR=2-4). Using a Kruskal Wallis 
test, a significant difference was detected between the 3 locations in terms of number of 
doctors working in the practice (H= 14.76, df =2; p=0.001). Examination of the 
median values indicated that practices in urban and mixed locations employed 3 doctors 
while rural practices employed 2 doctors. As Figure 5 shows rural areas had the highest 
proportion of single-handed practices (36%, n=16). 
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Figure 5 Size of practice (no. of GPs) by location of practice 
Practice Nurses 
The majority of practices employed a Practice Nurse (83%, n=286). There was a 
significant difference between practices with and without a practice nurse in terms of 
the number of doctors (U=4354; p=0.000) with a higher median number of doctors in 
practices with a Practice Nurse (Mdn= 3 IQR=2-4 vs. Mdn=2, IQR=1-3). While chi-
square analysis revealed a significant association between the location of the practice 
and whether or not a practice nurse was employed (χ²= 7.73, p=0.02), similarly high 
proportions of practices in each location employed practice nurses. Ninety-two percent 
of mixed practices employed a practice nurse (n=93) compared to 78% or urban 
practices (n=87) and 85% of rural practices (n=39) (Figure 6). 
Practice Managers  
Just over half of respondents had a practice manager (52%, n=134). Fifty percent of 
practices had both a practice manager and a practice nurse (n=128). There was no 
significant association between the location of the practice and employing a manager 
(χ²= 1.299, p=0.052) (Figure 6). However there was a significant difference between 
practices with and without a practice manager in terms of the number of doctors in a 
practice (U= 4162; p=0.000) with practices with a practice manager having a higher 
number of doctors (Mdn=3 IQR2-5 vs. Mdn=2 IQR=1-3).  
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Figure 6 Percentage of practices employing a Practice Nurse or Practice Manager  
3.3.3 Practice population 
Data on the practice population were positively skewed therefore medians and 
interquartile range are reported and non-parametric analysis was conducted. The median 
patient population for practices was 4000 patients (IQR=2200-6750) (Table 6). 
However it is important to note 62% of GPs indicated that patient figures were a best 
estimate (n=150) while 38% (n=92) said the numbers were based on information from 
the practice IT system. 
Table 6 Medical care and non-medical card (private) patient population 
 Medical Card 
Patients 
Non-Medical Card 
Patients 
Total Population* 
Median 1200 2755 4000 
IQR 703-2000 1200-4728 2200-6750 
Mean (sd) 1568 (1508.5) 3874 (4973) 5314 (4544) 
Range 0-10000 100-6000 100-25000 
*Some respondents did not provide total figures which were the sum of GMS and private patients. 
Size of Practice & Location 
A Kruskal-Wallis test detected a significant difference between the three types of 
practice location in terms of the number of patients (H= 6.979; df= 2; p<0.05). Rural 
practices appeared to have the lowest patient population (Mdn= 3000) followed by 
urban practices (Mdn= 4500) and mixed practices (Mdn=4750). Practices with a 
practice manager had significantly more patients (Mdn= 5645) compared to those 
85% 
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practices without a manager (Mdn=3000) (U = 3277; P<0.001). Similarly those 
employing a Practice Nurse had significantly more patients (Median=4400) compared to 
those who did not employ a Practice Nurse (Median=3000), (U=4290; p<0.001).  
Diabetes prevalence and incidence 
The overall prevalence of diabetes in the practice population was 3.6% (data available 
for 69% of practices, n=239) ranging from 0.2% to 23%. The prevalence of Type 1 
diabetes was 0.7% (range 0-5%) while the prevalence of Type 2 diabetes was 2.8% 
(range 0.06-16%) (Table 7). The cumulative incidence was calculated as 0.7 per 
thousand for Type 1 diabetics and 3.5 per thousand for Type 2 diabetics. Only 28% 
(n=66) said figures were based on data from the practice IT system. 
Table 7: Prevalence of diabetes by type 
 Type 1 
N=215 
Type 2 
N=219 
Overall 
N=239 
Mean (sd) 0.7 (0.85) 2.8 (2.27) 3.6 (3) 
Median (IQR) 0.5 (0.3-0.8) 2.1 (1.3-3.4) 2.9 
Range 0-5 0.06-16 0.21-23.3 
 
Diabetic patients in nursing homes/residential care  
The median number of patients in nursing homes was 1 (IQR= 0-5) (range=0-150 
patients). Seventy-two percent indicated these numbers were based on a best estimate 
(n=135). Of those GPs who had patients with diabetes in nursing homes/residential 
care, the majority reported that patients received care from the GP and hospital 
specialist services (51%, n=53). Forty-one percent of respondents indicated that care 
was delivered by the GP only (n=43) and 7% reported that care was delivered by the 
specialist service only (n=7). 
Suggestions for providing care to patients in nursing homes/residential 
care 
Respondents recommended the use of protocols and increased training to improve care 
delivery in nursing homes and residential care. Other suggestions included a community 
diabetes nurse providing care to patients in residential care homes and visiting 
specialists (Appendix VI).  
 
 
“there should be a mobile 'on the road' nurse to look after diabetes patients that are in 
nursing homes/residential care; should have a diabetic nurse to visit weekly/monthly.”  
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3.3.4 Organisation in the Practice 
3.3.4.1 Computer Systems 
Most practices had a computer system (93%, n=321). The most common software 
system in use was Health One (38%, n=121) (Figure 7). Forty-six percent had a diabetes 
module on their computer system (n=147) while 28% did not know (n=89). Of those 
with a diabetes module 61% reported using it (n=89, 26% of total sample).  
 
Figure 7 Percentage of practices using different computer systems 
*Helix software was the parent company of GP Dynamic and GP Clinical therefore respondents may 
have been using either of those two computer systems. 
3.3.4.2 Uses of Practice Computer System 
The use of computer systems is organised according to the following functions:  
i) Use of computer to gain payment and issue prescriptions 
ii) Linking with other services to receive information electronically, increasing 
efficiency  
iii) Becoming a „paper light‟ practice.  
 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
P
e
rc
e
n
ta
g
e
 o
f 
p
ra
c
ti
c
e
s 
63 
 
i) Gaining payment and issuing prescriptions 
In most practices the computer system was used for issuing repeat prescriptions (98%, 
n=229) and maintaining a register of all patients (97%, n=227). Table 8 lists the various 
uses of the practice computer system in order of frequency as well as details provided 
by respondents in open-ended sections (Appendix VI for themes). 
Table 8 Uses of the practice computer 
Practice Computer Use N (%)* 
To issue repeat prescriptions (n=223) 229 (98) 
To maintain a register/list of all patients (n=234) 227 (97) 
To issue acute prescriptions other than in consultations (n=231) 215 (93) 
To issue acute prescriptions in consultations (n=233) 215 (92) 
To maintain continuation records of consultations (n=231) 211 (91) 
To store reports from hospital laboratories (n=232) 211 (91) 
To store reports from X-ray departments (n=232) 202 (91) 
To record antenatal visits (n=235) 202 (86) 
To store reports from specialists (n=232) 194 (84) 
To make GMS claims (n=231) 158 (68) 
Store other reports (n=161) 
[E.g. Medico-legal reports] 
119 (74) 
To make claims for ante-natal care (n=231) 113 (49) 
To record Heart-watch visits (n=229) 98 (43) 
To record other forms of systematic care of patient groups (n=172) 
[E.g. Diabetes/endocrine care, maternity care] 
95 (55) 
To make other claims (n=175) 
[E.g. Vaccination claims, childhood immunisation claims] 
59 (34) 
 
ii) Receiving Electronic Reports- Linking with other services 
Eighty percent of GPs reported receiving electronic reports from hospital laboratories 
(n=194) and 33% received reports from X-ray departments (n=78) (Figure 8). Only 7% 
of GPs (n=13) received reports from other hospital departments such as out-patients 
departments, admissions and discharge, and specialists. Other sources of electronic 
reports included on-call and out-of hours‟ doctors‟ services (See Appendix VI).  
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Figure 8 Percentage of GPs receiving electronic reports 
Electronic reports were usually filed automatically in patients‟ electronic records (42%, 
n=87). A number of other methods were also used; automatically and scanning (20%, 
n=41), automatically and manual filing (3%, n=7), and manual filing and scanning (3%, 
n=6). Eleven percent who used manual filing alone (11%, n=22).  
iii) Becoming a „paper light‟ or paperless practice: Use of Electronic Records 
Just over half of respondents viewed themselves as paperless practices (51%, n=124) 
and 80% routinely use electronic records during consultations (n=209). Figure 9 shows 
the percentage of GPs who replaced paper records in favour of electronic records for 
various aspects of patient management. Other electronic records included medico-legal 
reports and practice correspondence (see Appendix VI for full analysis). 
 
Figure 9 Percentage of GPs who had replaced paper with electronic records 
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3.3.5 Organisation and Delivery of Diabetes Care 
This survey examined a number of features of diabetes care delivery displayed in Figure 
10. Overall 46% of practices maintained a diabetes register (n=157). While 30% (n=78) 
of practices had a formal call and recall system for reviewing diabetes patients a further 
20% (n=54) indicated a routine systematic approach to recall was in place by reporting 
the frequency with which patients were recalled (informal recall). Just over half of the 
practices surveyed reported using guidelines (55%, n=140). Almost one quarter of 
practices employed all three features (23%, n=60) [register, routine recall, guidelines] 
however a similar proportion did not utilise any of these features (24%, n=62). Each of 
the features in Table 9 will be examined in more detail. 
Table 9: Proportion of GPs with an organised approach to diabetes care 
 Total N n (%) SE 95% CI 
Specific Clinics for Diabetes 347 78 (22) 0.022 18-26% 
Formal Recall System 261 78 (30) 0.028 25-36% 
Informal Recall 262 54 (20) 0.025 15-25% 
Diabetes Screening 262 243 (93) 0.016 90-96% 
Guidelines 253 140 (55) 0.031 47-59% 
Diabetes Register 343 157 (46) 0.027 40-50% 
 
Figure 10 Percentage of GPs with features of diabetes care delivery 
  
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
Diabetes 
Register 
Specific 
Clinics 
Formal recall Informal 
recall 
Screening Guidelines 
66 
 
3.3.5.1 Specific Clinics 
Only 22% percent of respondents (n=78) held specific diabetes clinics thus the follow-
on questions were not applicable (NA) for the majority of respondents. Clinics were 
commonly led by the Practice Nurse (15%, n=37) followed by a combination of the 
Practice Nurse and the GP (10%, n=26). Most clinics occurred every three months or 
less frequently (Table 10). 
Table 10: Type and frequency of clinics held by GPs* 
Type of clinic Total N N (%) NA (%) 
Frequency of 
Clinic 
0-3 
months 
N (%) 
4-12 
months 
N (%) 
GP-led 250 22 (9) 203 (81) 16 (76) 5 (23) 
Practice nurse-led 252 37 (15) 202 (80) 26 (70) 11 (30) 
Combined practice nurse & GP 249 26 (10) 203 (82) 17 (69) 8 (32) 
Pharmaceutical nurse-led 245 9 (4) 203 (82) 7 (78) 2 (22) 
Other:  
E.g. dietician, insulin initiation, 
chiropody 
203 11 (5) 203 (86) 9 (82) 2 (18) 
*Responses were not mutually exclusive  % as a proportion of those who reported clinics 
What constitutes a clinic? 
Responses to the open-ended section suggested the definition of a „clinic‟ encompassed 
a planned routine recall visit at any time during the working day as well as a specific 
time set aside for diabetes related visits only: “the patient is invited in as part of the normal 
day”, similarly a clinic was part of “structured care- repeat appointment of 3 months- not a specific 
day for clinic”. (See Appendix VI for thematic analysis).  
3.3.5.2 Call/Recall 
Appointments for Diabetes Care 
Other than at specific diabetes clinics, diabetes management was attended to during 
appointments. The majority of practices (45%, n=117) used a combination of patient-
initiated appointments specifically for diabetes, doctor/nurse initiated appointments 
specifically for diabetes and opportunistic appointments. Fifteen percent of GPs (n=40) 
reported using opportunistic appointments only, that is the patient receiving diabetes 
care during a consultation for something other than diabetes (Figure 11).  
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Figure 11 Type of appointments used by GPs to provide diabetes care 
Call and recall for review 
Thirty percent of practices had a formal call and recall system for reviewing patients with 
stable Type 2 diabetes (n=78). A further 54 practices answered „no‟ to this question but 
went on to indicate the frequency with which patients with Type 2 diabetes were 
recalled for review. This suggested that while these practices did not have a formal 
call/recall system in place, they did recall patients on a regular basis. Therefore overall, 
50% (n=132) of practices were classified as routinely recalling patients with stable Type 
2 diabetes for review. Of those GPs who recalled patients (n=132), most did so every 1 
to 6 months (91%, n=120). Only 7% of practices (n=9) recalled patients every 12 
months for review. In open-ended responses a number of GPs (n=30) highlighted the 
flexibility of review and its frequency. GPs referred to recalling patients were recalled 
“as required” depending on their medical condition or HbA1c level:  
 
A number of GPs referred to barriers to developing systems and recalling patients 
including the “lack of incentive”. A lack of standard practice in recall for diabetes 
patients was raised by another respondent (see Appendix VI for full thematic analysis).   
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3.3.5.3 Review 
Attendance  
According to the GPs surveyed, on average 76% of patients with Type 2 diabetes 
attended for their diabetic review. This proportion ranged from 30-100% among 
practices. However in most cases this figure was based on a best estimate (82%, n=89) 
rather than on actual numbers from the practice IT system. A substantial proportion of 
GPs did not respond to the question (59%, n=154). There was a significant difference 
between GPs who provided actual numbers and those who gave a best estimate in 
terms the proportion of Type 2 patients who attended for review (U=470, p<0.05). The 
median of those providing actual numbers was 90% while the median of those 
providing an estimate was 80%. 
Processes of Care as part of Routine Review 
As part of a routine review GPs reported complete measurement of blood pressure 
(100%, n=258) and almost complete measurement of HbA1c (99%, n=257) and lipids 
(99%, n=257). Table 9 outlines the various processes of care undertaken by GPs as part 
of a routine check-up of patients with diabetes. Fifty-two percent of GPs (n=123) 
reported that patients had their blood taken prior to the diabetic review while 48% of 
GPs (n=116) took bloods at the time of review.  
Foot & Eye Care 
Less than 30% of GPs carried out an eye exam in the practice (28%, n=65), patients 
were more commonly referred to a community ophthalmic physician (53%, n=109) or 
an ophthalmic surgeon/medical ophthalmologist (83%, n=183). Almost two-thirds of 
GPs reported carrying out a foot exam as part of a routine check-up (61%, n=143). 
Open-ended responses detailed the contents of the examination including: “Skin and nail 
condition and peripheral pulses; Circulation (+/- Dopler); Sensation (Micro-filaments); footwear 
vibration, sense”. While it was part of the annual review in some practice, in others foot 
care was occasional and opportunistic. 
 
 
  
“A bit hit and miss…We often expect this to occur in the clinic. Microalbuminuria and 
ACR are covered at the hospital annual review”. 
69 
 
Table 11: Processes of care as part of a routine review of patients with diabetes 
 Process Total N N (%) 
Lifestyle Height 230 111 (48) 
 Weight 248 230 (93) 
BMI 231 165 (71) 
Waist Circumference 222 83 (37) 
Dietary Review 249 215 (86) 
Smoking status 252 245 (97) 
Management 
Review 
Medication review 259 259 (100) 
 Blood glucose monitoring diary review 257 244 (95) 
Aspirin Therapy Status 250 226 (90) 
Statin Therapy Status 254 246 (97) 
Tests Blood Pressure 258 258 (100) 
 Fasting glucose 246 219 (89) 
Random Glucose 219 109 (50) 
HbA1c 258 257(99) 
Serum Creatinine 252 244 (97) 
Lipids 258 257 (99) 
Urinalysis Dipstick 240 215 (90) 
 Microalbuminuria 237 150 (63) 
Albumin:Creatinine Ratio 229 102 (45) 
Eye exam Eye examination by GP 233 65 (28) 
 Eye examination by Community Ophthalmic 
Physician 
206 109 (53) 
Referral to Ophthalmic surgeon/medical 
ophthalmologist 
221 183 (83) 
Referral to optician/optometrist 183 76 (42) 
Examination as part of a screening programme 165 50 (30) 
Foot exam. Foot examination 234 143 (61) 
 
Other tests/procedures 
Other routine clinical and medical examinations performed in the practice included 
“overseeing yearly ECG”, vaccinations and testing “thyroid function”. As part of 
routine procedure, GPs indicated that they would refer patients to specialist services if 
they deemed it medically appropriate to do so.  
3.3.5.4 Screening 
Almost all respondents reported screening for diabetes in the practice (94%, n=243). 
Obesity and having a family history of diabetes were considered the most important 
factors when screening for diabetes (Table 12). „Other‟ factors considered important 
included renal failure/kidney problems, patient requests and thyroid dysfunction.  
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Most GPs reported re-screening patients every 6 to 12 months (72%, n=174) with 7% 
of GPs re-screening more frequently (<6months) (n=17). Screening was usually 
opportunistic with few or no protocols in place in the practice. In some cases the 
frequency of rescreening was dependent on patient risk factors (see Appendix VI for 
full analysis of open-ended question). 
Table 12: Patient characteristics considered when screening 
 Characteristic Total N N (%) 
1 Obesity 246 246 (100) 
2 Family history of diabetes 247 247 (100) 
3 Patients with recurrent infections 246 241 (98) 
4 Patients with ischemic heart disease 241 236 (98) 
5 Patients with peripheral vascular disease 242 235 (97) 
6 Patients with hypertension 243 234 (96) 
7 Women with history of gestational diabetes 245 234 (96) 
8 Patients with cerebrovascular disease 239 228 (95) 
9 Age 242 218 (90) 
10 Patients who have had a baby >4kg 237 181 (76) 
11 All pregnant women 240 145 (60) 
12 Ethnic origin 221 95 (43) 
13 Other 83 37 (45) 
 
Tests for screening patients 
Most GPs reported using more than one test to screen patients for diabetes. The most 
commonly used test was fasting venous glucose (97%, n=229) while only 19% of 
practices refer patients to the hospital for screening tests (n=38) (Figure 12).  
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Figure 12 Tests used by GPs for screening for diabetes 
3.3.6 Guidelines 
Just over half of GPs surveyed reported using guidelines for the care of patients with 
diabetes (55%, n=140). The most commonly cited guidelines were those developed by 
the ICGP (23%, n=59). Nine percent used local guidelines developed in the practice or 
in conjunction with the local hospital or consultant (n=24) (Figure 13). 
 
Figure 13 Types of guidelines used by GPs 
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3.3.7 Care Pathways 
This section presents results on the management of particular patient groups (newly 
diagnosed/requiring insulin). The level of integration and interaction between health 
care settings and providers is also outlined.  
3.3.7.1 Working with Secondary Care Providers 
Referrals to the local hospital-based specialist team 
Approximately half of GPs routinely provided patients with the contact details of the 
hospital-based diabetes team (53%, n=133). The majority of respondents (99%, n=255) 
always referred a child with a suspected diagnosis of diabetes to the local hospital-based 
specialist teams. Eighty-two percent of GPs (n=211) always referred women with 
gestational diabetes to the local hospital-based specialist team. Referral of patients with 
gestational diabetes appeared to work in two directions; “Patients with gestational DM tend 
to be referred by an obstetrician to a diabetes team” or “women get referred to a maternity hospital 
diabetes specialist”. Other patients commonly referred to the hospital-based team included 
patients with Type 1 diabetes, patients with complications and those with inadequate 
metabolic control (see Appendix VI for full analysis of open-ended responses).  
Newly diagnosed patients 
When asked to indicate how they would manage patient a newly diagnosed with Type 2 
diabetes, GPs indicated a combination of strategies. Seventy-one percent reported 
managing a newly diagnosed patient in the practice until the need arouse for additional 
care (n=158). In some cases GPs would work up the patient and then refer right away 
(53%, n=122) while 17% would refer patients immediately on occasions (n=35). 
Initiating insulin 
With regard to patients with Type 2 diabetes starting insulin, the majority of GPs always 
referred these patients to the local hospital-based specialist team (83%, n=213). Most 
GPs indicated they would rarely or never undertake insulin initiation in the practice 
(75%, n=178). Only 5% of GPs (n=11) indicated they would initiate therapy in his/her 
practice. Forty-five percent of GPs reported that patients were taught to adjust their 
insulin treatment in the practice (n=116).  
Twenty-seven percent of GPs (n=54) reported sometimes or always initiating insulin 
therapy depending on patient characteristics. The main characteristics identified by GPs 
for consideration were: patients understanding of his/her illness, metabolic control, 
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“No formal meeting but can phone Dr X & DNS in the hospital at any time”. 
 
compliance, motivation, ability to administer insulin and age (see Appendix VI. for 
themes).  
Liaising with the local hospital-based team 
Most GPs did not have a formal shared protocol with his/her local hospital based 
specialist diabetes team (90%, n=232). Only 10% of GPs reported having ever had a 
joint meeting with the hospital based team (n= 25) while only 3% had regular meetings 
with the hospital based team (n=7). Of those who had regular meetings, the meetings 
were usually held every 4 to 6 months (n=5).Some GPs commented on local 
arrangements with the hospital setting in the open-ended section. These links varied 
from information sharing to informal communication, to little or no contact with the 
hospital (see appendix 7.1.13 for thematic analysis of all responses).  
 
3.3.8 Access to auxiliary services 
As Figure 14 illustrates access to and waiting times for auxiliary support services which 
varied depending on the service under consideration. Most open-ended responses in 
relation to auxiliary services referred to disparate waiting times for appointments and 
the difference between public and private access to services (see Appendix VI for full 
thematic analysis).  
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Figure 14 Percentage of practices with access to auxiliary services  
Dietician 
Sixty-three percent of GPs had direct access to a dietician (n=164), most of whom 
referred patients with diabetes to this service (81%, n=134). Approximately half of GPs 
reported a wait of 1 to 3 months for an appointment (52%, n=77) while 24% of GPs‟ 
patients had to wait longer than 3 months for an appointment (n=35).  
Chiropodist 
Fewer GPs had direct access to chiropody services (58%, n=149). Again most GPs 
referred patients to this service (71%, n=111). Forty percent of GPs estimated a waiting 
time of less than 1 month for an appointment (n=51). Forty-five percent of GPs 
reported a wait between 1 and 3 months for an appointment (n=57) and 10% reported 
waiting times of longer than 3 months (n=13). 
Ophthalmic Examination 
Most GPs had access to ophthalmic examination for patients (91%, n=234). 
Ophthalmic examinations were carried out by a variety of professionals as outlined in 
Figure 15. Of the GPs reporting access to ophthalmic examination most had access to 
more than one such professional (54%, n=127). Seventeen percent of GPs (n=31) 
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indicated a wait of less than 1 month and 38% reported a wait of between 1 and 3 
months (n=70). Over one third of GPs had access to a systematic population-based 
retinal screening programme (36%, n=91). 
 
Figure 15 Percentage of GPs reporting access to providers of ophthalmic examination 
Access to Educational Information 
The majority of practices had space to display educational/health promotional materials 
(83%, n=214). The main source of educational posters was the Diabetes Federation of 
Ireland (DFI) (49%, n=105) (Figure 16). Commercial companies were the most popular 
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Figure 16 Percentage of practices receiving educational material from various sources 
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3.3.9 Relationship between having a diabetes register & practice 
organisation 
Maintaining a diabetes register was not significantly associated with practice 
characteristics. Mann Whitney U analysis showed no significant difference between 
practices with or without registers in terms of number of doctors in the practice 
(U=12667; p>0.05); number of patients overall (U=10559; p>0.05) or number of 
diabetes patients (U=7940; p>0.05). Having a diabetes register was not significantly 
associated with the level of staff employed by the practice (Table 13). The location of 
the practice was not significantly associated with maintaining a diabetes register (χ²=5.4; 
df =2; p>0.05). Sixty percent of rural practices maintained a register (n=28) compared 
to 48% of mixed practices (n=44) and 40% of urban practices (n=48). 
Table 13 Association between maintaining a register and features of the practice 
Characteristic Register 
N (%) 
No Register 
N (%) 
% Difference 95% CI p 
Practice Nurse 137 (88) 147 (79) 8% 0.6 to 16% P=0.06 
Practice Manager 64 (54) 69 (50) 4% -8 to 17% P=0.5 
 
Relationship with practice organisation 
Maintaining a diabetes register was significantly associated with the level of 
computerisation in the practice (Table 14). There was a significant association between 
having a register and whether or not there was a diabetes module on the computer 
system (χ²=12.714; df= 1; p<0.001) and whether or not a practice was paperless 
(χ²=5.676; df=1; p<0.05) although this was not significant after Bonferroni adjustment. 
Table 14 Association between maintaining a register and computerisation 
Characteristic Register 
N (%) 
No Register 
N (%) 
% 
Difference 
95% CI p 
IT Infrastructure 
Computer 
System 
148 (96) 169 (91) 5% -0.7 to 10% P=0.15 
Diabetes Module 96 (64) 49 (41) 23% 11 to 36% P=0.000† 
Paperless 69 (59) 54 (43) 16% 4 to 29% P=0.02* 
† Significant after Bonferroni adjustment. *Not significant after adjustment 
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3.3.9.1 Relationship with other features of diabetes care delivery 
As Table 15 illustrates, maintaining a register was significantly associated with features 
of diabetes care delivery; holding specific clinics (χ²=54.406; df= 1; p<0.001); having a 
formal recall system (χ²=61.753; df= 1; p<0.001) and the use of guidelines in the 
practice (χ²=43.249; p<0.001). Maintaining a register was also significantly associated 
with whether practices had a special interest in diabetes (χ²=10.732; p=0.001). Of those 
reporting a special interest in diabetes 84% (n=72) maintained registers compared to 
61% (n=62) who did not maintain a register. 
Table 15: Association between maintaining a register and organisational features of 
diabetes care delivery 
Feature of care delivery Register 
 
N (%) 
No 
Register 
N (%) 
% 
Difference 
95% CI p 
Specific Clinics for 
diabetes 
64 (41) 13 (7) 34% 25 to 
43% 
P=0.000† 
Formal Recall 65 (54) 12 (9) 45% 35 to 
56% 
P=0.000† 
Guidelines 91 (78) 49 (36) 42% 31 to 
53% 
P=0.000† 
Special Interest 72 (84) 62 (61) 23% 11 to 
36% 
P=0.001† 
Diabetes Screening 113 (95) 128 (93) 2% -4 to 7% P=0.08 
†Significant after Bonferroni adjustment. 
3.3.9.2 Relationship between maintaining a register & care pathways 
The relationships between maintaining a register and links with other service providers 
are detailed in Table 16. There was a significant association between having a register 
and having a formal shared protocol with the local hospital team (χ²=5.044; df=1; 
p<0.05) however this was not significant after adjustment for multiple testing and the 
percentage of GPs with a formal shared protocol was low in the sample (10%, n=26).  
Table 16: Association between maintaining a register and contact with other settings  
Characteristic Register 
N (%) 
No Register 
N (%) 
% 
Difference 
95% CI p 
Care Pathway 
Formal shared protocol 18 (15) 8 (6) 9% 2-20% P=0.03* 
Regular joint meetings 6 (5%) 1 (0.7) 4% 0.1-8% P=0.86 
Access to Dietician 95 (79) 67 (49) 30% 19-41% P=0.000† 
Access to Chiropodist 81 (67) 68 (50) 17% 5-29% P=0.009* 
Access to pop. based 
retinal screening  
56 (48) 35(26) 22% 10-33% P=0.001† 
† Significant after Bonferroni adjustment *Not significant after adjustment 
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After adjustment maintaining a register was significantly associated with access to 
auxiliary diabetes services; dietician (χ²=23.859; df =1; p<0.001), and population-based 
retinal screening programme (χ²=11.855; df=1 p<0.01).  Figure 17 demonstrates the 
difference between those with and without a register in terms of access. In each case 
access was greater among those maintain a register. 
 
Figure 17 Percentage of practices with/out a register with direct access to services 
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3.3.10 Special Interest in Diabetes 
While 73% of GPs reported a special interest (SI) in diabetes within the practice 
(n=138), only 55% of the total sample responded to this question (n=190). It was 
typically a GP or nurse who had a special interest in diabetes; 51% (n=81) and 45% 
(n=71) respectively. Other professionals in the practice with a special interest included 
the visiting dietician and the Diabetes Nurse Specialist (DNS) (see Appendix VI).  
3.3.10.1 Relationship between having a special interest & care 
delivery 
Practices reporting a special interest in diabetes were compared with those without a 
special interest in terms of practice characteristics and organisation (Table 17). There 
were no significant differences in terms of size and level of staffing. There was no 
significant association between practice location and having a special interest in diabetes 
(χ²=4.177; df= 2; p=0.124). Of those with a special interest 20% were rural practices 
(n=17), 38% were urban (n=32) and 42% were mixed practices (n=35). There were no 
significant differences in terms of the size of the patient population (U= 2559, p>0.05) 
or diabetes population (U= 1565, p>0.05). However there were a number of significant 
associations between having a special interest in diabetes and the organisation of 
diabetes care: having a register (p<0.001), holding clinics (p<0.001) (Table 17).  
Table 17: Association between having a special interest in diabetes and care delivery  
Characteristic Special 
Interest 
N (%) 
No SI 
N (%) 
% Difference 95% CI P 
Practice Nurse 121 (88) 36 (69) 19% 7-34% p=0.004* 
Practice Manager 38 (46) 11 (55) 9% -31-15% P=0.66 
Computer System 128 (93) 47 (90) 3% -5-15% P=0.69 
Diabetes Module 70 (68) 6 (24) 44% 23-60% P=0.000† 
Paperless 42 (54) 8 (42) 12% -13-34% P=0.5 
Diabetes Care Delivery 
Diabetes Register 72 (54) 13 (25) 29% 13-42% P=0.001† 
Specific clinics for DM 45 (33) 3 (6) 27% 15-36% P=0.000† 
Formal Recall 29 (35) 2 (10) 25% 3-38% P=0.06 
Guidelines 55 (67) 6 (30) 37% 13-56% P=0.005* 
Diabetes Screening  77 (92) 18 (90) 2% -9-22% P=0.8 
Access to/contact with other providers 
Formal shared protocol 8 (10) 1 (5) 5% -15-14% P=0.52 
Regular joint meetings - - - - - 
Access to Dietician 60 (72) 11 (55) 17% -5-40% P=0.23 
Access to Chiropodist 53 (64) 10 (50) 14% -9-37% P=0.38 
Access to retinal 
screening  
32 (40) 6 (35) 5% -21-26% P=0.93 
† Significant after Bonferroni adjustment *Not significant after Bonferroni adjustment. 
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3.3.11 Opportunities in Developing Diabetes Care 
Most respondents selected GP/Practice nurse training as the principal opportunity for 
developing diabetes care in their practice (76%, n=196) followed by easier access to 
specialist advice (65%, n=166) (Figure 18). Other suggestions put forward by 
respondents included access to dieticians and ophthalmology services in particular, 
shared care arrangements and protocols. (See Appendix VI for a summary of all themes 
emerging from analysis of responses.) 
 
Figure 18 Principal opportunities for developing diabetes care in the practice 
3.3.11.1 Remuneration for Diabetes Care 
Over half of the GPs surveyed thought that a mixture of capitation and fee per patient 
should be used as remuneration for diabetes (54%, n=136) while less than one quarter 
were in favour of target-based payment for diabetes care (19%, n= 49) (Figure 19). 
Figure 19 Remuneration options for providing diabetes care 
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3.3.11.2 Suggestions for improvements to diabetes care in Ireland 
The last section of the survey provided respondents with an opportunity to provide 
comments and suggestions on improving diabetes care. Most respondents elaborated on 
the opportunities for development presented in Figure 18. The most common themes 
are outlined in Table 18 (See Appendix VI for full thematic analysis). As illustrated by 
respondents‟ quotes, some issues such as time constraints and workload were proposed 
as barriers while remuneration and shared care were seen as potentially beneficial.  
Table 18 Emergent themes from suggestions to improve diabetes care 
Factor Sample of responses 
Incentives/ 
Remuneration 
“I won‟t get involved in the huge complicated task of looking after the 
diabetic needs of my patients unless there‟s a transfer of funds to pay for it” 
Working with 
secondary care 
providers 
“Better lines of communication with specialists [are] essential. Currently 
OPD is seeing patients who should be in primary care & we cannot get 
support for those who need it. Consultant care for all diabetics is unrealistic 
so a system where consultants provide quality support to primary care in 
managing diabetes is essential” 
“We‟d like the opportunity to have joint meetings with the hospital team & 
collaborate with them. At present they have different protocols & 
philosophies to us which are frustrating our care.” 
Access to 
Community 
Services 
 “Running diabetic clinic in GP practice pointless without dietician & access 
to community services such as ophthalmologist & chiropody - have to 
attend hospital for these, thus losing the patient to hospital, not GP run”. 
Lack of 
resources 
 “I would not attempt to look after diabetes needs of patients unless it was a 
1st class service I could provide, and with present resources it‟s not 
possible.” 
Time 
“Diabetes care takes a lot of patient contact time. Initially on diagnosis of T2 
diabetes there are numerous visits & education/bloods etc until the hospital 
appointment comes up. It would want to be well paid to make it worth GPs 
time as DM care to be done properly is very time consuming” 
Workload 
“It is demoralising to contemplate burgeoning workload involved in tandem 
with dwindling hospital resources”. 
“Due to workload we have had to reduce commitment to our diabetes 
patients, suspending dedicated clinics... & now referring all new diabetics to 
hospital (in spite of having acquired extra qualification in diabetes care!)” 
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3.4 Discussion 
The present study assessed the level of diabetes care delivered in general practice in 
Ireland and identified areas for further development. A substantial proportion of 
diabetes care delivery was unstructured with limited adoption of strategies to enhance 
delivery such as maintaining a register and engaging in routine recall. The survey 
showed that less than half of GPs maintained a diabetes register while only half of GPs 
operated some form of call/recall system for reviewing patients, whether formal or 
informal. The findings are consistent with the first national survey of diabetes care in 
general practice in 2003 (135), suggesting little progress has been made in organising the 
delivery of diabetes care.   
3.4.1 Integration between settings 
There was deficient access to dietetics and foot care services among the GPs surveyed. 
While most GPs reported access to ophthalmic examinations this service was provided 
by a variety of service providers. Respondents referred to a patient‟s public/private 
status as a key determinant of waiting times across all ancillary services.  The survey also 
showed that the majority of GPs did not have a formal shared protocol with the local 
hospital based specialist diabetes team and had little formal contact with this setting. 
Shared care and protocol-driven management in general practice have previously been 
found to relate significantly to metabolic control in an Irish sample of patients with 
diabetes (160). The lack of integration reported by GPs was echoed in the more recent 
survey of outpatient diabetes care in 35 public hospitals in Ireland. Over half the 
hospitals surveyed reported rarely or never discharging patients back to GP care (n=20) 
(161). The results from GPs in Ireland contrasts with findings from the UK survey of 
care provision where 39% reported a formal protocol and 14% had regular joint 
meetings with the hospital-based specialist diabetes team (155). The GPs in this survey 
did express interest and enthusiasm for integrated care arrangements with shared care 
emerging as one of the suggested opportunities for developing diabetes care into the 
future. There are a number of structural, resource and practice implications arising from 
these findings such as the development of communication pathways and patient 
tracking systems to facilitate integration between settings. 
3.4.2 Use of strategies to enhance organisation and delivery 
The survey found that approximately half the sample used guidelines for care. Less than 
one quarter of GPs referred to the national guidelines for diabetes care in the 
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community which emphasise patient registration, recall and regular review as the key 
components of comprehensive diabetes management (17). A patient registration system 
could facilitate the latter two components of integrated diabetes management as it 
allows patients to be recalled for review or referral at appropriate intervals based on 
evidence-based guideline, as well as facilitating the auditing of care and outcomes for 
quality improvement (162). This dual relationship is supported by the significant 
associations between maintaining a diabetes register and other aspects of diabetes care 
delivery demonstrated in this study. Among others, there was a significant association 
between maintaining a register and having a diabetes module on the practice IT system 
as well as engaging in formal recall. A survey of diabetes care in primary care health 
centres in Sweden found a positive association between having a call-recall system and 
the use of guidelines, echoing the synergy between quality improvement strategies 
indentified in this study.  
It seems likely that maintaining a diabetes register is a marker of a greater interest 
among practices in quality improvement activities overall (15). There was a significant 
association between having a special interest in diabetes and maintaining a register 
however the substantial proportion of missing data on the former variable should be 
taken into account. This study highlights the need for further exploration of the 
attitudes of GPs towards quality improvement. Health professionals are key players in 
the success or failure of quality improvement programmes depending on their 
willingness to learn, accept and adapt to changes in practice (163). A follow-up 
qualitative study with GPs, presented in Chapters 4 and 5, explores issues such as the 
possibly iterative relationship between having a special interest in diabetes and adopting 
strategies to organise care as well as the other factors driving engagement in 
improvement.  
The main barriers to developing care, lack of resources, time constraints and workload, 
concur with other studies and reflect published primary care concerns around providing 
diabetes care in general practice (135, 164). Our study extends prior results on barriers 
to care by also highlighting the principal opportunities for diabetes care improvement. 
Training for GPs or practice nurses was the most important opportunity according to 
GPs again suggesting willingness among GPs to deliver diabetes care with adequate 
support. Further investigation is warranted as to how special interest translates into 
practice.  
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Improving links with community services and secondary care were perceived as 
facilitators of care delivery. A number of GPs referred to arrangements with secondary 
care providers or expressed interest in developing such links. These responses reflect 
the variability of care characteristic of Ireland. The last 10 years has seen the 
introduction of specific structured or shared care programmes for diabetes in Ireland 
(137, 138). However some of these initiatives have not been sustained due to lack of 
funding and resources. This study reiterates the call for further research to identify the 
factors critical to the success of shared or structured care arrangements (132).  
Among this sample of GPs remuneration was cited as an important factor for the 
development and integration of diabetes care. A mixture of capitation and fee per 
patient was proposed as the most suitable method of payment. There may be credence 
in linking remuneration to the three pillars of effective integrated diabetes care; 
registration, recall and review. A comparable strategy has been proposed by the Obama 
administration in the U.S where bonus payments will be given to physicians who adopt 
and use electronic health records effectively (165). The NHS in the UK also has a well-
established incentive structure, the Quality Outcomes Framework, which links 
remuneration with quality assurance.  
3.4.3 Strengths and Limitations 
This study has some limitations because of the relatively low response rate however the 
profile of the sample in terms of urban/rural breakdown is broadly comparable with the 
national profile (159).While the response rate is lower than that achieved by an earlier 
GP survey of diabetes care in 2003 (135), it is similar to the 46% response rate received 
by the National Audit of Stroke Care Survey of GPs in 2006 which used the Irish 
Medical Directory rather than the ICGP approach to sampling and recruiting (166) and 
the survey of diabetes care conducted in the UK(155). A recent systematic review of the 
response rate in over 350 GP postal surveys found a mean response rate of 61%. One 
quarter of the studies had a response rate of less than 50% (n=91 studies). A number of 
strategies were incorporated to increase the response rate including endorsement by a 
professional association (ICGP) (167) and providing freepost return envelopes (168). 
The extent and intensiveness of follow-up was restricted under the regulations of the 
Irish College of General Practitioners which prohibited telephone follow-up of non-
responders to maintain anonymity.  
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Given the self selecting nature of survey research and thus the inevitable bias towards 
GP with an interest in diabetes one would expect to have found a bias towards optimal 
care delivery in this sample. Therefore given the significant deficits in the level and 
organisation of diabetes care documented in this study it is arguable that the problems 
highlighted here have been understated. With regard to strengths of this study, the 
survey instrument has also been used to assess service provision in the UK (155) and 
adapted and used previously in an Irish setting (154). 
3.4.4 Conclusion 
This study provides an important benchmark of the organisation of diabetes care in 
general practice in Ireland. The findings suggest limited progress towards more 
organised care delivery since 2003. Maintaining a diabetes register was associated with 
other quality improvement efforts and it is likely that a register is a marker of 
enthusiasm and investment in quality improvement for patients with diabetes in the 
practice. Despite the focus on improving diabetes care in recent years, considerable gaps 
in care remain suggesting that the problems and solutions stem beyond clinician 
engagement to systems level interventions addressing service design, care delivery and 
remuneration. 
87 
 
 
 
 
 
 
 
 
 
 
 
4 Providing Diabetes Care in Irish General Practice; 
Everyday Experiences and the Barriers and 
Facilitators to Optimal Delivery 
 
 
 
 
Sheena Mc Hugh 
Dr. Monica O‟Mullane 
Prof. Ivan J. Perry 
Prof. Colin Bradley 
 
 
 
  
88 
 
Abstract 
Aims: The aim of this qualitative study was to explore GPs‟ experiences of delivering 
diabetes care in more detail and to elucidate the models of care in Ireland. The second 
aim was to identify the barriers and facilitators to providing optimal care in everyday 
general practice.  
Methods: A purposive sample of 29 GPs and 2 Practice Nurses (nominated to 
represent the practice) participated in semi-structured interviews. Participants‟ practices 
varied by (a) location (rural/urban), (b) size (single-handed/group practice) c) extent of 
computerisation in the practice. The topic guide focused on 5 subjects, 3 of which are 
dealt with in this chapter: management and organisation of diabetes care in the practice; 
barriers and facilitators to delivering care; and finally a wish-list for the development of 
diabetes care in Ireland. A prompt on the factors promoting or hindering care, based on 
the findings of the preceding survey was used during the interviews. Analysis was 
conducted using the Framework approach. 
Results: Four dimensions of diabetes care delivery were identifiable in the data; 1) a 
continuum of organisation within the practice from “ad-hoc” to structured care, 2) the 
balance of care between general practice and the hospital setting, 3) the extent of 
sharing between settings 4) involvement in formal or informal initiatives to improve 
diabetes care. A proposed “ideal” arrangement was “sharing” responsibility rather than 
either/or care, combining the strengths of general practice and hospital services, 
however there were varying opinions about the need for joint involvement. The barriers 
and facilitators to optimal diabetes care delivery were intertwined as obstacles occurring 
at the systems level had a ripple effect at an organisational, social, professional and 
patient level. The “non-existent” remuneration for diabetes care created a sense of apathy 
in general practice and was perceived to be indicative of the lack of value placed on 
chronic disease management in the health system. There was a subset of GPs delivering 
structured care who were motivated by “vocational” incentives such as job satisfaction 
and personal experience. The lack of coordination within the system had a number of 
consequences including waiting times, overburdened hospital services, a bureaucratic 
“palaver” and “in the meantime” care for patients. The general practice setting was 
identified as a facilitator in the delivery of diabetes care however its potential was 
limited by the lack of resources. 
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Conclusions: The study explored the myriad of care arrangements in Ireland and the 
interrelated barriers and facilitators to optimal diabetes care which have an effect on 
practice organisation, professional attitudes and relationships as well as patient care. At 
present intrinsic motivation is a determinant of the provision of structured systematic 
diabetes care in general practice. However this will not be sufficient to drive widespread 
implementation of the proposed national model of integrated care. While a national 
programme needs to be flexible to account for local capacity and interest, there is still a 
need for coordination at a systems-level and accountability at a professional-level. 
 
  
The paper will be submitted for publication to Social Science & Medicine 
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4.1. Introduction 
According to an article on optimal diabetes management published in 1982, the “care of 
diabetics requires enthusiasm and organisation” (169). The authors recommended that the 
management of uncomplicated diabetes take place in general practice by trained staff 
working closely with specialists in the hospital setting. Features of effective diabetes 
care identified in 1982 included regular review, the use of special records for diabetes 
care and nurse involvement. Since then, there have been significant advances in the 
management and treatment of diabetes (42, 55, 59) however gaps have opened up 
between the ideal standard of care and the reality for clinicians and patients.  
4.1.1 Importance of organisation in providing effective diabetes care 
Enthusiasm and organisation, in various guises, have emerged from the body of quality 
improvement research, as the building blocks to bridge the gap (6-8, 63, 81). The 
Chronic Care Model (CCM) emphasises the role of a proactive practice team in 
delivering planned structured care for patients with chronic illness. The model also 
proposes major reorganisation within the practice to meet the needs of patients (81). 
There is evidence to suggest the reorganisation of care improves the quality of diabetes 
care processes and patient outcomes (14, 111). However a survey of diabetes care in 
general practice in Ireland (Chapter 3) highlighted the lack of structured delivery in this 
setting, reflected in the absence of patient registers and the lack of routine recall (170). 
The survey also found deficient access to services necessary to support the management 
of diabetes in general practice. Over 30% of GPs did not have access to dietetics 
services while more than 40% did not have direct access to chiropody services.  A 
similar survey of diabetes care conducted among public hospitals in Ireland also found 
insufficient support services in the secondary care setting (unpublished) (161). 
4.1.2 Importance of integration between settings 
The availability of community resources, including relationships and links with other 
health care professionals, is a key component of effective integrated chronic illness 
care(81, 84). Diabetes is particularly challenging to coordinate as there is the myriad of 
health care providers and settings involved in providing care, within which the patient 
can become lost. The organisation and delivery of diabetes services differs within and 
between countries involving secondary care and primary care providers to varying 
degrees (138). Over time the terminology surrounding models of care have developed 
multiple meanings, definitions and connotations. Terms scattered throughout the 
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quality improvement literature include „integrated care‟, shared care (Europe), 
transmural care (Netherlands), managed care (USA), structured care and more broadly 
chronic disease management (171) (see Chapter 2 for summary of models of care).  
Ireland reflects the intricacies of the literature as each model of care has context-specific 
connotations. There are currently ten formal diabetes initiatives across Ireland ranging 
from shared care arrangements between GPs and hospital teams (139) to structured 
care initiatives set up by GPs (137, 172). The national guidelines for diabetes 
management endorse an integrated model of care in which patients with stable diabetes 
would receive the majority of care in primary care while patients with more complex 
needs would have access to a greater level of specialist support (17). However the 
aforementioned surveys of diabetes care in general practice and the hospital setting have 
highlighted the lack of formal integration between settings. Over half of hospitals 
reported rarely/never discharging patients back into GP care. Only 3% of GPs had 
regular meetings with the local hospital diabetes team and most did not have a formal 
shared protocol with the hospital-based team.  
Given the array of care arrangements in Ireland it is difficult to quantitatively assess the 
extent to which diabetes care is coordinated between settings or provided independently 
by practices to meet the immediate needs of the local community, although certainly the 
aforementioned surveys highlight some of the barriers to coordination. This qualitative 
study will seek to untangle the myriad of models and levels of integration between 
settings in order to bring some clarity to the picture of diabetes care in Ireland. 
Qualitative research is no longer seen as an add-on in health services research (173). 
Particularly in the area of quality improvement, one of the key questions for health 
services research is the barriers for clinicians in meeting the needs of patients with 
chronic illnesses (174).  
4.1.3 Aims & Objectives 
As part of the wider aim of this thesis to investigate the „quality chasm‟ in diabetes care 
organisation in general practice, the two objectives of this study were; 
1. To elaborate on experiences of delivering diabetes care in general practice and 
elucidate the models of care functioning in Ireland. 
2. To explore perceptions of the barriers and facilitators to providing diabetes care 
in everyday general practice. 
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4.2 Methodology 
4.2.1 Design 
A qualitative study was carried out involving face-to-face semi-structured interviews 
with a sample of GPs and Practice Nurses. The study was conducted by 2 researchers 
(SMH and MOM). Each researcher followed the same procedure when independently 
interviewing participants. Results were analysed separately before comparing the 
convergence and divergence of findings. 
The qualitative design and methodology underpins two chapters in this thesis (Chapter 
4 and 5). This chapter constitutes the second phase of a mixed method sequential 
design, which was preceded by a quantitative GP survey (Chapter 3)(153). The findings 
of the survey were used to inform the topic guide for this study while the results of this 
qualitative investigation will be used to understand in more depth the patterns and 
differences which emerged in the cross-sectional study.  
The themes presented in Chapter 5 emerged from the same qualitative methodology 
and phase of data collection, but dealt with the issue of quality improvement and 
participants‟ attitudes towards change. 
4.2.2 Participants 
4.2.2.1 Recruitment 
Participation in the qualitative study was by means of „opting-in‟ during the preceding 
GP survey. GPs, who indicated willingness to be contacted by providing their contact 
details on the last page of the survey, were eligible to participate (Appendix IV).  
4.2.2.2 Sampling Frame 
In total 213/262 survey respondents provided follow-up details (81%) representing 25 
of the 26 counties in the Republic of Ireland. A purposive sample was selected from 
this pool, based on three sets of criteria previously used to distinguish between practices 
in Ireland(160). 
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4.2.2.3 Selection criteria 
1. Urban/Rural practices 
2. Single handed/ Group practice: group practices were defined as those with >1 
GP employed.  
3. Fully computerised using the system for clinical consultation / Computer 
system used for administration only or no computer.  
There were 8 categories from which to recruit participants (Table 19). All potential 
participants were screened by telephone to establish their profile. During screening a 
number of GPs could not be contacted and so could not be included in the sample. 
Table 19 Combinations of selection criteria 
Rural/ Single / Computer Urban / Single/ Computer 
Rural/ Single/ Non-computer Urban /Single /Non-computer 
Rural/ Group/ Computer Urban/ Group/ Computer 
Rural/ Group/ Non-computer Urban/ Group/ Non-computer 
4.2.3 Sampling Matrix  
The 3 sets of inclusion criteria formed the sampling matrix, containing a number of 
cells in which a quota of GPs was specified (Table 20)(158). The quota indicates that 
some coverage was required in each cell. The ranges given in each category of 
computerisation are slightly different (4-5 or 3-4) so that they add up to achieve the 
correct numbers overall. The specification would achieve a sample of 28-32 GPs.  
Table 20 Proposed Sampling Matrix 
 Urban (14-16) Rural (14-16) 
Single 7-8 7-8 
Computerised 
Non-computerised 
4-5 
3-4 
4-5 
3-4 
Group 7-8 7-8 
Computerised 
Non-computerised 
4-5 
3-4 
4-5 
3-4 
Overall 31 participants were interviewed. The group was composed of 29 GPs and 2 
Practice Nurses who were nominated by the GP in their practice to participate. All 
criteria were represented in the group although the non-computerised practices were 
more difficult to recruit as illustrated in Table 21.  
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Table 21 Participant Matrix (N=31) 
 Urban (16) Rural (15) 
Single (15) 6 9 
Computerised 
Non-computerised 
4 
2 
8 
1 
Group (16) 10 6 
Computerised 
Non-computerised 
10 
0 
6 
0 
4.2.4 Topic Guide  
The semi-structured topic guide was informed by both the objectives of the study and 
the results of the GP survey outlined in Chapter 3. It included five broad subjects for 
discussion (Appendix VIII); 
 Current provision of diabetes care 
 Factors influencing the optimal delivery of diabetes care 
 Wish list for diabetes care in Ireland  
 How have things changed locally and nationally  
 Attitudes to the development of a national diabetes register and engaging in 
audit in the practice. 
Themes which emerged from the latter two topics are presented in Chapter 5 which 
focuses on change in the health system and attitudes to quality improvement. 
A written prompt of the factors influencing the provision of care was also included in 
the interview schedule to stimulate discussion (Appendix IX). The prompt was 
developed from the responses to the following two open-ended questions in the 
preceding GP survey: 
Q What do you see as the principal opportunities for developing diabetes care in 
your practice?  
Q We welcome your insight into diabetic care and thus any comments/suggestions 
for improvements are appreciated whether positive or negative. 
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Originally the prompt was devised as a checklist in which the interviewee would indicate 
whether a factor was a barrier or facilitator to care delivery (Appendix IX). However 
feedback from GPs and experience during the interviews suggested that this format was 
restrictive and superficial as a number of GPs conceptualised certain factors as both 
barriers and facilitators depending on their presence or absence in the practice e.g. 
resources. It was decided by the research team to modify the checklist, resulting in a 
written prompt around which GPs could discuss their views and experiences. 
4.2.4.1 Pilot 
The first two interviews were used to pilot the topic guide highlighting which questions 
worked well and where changes were needed. It also allowed the researcher to assess 
the timing and pace of the interview. As the content and focus of the topic guide did 
not change substantial the two interviews were included in the overall analysis. 
4.2.5 Procedure 
A total of 31 interviews were conducted by 2 researchers (MOM and SMH) between 
July and January 2010. A letter of invitation was sent to the sample of GPs (Appendix 
X). This letter indicated that a researcher would contact the GP in the coming week to 
register his/her interest in the study and arrange a suitable time for the interview if 
applicable. GPs who indicated interest in taking part during the follow-up phone calls 
were then sent an outline of the topic guide and a letter of reminder regarding the time 
and date of the interview. Interviews took place in the GP surgery or the participant‟s 
home at a time selected by the participant. The interviewee was given an information 
sheet and consent form to sign (Appendix XI). The interviews lasted between 25 
minutes and 1.5 hours and were digitally recorded with permission. A summary of the 
interview was sent to each participant upon completion of the analysis. This was a 
stipulation for the ethical approval but also provided an opportunity for respondent 
validation. Participants were given 4 weeks to respond with comments however none of 
the participants replied.  
4.2.6 Analysis 
Analysis was an ongoing and iterative process. All interviews were digitally recorded and 
transcribed verbatim by the individual interviewer. A pragmatic approach was adopted 
for analysis using Framework Analysis (158) which is increasingly popular in Health 
Services Research (175). To begin, the researchers familiarised themselves with the data 
(reading and re-reading), moving on to open-coding of the transcripts to identify initial 
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themes and concepts. A thematic index or conceptual framework was developed from 
these codes based around the core topics of the interview topic guide but also including 
newly emerging themes. In this study, it was decided not to apply the index to the data 
as data were already quite orderly given the semi-structured nature of the interview 
schedule. Data were then sorted and synthesized by theme bringing similar concepts 
together (thematic charting). Throughout this stage the language and expressions of the 
GPs were maintained as far as possible to avoid losing the meaning and context. In the 
quotes presented in this chapter words in parenthesis and ellipses (…) were added by 
the researcher; to clarify meaning in the first instance or to indicate the removal of 
unrelated text in the second instance. An identification number was assigned to each 
participant reflecting the order of the interviews as well as the researcher who 
conducted the interview (GP 1=MOM, GP101=SMH). Alphabetic codes were also 
applied to quotes to reflect location (U=urban, R=rural), practice size (S=single, G= 
group) and level of computerisation (C=computerised, NC=non-computerised). 
 Memos 
Memo writing was also used as an analytic tool in conjunction with coding. Charmaz 
(2006) compares memo writing to having a conversation with yourself, allowing space 
to clarify thoughts and questions, identify avenues to pursue, make connections or 
comparisons between data and uncover assumptions of both the participant and the 
researcher (176). The last function reflects the role of memo writing in researcher 
reflexivity; writing and acknowledging your own thoughts, actions and decisions (177). 
Memo writing was guided by a typology proposed by Saldana as „recommended 
categories for reflection‟ (Table 22) (178). Appendix XII includes a sample of the 
memos written during the analysis based on but not restricted to this typology.  
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Table 22 Recommended categories for reflection (178) 
Reflect on and write about... 
How you personally relate to the participant of the experience 
Your research question 
Your choice of codes and how you define them 
Emergent patterns, categories, themes 
Possible relationships, networks, connections between themes 
Emergent or related existing theory 
Any problems with the study 
Personal or ethical dilemmas with the study 
Future directions for the study 
Final report of the study 
4.2.6.1 Inter-coder reliability 
Following the initial wave of analysis a number of interviews (3 from each researcher) 
were subject to inter-coder reliability by an independent party familiar with the aims of 
the study (CB). Following independent analysis, the two researchers examined the 
convergence and divergence in their findings outlined in the next section. 
4.2.6.2 Triangulation 
The qualitative study was conducted by a team of researchers from inception to 
completion. Two researchers were involved in the collection and analysis of the data. 
Each researcher analysed their set of interviews separately1 generating a set of themes 
and concepts pertaining to their data. The two researchers examined the convergence 
and divergence in their findings. Discrepancies arouse from two conditions; 1) different 
labels or codes applied to the same concept or 2) unique concepts emerging from one 
researcher‟s analysis not identified by the other researcher. More often than not, a 
similar “constellation of themes” were identified, the difference lay in the labels applied to 
the themes i.e. “packaging” as described by Armstrong et al (1997) in a study employing 
multiple analysts (179). Through discussion it became clear that the codes related to the 
same concept. Occasionally, unique codes emerged from one analysis which was then 
discussed with the wider group (other researcher and independent rater) (Appendix 
XIII). These unique insights are maintained and highlighted in the results section.  
4.2.7 Ethical Approval 
                                                          
1 Fifteen interviews were conducted by Sheena Mc Hugh and sixteen interviews were carried out by Monica 
O‟Mullane. 
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Ethical approval was sought and granted by the Irish College of General Practitioners in 
June 2009 (Appendix XIV). 
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4.3 Results 
This section presents the emergent themes from GPs‟ experiences of providing care to 
patients with diabetes. It is organised in two parts. Section 1 examines the experiences 
of delivering care in general practice illustrating the four dimensions of diabetes 
management which emerged from GPs‟ accounts. GP descriptions included practice 
procedures, links with secondary care and the use of support services which were used 
to elucidate the models of diabetes care in practice (Section 1A). Section 2 outlines the 
barriers and facilitators to providing diabetes care in everyday general practice. 
Section 1: Dimensions of Diabetes Care Delivery 
Emergence of themes 
Four dimensions of diabetes care were delineated from GPs experiences in everyday 
practice (Figure 20*). The 1st dimension pertained to whether care was “ad hoc” or 
structured within the practice. This was a practice level issue and does not seek to infer 
about the nature of care delivered in the hospital which was not the focus of the 
interview. The 2nd dimension was the varying balance of care between settings which 
emerged from GPs accounts of how care is delivered between settings and the extent to 
which patients are managed in general practice. Some participants referred to the ideal 
scenario of greater sharing between settings, implying that it was not the current reality. 
The theme also reflects how GPs felt about anchoring diabetes care in general practice.  
The 3rd dimension reflected the extent to which care was shared between settings. It was 
identified as a separate dimension as there were a subset of GPs providing the majority 
of care for patients with Type 2 diabetes (i.e. balance of care in general practice) and 
were not sharing management with the hospital team according to their accounts. The 
4th and final dimension distinguished between formal initiatives to improve care delivery 
and care arrangements established independently by the GP (informal) without the 
support of a formal initiative (See Appendix XIII for development of dimensions) 
*Note Figure 20-GPs on the right-hand side of the diagram were those providing 
structured care to patients. GPs placed in the top portion of the diagram were providing the 
majority of routine diabetes management (GP-led care). On the right-hand side moving 
from top to bottom practices were involved in greater sharing of care with the hospital 
team. For example, GP105 referred patients to hospital for routine management (hospital-
led) and attended to patients‟ diabetes as they presented as the practice for other issues (ad-
hoc). 
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4.3.1 Nature of care delivery: continuum from ad hoc to structured care 
The first distinction which emerged from the data was between practices providing care 
in a structured way and those providing care on a more “ad-hoc” basis. The distinction 
was made by the GPs themselves and was also reflected in their descriptions of how 
care was delivered. There was a continuum of structured to ad-hoc (non-structured) care rather 
than an all or nothing situation, as there were elements of opportunism in structured 
care namely; GPs providing care as part of a daily surgery, manual recall and the role on 
patient responsibility. Equally there were some indications of structure in practices 
providing care in an ad-hoc way e.g. having targets for regular review although it was 
patient-initiated. 
4.3.1.1 Features of a Structured Approach to Care 
 
Figure 21 Features of a structured approach to diabetes care. 
Structured care was characterized by certain features that made delivery more organised 
(Figure 21) but was also reflected in the sequential stages of delivery which GPs referred 
to. For example, when asked to describe care GP112 identified 3 key features from the 
outset: registration, referral and recall. Upon diagnosis patients were registered and 
referred to the nurse and the dietician and entered into the recall system of the practice. 
The common features of structured practices were registration, recall and regular 
review, using a protocol and “keying into that” on the computer or following guidelines. 
A number of practices held special clinics often led and coordinated by nurses. „Clinics‟ 
referred to both special dedicated clinics within the practice for patients with diabetes 
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(e.g. Thursday morning) or protected time for diabetes care used and organised at the 
discretion of the nurse (e.g. fitting  a number of diabetes appointments into the diary 
over the course of a week). 
Delegation within Practices & the Facilitating Role of the Nurse  
Another feature of practices providing structured care was the delegation of tasks 
between the GP and the Practice Nurse. Participants‟ descriptions reflected a clear 
understanding of who was delivering different components of diabetes care, as part of a 
team approach to regular management (Figure 22). This approach was best described by 
one GP as “a combination of themselves and ourselves” (GP112, RGC). It illustrates the 
integral role of the nurse in facilitating the delivery of planned structured care. 
 
Figure 22 Teamwork approach to regular diabetes management 
  
GP  involved in problem-solving & prescriptions 
“We would see them, check their BP and stuff like that, do their bloods and then we‟d get 
them to come and see the nurse for a full sort of a diabetic review at least twice a year or 
whatever.” (GP101, RSC) 
Nurse-Led diabetic clinic 
“They're invited in to what she calls a 'diabetic clinic'..She's got a routine she works 
through...she does their bloods, the usual bloods you'd expect to do with HbA1C, the lipids 
and all that kind of thing....goes over diet and exercise and checks their feet. So, she's done it 
fairly independently...” (GP110, RGC) 
Nurse coordinating & delivering reviews 
"I set aside half an hour/40 minutes every month in my diary to go through the list and see 
who‟s due and I write to them then and say „mister b it‟s now time for your bloods to be 
done can you please book an appointment to come in and see the nurse‟ and they come in 
then, that‟s how we work it ” (PN 104, RGC). 
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Opportunistic aspects of care within a structured approach 
Despite the features of structured care, there was an inevitable level of opportunism to 
diabetes management due to a number of factors. 
 Diabetes as part of GP‟s daily surgery  
Firstly management was opportunistic for GPs themselves as they would see patients for 
particular problems and also attend to their diabetes management as part of everyday 
surgery. For example GP110 felt care was provided “partly” on an ad-hoc basis by the 
GP during a routine surgery while the nurse had a systematic approach of fitting 
diabetes sessions into her day. 
 Lack of electronic recall system 
Even structured care practices were reliant on manual recall of patients, via a paper-based 
system usually coordinated by the nurse. For example Practice Nurse 104 talked about 
setting aside time each month to go through the list to see who was due and writing to 
notify the patient. GP 108 also talked about the Practice Nurse working through the list 
and keeping a diary to co-ordinate appointments for shared care clinics. 
 Patient Responsibility: an “adult approach” to recall 
Finally the recall process was ultimately reliant on the patient returning. A number of GPs 
spoke about having regular but patient-initiated follow-up. In describing her 
opportunistic approach to recall and review, GP115 highlighted the enabling role of the 
nurse in coordinating care;  
“The patients come back themselves, I say to them during the consultation to come 
back for a check-up. I don‟t send letters or anything like that….I try to avoid 
reminders, it‟s their responsibility...I mean maybe if you had a nurse you could do 
those things....” (GP115, RSNC) 
As this quote reflects, the seemingly ad-hoc approach to recall was purposeful among 
some GPs. Furthermore, this approach was not only adopted by single-handed GPs 
who did not have the support of nurses. GP108 (RGC), whose practice provided 
structured care, adopted a new “adult approach” to follow up whereby patients are 
contacted with an appointment and advised to come to the surgery for their bloods 
prior to the appointment. For those who don‟t attend, “it‟s their problem”. This approach 
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was compared to a previous system of nurses “pursing” patients which led to patients 
becoming “dependent and incapable”.  
An important distinction between the two approaches to follow-up, noted by GP108, is 
that it was possible to pursue patients when they had more nurses. GP101 (RSC) also 
referred to periods in the practice history when a practice nurse was not available and as 
a result “care went back to an ad hoc thing”. This theme reiterates the central role of the 
nurse in providing regular follow-up (Appendix XII). 
4.3.1.2 Features of ad-hoc care 
Ad-hoc management was described by one participant as “picking up a diabetic at random, 
giving medications and checking BP” (GP105). The two prominent features of ad-hoc care 
which emerged from GPs‟ descriptions of care were opportunistic follow-up and 
problem-led rather than routine management. Both elements of ad-hoc management 
were intertwined as opportunistic follow-up occurred when a patient presented with a 
problem or for a prescription. For instance, one GP spoke about following-up through 
medicines; “they do require meds, that‟s how we treat them” so they “probably” come back in for 
them (GP109 RSC). Another GP in an urban group practice described care as “ad hoc” 
because he did not run structured clinics and attended to patients when they presented 
with their problems (GP106, UGC). It was suggested by one GP that unstructured 
opportunistic management of Type 2 diabetes in general practice was the rule rather 
than the exception. The lack of a patient register was given as a reason for the 
opportunistic follow-up of patients, reflecting the synergy between elements of 
structured care. 
4.3.1.3 Continuum of Structured to Ad-hoc Care 
Just as there were elements of opportunism in structured care practices, there were also 
shoots of structure appearing in practices with an ad-hoc approach. For example GP111 
was placed along the continuum in Figure 20 as she referred to becoming more 
organised for newly diagnosed patients. While initially suggesting care was “not 
particularly organised”, the GP also spoke about having her “own agenda” to check things 
when the patient visits and not just responding to problems.  
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4.3.2 Balance of Care 
The 2nd dimension of diabetes care related to the balance of care between general 
practice and the hospital setting. A number of GPs felt they were providing the majority 
of care, particularly structured care practices (GP2, GP3, GP112 RGC, PN104 RGC, 
GP110 RGC, GP101 RSC, GP103 UCG). 
“When we have to initiate insulin we do it here, under the guidance of the nurse 
who's been trained in that and ourselves…to be honest, I would say, 85% of our 
diabetics are managed exclusively here.” (GP112, RGC) 
Practices providing care in an „ad-hoc‟ way usually referred patients to the hospital for 
management and dealt with problems as they arouse on a daily basis (See Figure 22) 
(GP105 UGC, 106 UGC, 113 USC, 114 USC, 115 RSNC). GPs were classified as being 
involved in a model of hospital-led care if they stated it explicitly; did not appear to 
provide systematic care in the practice; or more often than not provided little detail on 
how care was delivered (Appendix XIII). A lack of detail was reflective of a lack of 
engagement or familiarity with the care pathway for patients.  
“Basically we have a very good diabetic clinic in [the hospital]. So [the consultant] 
does a lot of the management for us so we would really be screening and referring on 
there” (GP107, RSC). 
Figure 23 illustrates the factors which determined whether the balance of care fell 
towards hospital-led management or general practice-led diabetes management.  
 
Figure 23 Factors influencing the balance of diabetes between settings  
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4.3.2.1 Factors determining the balance of care 
 Availability of resources 
For some participants the balance of care was determined by the resources available in 
the hospital and/or unavailable in general practice. For example, GP5 (UCG) perceived 
his role to be to “diagnose, prescribe and refer” as without adequate support and 
communication with other service providers it was difficult to do anything else. 
“I normally do the initial diagnosis and work up but then they would go to the hospital. 
They can get their eyes checked there you see and all that stuff.” (GP102, USNC) 
4.3.2.2 Capability vs. Availability of resources 
The lack of resources was highlighted as a barrier to greater primary care involvement in 
diabetes care. Despite consensus among participants that general practice was an 
appropriate setting for managing diabetes, some participants felt they were at a 
disadvantage to the hospital setting in terms of “access to all the specialties involved” (GP107, 
RSC). Those who delivered structured care to patients recognised the resource 
implications of their approach. 
“It is very labour intensive and some practices would find it very difficult, well we find it 
difficult and we‟ve 2 nurses, but particularly practices that have very little nursing 
resources or none, very, very difficult.” (GP103, UGC) 
More specifically a number of participants felt general practice was „capable with 
resources‟. The use of the conditional tense in the following quote gives a sense of the 
untapped potential in general practice and the scope for improvement; 
“GPs are competent and capable of doing it but because of manpower and 
infrastructural issues it‟s not being delivered to the standard that it could be” (GP106) 
 History repeating itself 
The 2nd factor which influenced the balance of care was the tradition of referring all 
patients to the hospital specialist. One GP suggested the tradition of referring all 
patients to “one tsar of diabetes” was “totally disempowering a whole generation of young doctors” 
(GP108, RGC). Such traditions were being carried on by GPs in this study; 
“I was in a 3 doctor practice and I was following the lead of the others, which was the 
historical thing that anybody with diabetes was referred to the hospital.” (GP113, USC) 
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 Location 
The location of a practice had an influence on the balance of care as GPs in rural areas 
had little choice but to manage patients with diabetes given the distance from hospital 
services. The move towards primary-care based management was not a new 
phenomenon in rural areas: 
“There are individual GPs who‟ve been working away like mad…out in the west of 
Ireland y‟know, single handed, who‟ve been just doing it all the time. It‟s a special 
interest for them because they‟ve been 100 or 150 miles from a clinic so they‟ve had to do 
it. They‟ve become the specialists” (GP103, UGC) 
 Special Interest 
Finally the balance of care residing in general practice was related to a GP‟s interest in 
diabetes and therefore his/her willingness to take charge. As a practice nurse reflected; 
“We do a very heavy workload for diabetics but that‟s because diabetes is one of our big 
babies here” (PN 104, RGC) 
As well as being a determinant of the balance of care, special interest also emerged as a 
facilitator of high quality care which will be outlined in the 2nd section. 
4.3.3 Extent of sharing care 
The third dimension of diabetes care delivery was the extent of sharing between settings 
which varied across GP experiences. Some practices were involved in a formal shared 
care scheme which comprised of a diabetes nurse specialist clinic in the practice once a 
month. Other GPs had more informal arrangements such as GP107 from a rural 
practice which was sharing care by “supporting the hospital”; 
“I suppose we do share care in that we do the blood monitoring for the hospital and 
we send them all with the patient. I suppose that‟s part of shared care that we‟re 
doing at the moment” (GP107, RSC) 
Other GPs were managing diabetes primarily in the practice with referrals to the 
hospitals for particular issues. GP103 had evolved from a formal shared care initiative 
to more structured care which meant “virtually all their diabetes work is done in the practice” 
(GP103, UGC). This quote reflects the interrelationship between the balance of care 
and the extent of sharing between settings. However there were instances where most 
of the care was being provided in general practice and participants did not perceive 
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themselves to be sharing management with the hospital-based team, which led to the 
separation of these dimensions. 
“I know that in Dublin there would be combined care. I think that‟s a good idea 
but I don‟t think it‟s necessary if you‟re a well-trained doctor” (GP112, RGC) 
4.3.3.1 Reasons for Referral 
Reasons for referral typically emerged when GPs were asked about the relationship with 
the hospital, suggesting this is a defining characteristic of that relationship. As Table 23 
illustrates the historical context underlying the balance of care manifested itself in 
referral patterns; those who always went to the hospital continued to do so.  
Referrals were occasionally based on a GP‟s feeling as a professional or their personal 
assessment of the case. The GP had often tried to manage the patient first but reached a 
threshold of expertise. In particular, there was a threshold of expertise and confidence 
around initiating insulin and managing Type 1 diabetes:  
 “…if we have difficult problems or we‟ve people coming to the end of the line; we   
wouldn‟t be initiating insulin in this practice just yet, we‟re not at that level 
of…competence” (GP101, RSC) 
Table 23 Reasons for Referral to the Hospital-based team. 
Reason Quotes 
Timing “Clinically often they‟re not ill, so you don‟t automatically refer 
them” (GP109, RSC) 
“It‟s not coordinated, it‟s just referral as required” (GP111, UGC) 
Problems/Complications “We would use the hospital where it would be difficult to control 
cases” (GP112, RGC) 
“…if they have secondary issues like neuropathies” (GP114, 
USC) 
Professional feeling “You feel that you‟re not getting good control for all that you‟re 
doing, everything you think you should be doing, you‟re hoping 
that maybe sometimes they‟ll do better by sending them to 
hospital” (GP111, USC) 
History “…we inherited patients from another practice and they go to the 
clinic but we generally encourage them to come here (practice) 
anyway” (GP112, RGC) 
“If the patient‟s going to the hospital regularly they‟re not 
inclined to come here”(GP111, USC) 
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4.3.3.2 Resisting referral 
Just as there were reasons to refer, there were reasons not to (Table 24). Reasons given 
by GPs for resisting referral included the perceived risk of losing of patients to 
secondary care. This rationale related to the degree of communication between settings. 
While this was the GP‟s choice, a more unsatisfactory fruitless referral situation was 
highlighted by a rural single-handed GP; you could refer to the diabetes nurse specialist 
but there was “no room really”. 
Table 24 Reasons for not referring patients to the hospital 
Reason Quote 
Patient 
considerations & 
preferences 
“They don‟t like hospital clinics, because they sit all day to see a nurse or 
intern…whereas there is a good relationship between the GP and the 
patient here”. 
Patients lost to 
secondary care 
“I try to keep the patient here (in general practice) as much as 
possible” (GP2, RCS) as there is a possibility of losing patient 
management to the secondary care services where 
communication was poor. 
Better results in 
primary care 
“The 3 nurses we have are very good, and their success in 
weight reduction is much superior to that of the hospital, their 
success in lifestyle changes are definitely superior to that of the 
hospital, so we don‟t really [refer]” (GP112, RGC) 
Limited hospital 
capacity 
“I mean they‟re certainly going to be overwhelmed if we send everybody 
up to them so I don‟t tend to do that” (GP114, USC). 
4.3.4 Formal vs. Informal Initiatives 
The final dimension of care delivery which emerged during analysis was the distinction 
between GPs involved in formal initiatives and those providing structured care „off their 
own bat‟. This dimension related to a subset of proactive GPs who had a special interest 
in diabetes or were presented with an opportunity to develop care in their practice.  
“In this part of the city in 1998, 3 of our small inner city hospitals closed and moved 
out to [place] so a group of GPs, perhaps 15 practices in all, formed a sort of 
partnership with the then Health Board to share some services like a podiatrist, a 
dietician...Subsequently this group of GPs and the Health Board then decided to enter 
negotiations with [hospital] and we started with educational sessions for ourselves and 
reasonably frequent meetings with the hospital people… We educated ourselves, wrote a 
set of guideline which we have from time to time updated.” (GP103, UGC) 
The existence of formal initiatives shaped some GPs understanding of the terms such as 
„shared‟ care and „structured care‟ which will be explored in the next section. 
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Section 1A: Models of Care; GPs‟ Interpretation & the Ideal Scenario 
Emergence of themes:  
This section presents GPs attitudes to and understanding of models of care based on 
actual experience (e.g. involvement in initiatives) and perceptions of how models of care 
operate. Discussions about the balance of care between settings and how care was 
provided gave an indication of GPs‟ understanding of common terminology namely 
„shared‟, „structured‟ and „integrated‟ care. Integrated care was proposed by some 
participants as an ideal model.  
4.3.5 GPs‟ Understanding of Models of Care Terminology 
Confusion of multiple meanings and uses 
Firstly, the multiple meanings and interchangeable use of the terms was highlighted by 
one participant who suggested understanding “depends on your own interpretation…you‟d have 
to define that term [shared care] but all these terms…they mean different things to different people” 
(GP113, USC). There were several examples in the data of ambiguous interpretations. 
For example GP5 (UGC) stated that there was shared care available to patients however 
multidisciplinary services from secondary care would be welcomed, calling into question 
the understanding and nature of the shared care experienced.  
4.3.5.1 Experience and Understanding of Structured Care 
At the start of this results section a structured approach to care was defined in terms of 
organisational features in the practice (registers, recall, nurse coordination etc.) as 
distinct from an ad-hoc approach. However GPs‟ understanding of „structured care‟ 
also related to general practice-based management. As mentioned previously GP103 
referred to structured care as meaning “virtually all their diabetes work is done in the practice”. 
Structured care also encompassed continuity and consistency of contact with the 
hospital and definite boundaries between the settings (GP113, USC). 
 “There doesn‟t seem to be any structured care, they‟re seeing different doctors and 
stuff like that.” (GP15 UCG)  
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Advantages of adopting a structured approach to care  
Those providing structured care in the practice highlighted a number of benefits which 
overlap with the advantages of the general practice setting which will be outlined later in 
Part 2 (Table 25). Advantages of structured care in general practice included 
conveniences and continuity for patients. 
Table 25 Advantages of adopting a structured approach to diabetes care 
Advantage Quote 
Convenience “It was much easier for them to come in and speak here in the surgery 
where it wasn‟t 20 miles in and the issues with parking and queuing up in the 
diabetic clinic for maybe 2 hours because things are running behind” (N104) 
Continuity & 
familiarity 
“There was also continuity because I‟m here all day everyday so everybody 
that comes in knows me and they know that if they can‟t get to a clinic but 
they have a question they can pick up the phone so there‟s a familiarity 
about it and their comfortable” (PN104) 
Improvements 
in monitoring 
& outcomes 
“…meticulous care does improve health and prevent things like 
cardiovascular problems later….our podiatrist is always saying every…every 
amputation is preventable. I mean I don‟t think we‟ve had any amputations 
since we‟ve started this, it may be a pure coincidence but…” (GP103) 
 
Challenges: time and resources 
The most commonly cited challenges to providing structured care for patients were 
time and resources. Local initiatives were “a great idea but need to be supported and funded”. 
“Simple sort of communication things” between the practice and the hospital were also 
difficult therefore the practice faced the challenge of trying to avoid duplication or 
omission when providing structured care in the practice (GP103, UCG). Even those 
who had not undertaken structured care or joined a particular initiative were aware of 
the demands. GP107, who had developed structured cardiovascular disease 
management, had learned the pressure such initiatives can put on the practice; 
“It took up so much time that [the nurse] could do absolutely nothing else, which puts a 
lot of pressure on the rest of the practice then because she wasn‟t taking bloods which 
meant I had to, which means I couldn‟t see the sick patients…” (GP107, RSC) 
These challenges overlap with the barriers to managing diabetes care in everyday general 
practice.  
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4.3.5.2 Experience & Understanding of “Shared Care” Initiatives 
GPs involved in formal shared care schemes referred to features such as educational 
sessions, meetings with hospital teams, developing a set of common guidelines or a 
protocol within the scheme, sharing services and sharing a diabetes nurse specialist 
(GP103 UGC, GP108 RGC) (See Appendix XIII). The benefits of shared care 
arrangement included easier access to secondary care, thus the initiative was a facilitator 
to providing care. 
“Now, if it turns out that he (patient with high blood sugar) needs to see someone, we 
can fast track him and get him seen by consultant within a week, because of this shared 
care arrangement.” (GP13 RCS) 
There were also benefits for the practice involved. Shared care was considered a “useful 
resource for up-skilling GPs” but it also saved GPs time having “70 diabetics managed to a large 
extent by others” (GP108, RGC).  
Extent of sharing in shared care 
These benefits call into question the extent of sharing involved in „shared care‟. The 
potential downsides to having others provide care was that the GP could find 
him/herself disconnected from patient management; 
“I think it‟d be nice if their registrars came out here once in a blue moon to visit us, see how things 
are. Another weakness of the existing system is, the nurses do it and we don‟t interact with them 
afterwards. There isn‟t time to sit down and talk about the people they‟ve seen, that‟s partly to do 
with the way we have it organised here” (GP108, RGC). 
The lack of interaction suggested that the GP was outside the care process. This 
impression was strengthened by the use of the word “they” in the following quote; 
“They shouldn‟t expect their diabetic teams [to be] coming into my practice for free.” (GP108 RGC) 
„Shared Care‟: “2nd best system” or best of both worlds  
There were divergent opinions and understandings of shared care among the 
participants. One GP had a negative perception of 'shared care‟ as reducing general 
practice to “a 2nd best system”. This single-handed GP imagined care being delegated to 
GPs in a system “whereby the GP sees the patients for the bloods and whatever, the initial diagnosis 
and that but then the hospital would be saying do this and do that you‟d be under the thumb, GPs like 
puppets. We need to keep some level of autonomy.” (GP102, USNC).  
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However for other participants „sharing‟ care represented the best of both worlds for 
practitioners and patients. From this perspective a shared model of care was not a 
system of hospital delegation but rather routine diabetes management in the practice 
with support from the hospital setting. The features of sharing care according to 
participants are outlined in Table 26 as well as the perceived benefits. 
Table 26 Features & Benefits of Sharing Care 
BENEFITS FEATURE 
Best of both worlds Expert opinion with practice based routine management 
 “I‟d love to see more patients going through shared care. I think it‟s very reassuring when 
you‟re on your own in general practice to see what they can do as well and to have the 
benefit of renal physicians and specialists in the hospital setting” (GP114, USC).  
 
 Shared care is a “good combination [because] we get the best of his annual updates and yet 
with the help of the nurses we manage them pretty effectively here” (GP108, RGC) 
Shared Responsibility Between the hospital, GP and the patient 
 “I would much prefer to share care, like with antenatal. So when a patient drops dead or 
[has an] MI or whatever, it‟s not all on my head…We share responsibility” (GP115, RSNC) 
 
 “They see what they need to do in the hospital and I stay informed of what the hospital is 
doing…Under this model, the care is shared with the patient too, so the locus of ownership 
is shared and the patient is responsible too” (GP4, UCG) 
Seamless care Rather than continuous referral & discharge 
 “I would love a more formal shared care arrangement…but not with this thing of the 
patient being discharged to you and then if you want them seen you‟re referring them 
again…If you‟re worried about something you should be able to get them seen, that they 
haven‟t been discharged in the 1st place. Then if everything was going smoothly and there 
were no problems, maybe those people who were still being seen in the hospital maybe 
once a year for type 1 diabetics or even every 2 years for a type 2.” (GP111, UGC)  
Communication Compared to antenatal care, in particular the shared record of 
care 
 “…since it‟s working so well in that [antenatal care], why can‟t it work for diabetes in 
general practice? If there‟s a piece of paper, a chart that the patient carries, I see what on 
that chart I need to do, they see what they need to do in the hospital, and I stay informed of 
what the hospital is doing and what I should next do, what‟s necessary for the patient” 
(GP4, UCG) 
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4.3.6 Ideal Model of Care: greater sharing, not either/or care 
Greater sharing between settings was proposed by GPs as the ideal relationship with the 
hospital or perfect balance of care between settings. This was also referred to as 
increased integration between settings. As reflected in the quotes above (Table 22) the 
optimum model for diabetes care would combine the strengths of both settings, 
outlined as follows: 
“2 points of access so people have got a day-to-day support network and then they‟ve got 
somebody acute who‟s a specialised person looking into their care” (PN104, RGC) 
“The ideal would be that every diabetic would be under consultant care or would have a 
consultant look over them from time to time and then the GP would do the fine tuning 
in between times but the consultant would oversee the overall thrust of care” (GP106, 
UGC) 
The emergent theme was one of defined joint involvement between consultants and 
GPs rather than an either/or situation; 
“If you only deliver care in acute services then people are left floundering for 6 or 9 
months in between…but equally if you only see them in the community and they don‟t 
have a link of some description with the hospital when they run into a problem its 
sometimes very difficult to get somebody in quickly because they‟re not part of the system” 
(N104, RGC) 
There were “reservations” about managing diabetes in general practice alone based on the 
scale of the illness today “the sheer complexity of diabetes and all the complications” (GP115, 
RSNC). 
4.3.6.1 Attitudinal challenges to integrating care between settings 
GPs own perspective on the need to share care between settings and their experience of 
patients‟ attitudes suggested potential challenges to the ideal model of care. 
 Is sharing really necessary? – 2 anomalies 
Two GPs felt that sharing care was unnecessary but both for different reasons. On the 
one hand, GP112, from a rural group practice, felt that combining care with the hospital 
setting was “a good idea” but “unnecessary if you‟re a well trained doctor”. Conversely GP102, a 
single-handed GP from an urban practice, felt the hospital was the most obvious setting 
of diabetes care and that shared care was a threat to GP autonomy; 
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“They say about patients going into the hospital and all that but then what else 
would they be doing really” (GP102, USNC). 
 Patients‟ understanding of and attitudes to the model of care  
In addition to their own preferences, GPs were cognisant of patients‟ attitudes towards 
the different care settings which could act as a barrier to care arrangements, whether 
trying to share care between settings or trying to structure care in the practice. These 
positive and negative attitudes were probably related to a patients understanding of their 
care: 
“…it can often be difficult for the patient to see the need to come back for a review if 
they don‟t understand its part of a structured care programme” (GP106, UGC) 
“some people who would, frequent DNA‟s of the hospital, kind of felt a bit like „hang on their 
on my back now you‟re on my back too‟…And you were sort of saying „well if you‟re not 
attending them and I do understand why, 10 minutes of your time every 6 months is just going 
to keep things in check‟…” (Nurse 104, RGC) 
However equally GPs spoke of the patients preference for the GP setting (GP103, p7.2) 
which could act as a barrier to sharing care as patients don‟t see the need to go to the 
hospital. Although in favour of sharing care with the benefit of specialist input from the 
hospital, GP114 pointed out; 
“The only problem is the patients don‟t see it that way and don‟t understand why 
they need to go to clinics all the time….they want us to do everything in the primary 
care setting which is understandable” (GP114, USC). 
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Section 2: Barriers and Facilitators to the Delivery of Diabetes Care 
This section outlines the factors identified and discussed by GPs‟ as barriers and/or 
facilitators to delivering high quality care to patients with diabetes. A number of factors 
helping and hindering care were raised initially by GPs during discussions about the 
routine management of diabetes. These themes were followed-up and expanded upon 
when participants were presented with the prompt containing a list of 8 topics identified 
during the GP survey as influential factors. This section is organised around the 8 
potential barriers and/or facilitators as well as the additional factors raised by 
participants.  
4.3.7 Barriers & Facilitators to Optimal Diabetes Care 
Emergence of Themes 
Barriers and facilitators occurred at multiple levels within the health system and had 
knock-on effects as illustrated in Figure 24. It is important to note that the absence of 
barriers did not equate to the presence of facilitators as highlighted by the following 
quote from a GP;  
“…there were no barriers, there were just no incentives.” (GP112, RGC) 
Furthermore the absence of a particular factor was often a barrier for GPs and 
consequently its presence would be a facilitator. Thus barriers were also „would be‟ 
facilitators. For example practices with a nurse talked about the enabling role of nurses 
in providing structured systematic diabetes care. However, the absence of a nurse was a 
barrier to providing care and a „would-be‟ resource. 
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Figure 24 Barriers & Facilitators to Delivering Quality Diabetes Care 
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4.3.8 Lack of Financial Incentives & Remuneration 
Emergence of themes 
The lack of remuneration/financial incentives was one of the factors which received the 
most attention during interviews as a barrier to care delivery in both group and single 
practices, across urban and rural areas. At the time of interview remuneration for 
diabetes care was “non-existent” for most GPs in Ireland. Participant had varying 
opinions on the merits of pay-for-performance payment. Despite the method of 
recompense it was widely agreed that the lack of remuneration impeded diabetes care 
and led to barriers at other levels of the system including stunting practice development, 
imposing a cost barrier on patients and creating a sense of apathy among professionals. 
Some GPs made the distinction between financial incentives and those incentives which 
relate to the patient or professional satisfaction. Financial incentives and remuneration 
will be discussed in tandem with each other followed by an outline of the other 
incentives driving GPs. 
4.3.8.1 “Whether you like it or not general practice is a business”  
Remuneration was discussed synonymously with financial incentives. Occasionally, GPs 
were not comfortable citing remuneration or financial incentives as a factor influencing 
the development of care using phrases such as “I hate to say it but…” (GP114 USC, 
GP102 USNC, 105 UGC, GP106 UGC). GPs may feel they should be motivated by 
other factors. There were varying opinions as to how important remuneration or 
financial incentives were. A small number of GPs did not expect remuneration as they 
felt providing diabetes care was part of their remit as general practitioners [GP13 RCS, 
GP9 RCS, GP5].  
“I think it‟s [diabetes] just part of treating people, so I don‟t think it‟s [incentives] a 
barrier” (GP109, RSC) 
Moving along the scale, GP1 felt that “incentives would help” but were not necessary, while 
GP9 suggested it was “debatable” whether remuneration would facilitate care provision. 
At the other end of the scale remuneration was marked as “the 1st incentive that comes to 
anyone‟s mind in general practice” (GP111, UGC) primarily because general practice is a 
business (GP114, USC, GP104, RGC) and the money has to come from somewhere. 
 “Unfortunately whether you like it or not general practice is a business and it has to 
pay bills” (GP114, USC) 
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Hence, from a business perspective providing diabetes care in general practice was a 
financial disincentive. Even with a “small payment” provided as part of a formal initiative, 
the development of a systematic structured approach to care resulted in “a financial loss” 
for the practice (GP103, UGC). Another GP described taking on the primary 
management of diabetes as “pro bono” work (GP112, RGC), the Latin phrase which 
translates as “for the public good”. This suggests that for those who have developed a 
systematic structured approach to care in their practice, the lack of remuneration was 
outweighed by other incentives which will be presented later. 
4.3.8.2 Financially incentivizing care – pros, cons and concerns 
There were concerns about financially incentivising diabetes care in general practice and 
differences of opinion about the most appropriate method of recompense. GPs were 
mostly familiar with performance-based remuneration and concentrated their opinions 
in this area. Participants drew on familiar schemes such as antenatal care (GP111) and 
Heart Watch (GP 113, 101) as possible models for remunerating diabetes care. These 
models are performance-based remuneration models. Another proposed option was 
skewing GMS payments to reflect the workload associated with diabetes (GP106), in 
particular for the annual review of patients (GP RSC). There were divergent opinions as 
to whether financially incentivizing care would have a positive or negative effect on 
diabetes management (Table 27). The main concern was that performance based 
remuneration would pervert or “corrupt” the provision of care (GP1 UCG, GP12 RCG). 
 “…the worry is that once you incentivize it that other things that you can‟t 
incentivize get lost or diminished in the process” (GP106, UGC) 
It could create a ripple effect throughout chronic disease management whereby all 
chronic illnesses would have to be incentivised.  
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Table 27 Advantages and Disadvantages of a Pay-for-Performance Model 
ADVANTAGES 
“Straight-forward” method of payment 
“if you do it you get paid, if you don‟t do it you don‟t get paid…it‟s a set amount of care… and 
only when all 10 or 12 items are completed or a proportion [you get paid]” (GP111, UGC) 
Worked for other types of care 
 “things like flu vaccines and payment for vaccinations, that‟s national…antenatal 
care…because there‟s quite a straight-forward way of claiming remuneration” (GP111, UGC) 
“if the diabetes patient was flagged in some way, particularly by payment and targets, for 
instance we get paid for accounting for 95% of our children that are vaccinated” (GP4, UCG). 
Worked in other countries 
 “Similar to the framework quality thing in the UK…if you recorded blood pressure or the 
glomular filtration rate or whatever and you can show that you‟ve done that in your diabetics in 
the past year that you should get financial incentive or reward” (GP106, UGC) 
DISADVANTAGES 
Ineffective for providers & patients 
“I look at the way the UK‟s doing it and it isn‟t working…it's not good for doctors and the 
patients aren‟t any healthier so I don‟t think it‟s a good way of doing it.” (GP107, RSC) 
Risk of scamming the system 
“…the real keen boys who are getting the sugars down…inappropriately low…using insulin to 
bring down the haemoglobin A1c more could, in theory, be killing them” (GP112, RGC) 
“…you‟ll get the sly boys who do well. And there‟ll be guys giving a very good service, and 
there‟ll be guys giving a middling service but the guys who give the middling service, in theory, 
could be getting paid more” (GP112, RGC) 
4.3.8.3 Lack of remuneration creating further barriers in the system 
According to participants the lack of remuneration created both physical and attitudinal 
barriers to care deliver. The ramifications of were conceptualized on 4 levels; patient, 
professional, organisational and system level (Figure 25). This illustrates how a barrier 
can create or exacerbate problems at other levels of the health system. 
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Figure 25 Impact of a lack of remuneration at different levels of the health 
system 
 Financial Barriers at the Patient Level 
Firstly there was a cost for some patients to receive regular diabetes care in the general 
practice setting. One single-handed GP felt he had no choice but to pass on the cost of 
care to patients. 
“I mean if we‟re getting no recognition and no incentive and no remuneration or 
anything to do this work, I‟d be mad in the head to… keep doing it unless I charge 
the patient and I don‟t like doing that but I don‟t have any choice” (GP101, RSC) 
There was a sense of relying on patients‟ understanding that this work was valuable and 
that “somebody has to pay”, the doctor couldn‟t provide it “just because I want to” (GP101, 
RSC). The cost could deter patients from attending general practice for their diabetes 
care, creating an access barrier to this setting. Providing a medical card to all patients 
with diabetes, which would entitle them to free GP care, was suggested as a way to 
remove this financial disincentive (GP3, RSC).  
 
Professional 
Apathy 
Limited 
Practice 
Development 
Lack of  
Remuneration 
Culture underlying Health System: Different values between HSE and GPs 
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 Impeding Practice Development at an organisational level 
The lack of remuneration also had a limiting effect on practice development (GP114, 
USC). Those who were providing care on an ad-hoc basis felt there was no incentive “to 
do more” (GP115, RSNC). Another single-handed rural GP highlighted the  “disincentives 
in the system” as “a barrier that needs to be repaired”, relating to the fact that 90% of his 
patients with diabetes were General Medical Scheme patients for whom he was paid a 
capitation grant each year regardless of the intensity or quality of care. This had financial 
implications for his practice and the manner in which care was delivered. There were 
limited incentives at a practice level, both in terms of finance and resources, to improve 
the way care was delivered to patients: 
“Incentives are a barrier. At the moment care is opportunistic but if there were incentives 
for me to hold a clinic that would help. We could keep flow charts and I‟d get 
remuneration because there is none and this takes a lot of time, manpower, secretarial 
time, nurse time, and at the moment there‟s no incentive to do that.” (GP5, UCG) 
 Apathy at a Professional level 
The lack of remuneration created “bad feeling” among GPs at a professional level 
(GP110, RGC) with GPs perceiving themselves as being taken advantage of by the 
health system (GP102 USNC).  
“There's no real recognition for it, which is important, because I think that if things do 
come down on us, things like the flu vaccine, which is a minor point, we'll sort of say 
'fine', but it'll show apathy and then it'll be 'okay, we'll see our diabetics once a year 
now', because we have to end up making money elsewhere.” (GP112, RGC) 
As the last quote suggests the lack of remuneration for diabetes could have a negative 
influence on GPs willingness to take on other patient groups or care procedures. It also 
suggests that recompense reflected recognition in the health system. GPs felt the lack of 
remuneration was a sign of the lack of value placed on chronic disease management and 
the work carried out in general practice. The lack of recognition was particularly 
disheartening for GPs providing the majority of routine diabetes management in their 
practices in a structured way, in some cases off their “own bat” (GP101 RSC, GP112 
RGC, GP110 RGC). There was no “encouragement” to provide more and better services. 
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“In essence, if I may say so, this a reasonable service we‟re offering here, we‟re not getting 
paid for it” (GP110, RGC) 
“Nobody asked us to do it and now that we are nobody really thanks us for it” 
(GP112, RGC).  
 Cultural difference in health system: different values among GPs & 
the HSE 
As Figure 24 illustrated the absence of remuneration was seen to reflect the different 
values among GPs and HSE which created the barriers above the surface.  
“It‟s typical of the HSE that things that we value highly we don‟t get paid for so it‟s 
really your own interest” (GP101, RSC) 
According to participants the difference in values were also reflected in the current GP 
contract which does not support comprehensive chronic disease management and 
preventative care.  
“I would love to see the care of all chronic illnesses recognised as a core part of our health 
system and general practice is really the only place that it can be done efficiently or 
economically but our present contract doesn‟t reflect that…Whatever the current 
recession, we need, and I believe the country needs a new contract which recognises and 
rewards good care of chronic illnesses” (GP103, UGC)  
The difference in values was conceptualised as a cultural dimension because it speaks to 
the tradition within the Irish health system to focus on acute reactive medicine as 
opposed to preventative medicine or chronic disease management. While policy 
documents refer to chronic disease management in the community, there was a lack of 
tangible support for these proposals. For example the GP contract was marked as an 
ongoing “bone of contention” in relation to the proposed implementation of an integrated 
model of care which would see General Practice being responsible for providing the 
majority of diabetes care (GP13, RCS). The HSE “needs to back up their policy of shifting from 
secondary care to primary care” (GP12) relating to the earlier theme of general practice being 
at a disadvantage in terms of resources and access to services. 
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4.3.9 Motivations beyond money: “vocational” incentive 
Participants made the distinction between financial “disincentives” of providing diabetes 
care and other incentives which were “vocational” or personal. Table 28 outlines the 
aspects of these incentives including the motivations such as a sense of professional 
duty and personal experience. The GPs quoted in the table below had developed an 
organised structured approach to diabetes management both formally as part of a local 
initiative and informally. Hence, in a subgroup of GPs the vocational and personal 
incentives appeared to be overriding the financial disincentives. Similarly GP 13 (RCS) 
felt “personal gain” was the entire incentive for providing diabetes care. 
"We feel that we've improved the service that they've [patients] been given, so that 
was the incentive, but that‟s the only incentive" (GP112) 
Perhaps these were the types of incentive that participants felt they should be motivated 
by as opposed to monetary factors. As GP112 surmised; “we are doctors after all”.  
Table 28 Aspects of personal and vocational incentives 
Personal Incentives 
Personal 
satisfaction 
“I get a joy out of thinking we do a great job…there‟s the incentive for me, 
that‟s what counts” (GP108, RGC) 
Personal 
experience 
My own father was in hospital 7 or 8 years ago. He was on the ward and 
there were 7 other guys, it was a vascular ward, and they were all diabetics. 
Some of them were in for 8, 12 weeks, or 16 weeks, incredible. At the same 
time I read somewhere that if you can get, is it, a 1% drop in the HbA1C, 
reduces the complications by 25%.So that kind of struck a chord with me...” 
(GP110, RGC)  
Vocational Incentives 
Job 
satisfaction 
"If we can get the older diabetics some better control, we'd be doing some 
good...so from a personal, job satisfaction professional point of view that 
would be a huge incentive for me" (GP110, RGC) 
Seeing 
improvement “I love to see all these nice normal HbA1cs coming back” (GP110, RGC)  
Patient 
Feedback 
"We're starting people on insulin who really need it and they feel so much 
better. [Patients say] 'my energy‟s back up'...so it‟s very rewarding, you get a 
lot of good feedback from patients" (GP103, UGC) 
"I get encouragement from the patients because I think they have seen that 
[we emphasize prevention], they buy into that and hopefully care is good" 
(GP101, RSC) 
Personal Value 
on prevention 
"Depending what your attitude is and your enthusiasm [for] preventative 
stuff, which to me is just as important if not more important and it's 
enjoyable" (GP101, RSC) 
Professional 
Duty 
"...the international evidence is such that we felt duty bound to offer as tight 
control as we can for patients" (GP103, UGC) 
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Other Incentives 
GPs referred to other incentives for providing care including being motivated by the 
potential in general practice to provide a lot of diabetes care (GP13); practical support 
for practices such as making a dietician available to the practice (GP111, UGC, GP107, 
RSC), financial support for education and training (GP15, RCS) and a “clinical incentive” 
to encourage GPs to manage patients in the practice;  
“If you admit and refer very few [to the hospital], hence you‟re keeping your care out in the 
practice, once again there is no incentive. That‟s where a reward system should come into the 
thing. If you use your resources well, when you ask for use of other resources [referral to 
hospital], you should be given preferential use of them, because you are using them 
appropriately” (GP112, RGC) 
However there were doubts expressed about rewarding behaviour such as referral or the 
performance of certain tasks.  
4.3.9.1 “Pockets of Interest” 
As previously highlighted the theme of vocational incentives was notable among GPs 
providing structured routine care in their practices or involved in particular initiatives 
(GP101, 103, 112, 108, 110). However GPs acknowledged that special interest was 
limited to “pockets” and “you can‟t expect all GPs to be desperately keen on it” (diabetes) 
(GP103, UGC). The “real bunch of keen ones” were well known to one another.  
 “Some GPs are really into diabetes…If you talk to Dr Y he is super organised 
and really interested…I see a lot of psychiatric patients and foreign 
nationals…Diabetes is definitely Dr Y‟s thing” (GP102, USNC). 
It is arguable that beyond this group, remuneration and financial incentives would be 
the main facilitator to providing high quality care in the practice and therefore the 
biggest barrier to engaging all GPs at present. There aren‟t enough GPs who are 
interested in diabetes and “…there are no incentives to motivate them” (GP3, RCS). 
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4.3.10 Barriers & Facilitators to Integration  
Emergence of themes 
Originally this theme was defined as „relationship with hospital‟ however it was 
subsequently sub-divided to reflect the multidimensional nature of the relationship 
between general practice and the hospital setting (Appendix XIII). Each dimension was 
considered a separate theme:  
- The actual relationship with hospital (model of care) vs. desired: how care is 
organised between settings as outlined in Part 1. 
- The nature of the relationship between settings; positive or negative relationship 
with consultants and the hospital-based team acting as a barrier or enabler to 
care (social context within system relating to collaboration and teamwork) 
- Barriers to interfacing and integrating; issues of coordination and 
communication (organisational context) 
The latter two components will be dealt with in this section as barriers or facilitators to 
delivering diabetes care.  
4.3.10.1 Nature of the relationship between health care providers  
The nature of the relationship between the GP and the hospital consultant and/or team 
was gleaned from discussions about interactions with the hospital and referring patients. 
In some instances a positive relationship was facilitating the delivery of care. A number 
of GPs referred directly to a good relationship with the hospital based team [GP5, 6,7, 
13, 14] including those GPs providing structured care in their practice [GP101 RSC, 
GP13, 14, 6]. The hospital was perceived as a resource for GPs providing care as well as 
a “doorway to services”. However in other cases the relationship between the health care 
providers, and more abstractly the settings, was a barrier to integration. 
Hospital as a “resource” and a doorway to services  (F) 
A positive relationship with the hospital team enabled the provision of care in the 
community as specialist services were a “resource” for GPs. GP12 (RCG) stated that 
advice from specialist hospital consultants „would be‟ a major facilitator in delivering care 
in general practice. Having the support of hospital expertise was particularly reassuring 
for single handed GPs (GP115, GP11 SNC, GP3 RCS, GP114 USC).  
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“It is very reassuring when you‟re on your own in general practice to see what they 
can do as well and to have the benefit of renal physicians and specialists” (GP114) 
A rural single-handed GP stressed the hospital was “an essential support” to GP 
management as diabetes care could not be provided without hospital involvement 
(GP115, RSNC). This GP tried to maximise the benefit of the available expertise by 
doing the blood work in advance of patients‟ visits so that if she had a concern the 
specialist could address it at the upcoming visit. For GPs involved in shared care 
programmes (GP13, 6), the supportive relationship with the hospital enabled GPs to 
manage diabetes on a large scale in the community. The advantages to the relationship 
between settings included fast-tracking patients to specialist care and facilitating GP 
management of Type 1 insulin adjustment.  
The other dimension to the hospital as a resource was as a doorway to auxiliary services. 
Some practices were “still” reliant on hospital for access to services such as retinopathy 
screening and foot care which was “the main advantage of the hospital visit” from one 
practice nurse‟s point of view.  
“Poor Relationship” between professionals  
Some GPs did not have a constructive relationship with the hospital based team which 
was a barrier to delivering care. For example GP3 found specialists in the hospital 
difficult to pin down and felt it would be hard to take part in formal shared care, 
especially “with the power struggle between primary care and secondary services”.  Two factors 
emerged which appeared to shape participants relationship with the hospital setting; 
losing patients to secondary care and poor communication.  
 Holding on to patients 
Part of the power struggle was the conscious effort to retain patients as GPs were wary 
of losing patients to „the system‟.  A minority of GPs conveyed a sense of wariness 
about the sharing diabetes care having experienced specialists holding on to patients. As 
discussed previously, one of reasons why some GPs resisted referring patients from 
primary care into the hospital was the risk of losing the patient to secondary care (Part 
1). On the other side of the boundary GP13 (RCS) also experienced the hospital system 
refusing to „let go‟ of patients from secondary care to primary care; 
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“Once they go into the hospital system, they stay in the hospital system, stay there 
more often actually. And so I need to be extra vigilant with them as they get more 
concentrated attention in our GP setting” (GP10, USC) 
Therefore some GPs‟ attitudes and wariness towards secondary care providers was 
influencing the care pathway for patients.  
 Poor Communication  
The sense of mistrust and wariness among some GPs was also fuelled by poor 
communication between the settings. In some instances poor communication was 
synonymous with a poor relationship (GP15, RCS).  
“It‟s [care] is disjointed, hospitals letters don‟t come out at all and there are no 
recordings of bloods or exams in general”. Because of this “there‟s definitely 
tension between GPs and hospitals, with us and the diabetes clinic.” (GP10, USC) 
The following quote also illustrates the pressure and tension within the system creeping 
into communication: 
“The letters that have come from the hospital recently would…sound more and more 
irritable to me because they seem to be under a lot of pressure” (GP106, UCG). 
What constitutes good communication; open, reciprocal and continuous 
During the interviews carried out by this researcher, participants occasionally raised the 
issue of communication of their own accord; usually to illustrate a broader point (e.g. 
GP106). When prompted the common response of contact via referral letter suggests 
referral letters equate to communication.  
“It‟s good I mean they certainly send us a lot of detail…But I think patients are 
kind of divided into, if the patients going to the hospital regularly they‟re not inclined 
to come here.” (GP111, UGC) 
The “standard letter” included information on parameters, a brief narrative on patients 
progress and “what the future plan is” (GP113, USC). However, this GP typically referred 
patients to the hospital for routine management so there was little sense of engagement 
with, or indeed consultation on, the plan. It was more an FYI than two-way 
communication. Two-way communication was referred to by those who had phone 
contact with the hospital consultant for particular patients when necessary (GP101 
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RSC/ GP107 RSC). These GPs appeared to have a close working relationship with the 
consultant referring to them by name rather than “they”.  
Co-operation and a more open relationship whereby specialists were approachable 
would improve the relationship between settings (GP12, RGC). GP113 (USC) called for 
continuous communication between settings to improve care and facilitate integration; 
“not just a single meeting, a dialogue”. Indeed communication systems were one of the 
suggested facilitators to integrate care between settings which will now be outlined. 
4.3.11 Lack of Coordination at the Primary-Secondary Interface 
Emergence of themes 
While the nature of the relationship was positive for a number of GPs, barriers arouse 
in relation to the coordination and integration between settings. As one GP summarised 
the relationship was “accessible but not structured” (GP115, RSNC). There were a number 
of symptoms of the lack of coordination and organisation within the system including 
waiting times, overburdened hospitals and “in the meantime” care. These consequences 
were barriers in and of themselves.  
4.3.11.1 Lack of coordination within system  
Lack of coordination between settings was identified by GPs as a barrier when 
discussing their relationship with the hospital setting. The historical remnants of the 
separation of acute and community services were seen as the root of current 
coordination difficulties; 
“…it isn‟t really to do with communication, it has to do with the whole system 
really, and it hasn‟t ever really been properly coordinated or funded. I think that any 
mess that‟s in the health system really historically goes back 30, 40 years in my 
experience. There has never been a proper management of medical, nursing 
community coordinated care…ever in this country” (GP109, RSC) 
The lack of coordination within the system had a knock on effect on the integration 
between primary and secondary care settings reflected in the confusion and lack of 
clarity around sharing care and roles of responsibility. A number of GPs felt there was 
no sharing between settings and instead care was disjointed (GP10 UCS) while other 
GPs were unclear about what was expected of them in terms of diabetes management; 
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“…I‟m still not sure where the hospital ends, it‟s not clearly defined. We need 
to…there needs to be a clear definition as to what the hospital is going to do, what 
we‟re expected to do” (GP113, USC) 
The recall process as an example of the lack of coordination 
The process of recalling patients was a stark reflection of the lack of coordination 
between settings. For example, GP106 (UGC) indicated that patients were recalled “by 
the system” “as the hospital deems appropriate” with problems referred to the hospital in the 
meantime. The GP concluded “that‟s as much of a protocol as there is”. Thus the process 
appeared one-sided and was not collaborative or even consultative. This picture 
suggests that patients were managed in both settings but rather independently of each 
other. Similarly, GP111 (RGC) felt care was not really shared as the hospital brought 
back the patient until such time as they perceived no problem. The patient might return 
to the GP but there was no sharing of information in the meantime. GP12 reiterated 
this point stating that cooperation with secondary care services was lacking and hinders 
comprehensive care.  Even within shared care initiatives coordination between settings 
could be difficult; 
“The difficulty has been in coordinating the half yearly reviews and the annual 
reviews with the nurses here because they go to annual review in the clinic and 6 
monthly here I think” (GP108, RGC) 
4.3.11.2 Symptoms of the Lack of Coordination 
The following sub-themes are categorised as delivery-level manifestations of the lack of 
the coordination in the system. Each symptom of poor coordination was a barrier in 
itself for patients and providers trying to navigate the system. This reflects the entwined 
nature of barriers and facilitators throughout the health system illustrated in Figure 26. 
 Hospitals “Overburdened”  
One of the main symptoms of poor coordination was the overburdened hospital clinics 
which could not meet the demands of growing patient numbers. This led to poor access 
to specialist expertise for both GPs and patients. GPs were acting as gatekeepers when 
referring patients with diabetes. For example GP114 referred to „keeping‟ the hospital 
for “complicated cases” suggesting the hospital was used as a finite and valuable resource. 
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“I mean they‟re certainly going to be overwhelmed if we send everybody up to them so I 
don‟t tend to do that.” (GP114, USC) 
GPs acknowledged the burden on the hospital setting and the insufficient manpower 
including endocrinologists in Ireland to meet the demand. Highlighting the barriers was 
not about a proportioning blame. 
“Consultants just don‟t have time, they can‟t see everybody. It‟s just not possible. They‟re 
doing their best…I‟ve no complaints about their service at all” (GP113, USC) 
 Leading vs. Delivering care 
The lack of coordination was reflected in and further exacerbated by the delegation of 
care within the hospital. A distinction emerged from the GP perspective, between care 
which was “consultant-led rather than consultant delivered” (GP10) with nurses and intern staff 
delivering most of the care. GP106 also made the distinction between consultant-led 
and consultant-delivered care; 
“The care that‟s delivered should be consultant-delivered but not just consultant-
led…There is no point in sending somebody to the clinic and having a relatively 
inexperienced SHO just bringing them back in 3 months and not answering the 
particular query you have” (GP106, UGC) 
This theme resonates with the view of the consultant as a resource whose expertise 
were valued by the GP. The situation may also be consequence of the insufficient 
consultant endocrinologists in Ireland. The issue of who was delivering care in the 
hospital setting was also noted by patients and impacted on the continuity of care.  
“I mean most of the patients wouldn‟t see the consultant probably…they‟d see the 
junior doctor. Some of them might have been attending the clinic for 2 or 3 years and 
never seen a consultant. That‟s what they tell me…I haven‟t studied that to be 
verifying that” (GP113, USC) 
The dichotomy between leading and delivering care further suggests a lack of clarity and 
coordination around the overall responsibility for patients‟ care (Appendix XII). 
 
 
132 
 
 Barriers to Access: Waiting Times  
As a result of the overburdened hospitals and the inadequate staffing, GPs often 
experienced difficulty accessing secondary care services both in urban and rural areas 
[GP3 RSC, GP4 UGC, GP11 (USNC)]. This lack of access hindered care in general 
practice just as it enabled care in areas where the hospital was seen as resource. Hence 
better access to secondary care was identified by a number of GPs as a potential „would 
be‟ facilitator [GP7 UCG, GP3 RCS, GP1 UCG, GP4 UCG]. 
“There‟s a massive diabetic clinic in the hospital but care is not better. It‟s difficult 
to make appointments, get access to services, especially when it‟s urgent” (GP10, 
UCS) 
The issue of waiting times was raised by a number of GPs however there was significant 
variation between lengths of waiting time experienced. This experience was not unique 
among urban or rural areas or among group or single-handed practices. One urban-
based GP had noticed that waiting times have lengthened substantially; 
“I notice that they‟re pushing them [reviews] out further and further, the reviews 
would have been 6 months some time ago…its gone to 2 years” (GP113, USC) 
In one rural area in the South, a GP referred to a “short wait” of up to 6 weeks (GP107, 
RCS) compared to another rural area in the South West (GP110 RGC) where patients 
could be waiting a “couple of months” to be seen in the hospital. One factor which 
appeared to determine the length of the wait was the severity of the patient. If a patient 
had a serious problem they would usually be seen quite quickly but patients with less 
serious issues could be “waiting for ages” (GP113, USC).  
Uniquely, a GP involved in a formal shared care initiative, felt a waiting time of 6-9 
months was “no harm” as patients were taken care of in the local diabetes programme 
(GP108, RCG) and were prepared and educated when it came to their hospital 
appointment. However in areas where no such programme exists, waiting lists could be 
harmful. 
 “In the meantime” care  
The lack of coordination and integration between settings was reflected in the theme “in 
the meantime care” (GP113, p2.1). The phrase “in the meantime” was used to define the 
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unknown period of GP management between hospital reviews and emerged on a 
number of occasions in relation to the tenuous link between hospital and GP care. For 
example GP105 (UGC) described his practice as providing care “in the meantime” of 
clinic visits; initiating treatment, giving dietary advice and monitoring while waiting. 
Given the lack of consultation about responsibilities and boundaries between settings, 
GP113 (USC) „supposed‟ “that we‟re to pick them up in the meantime”, that is between 
reviews, but “there‟s been no communication, there‟s been no meetings, there‟s been no working 
group… it‟s just sort of left like that”. 
There were varying opinions as to whether the uncertainty of “in the meantime” care was 
problematic or detrimental. As mentioned previously, GP108 (RGC; involved in a 
shared care scheme) felt the waiting time was “no harm” because “in the meantime” 
patients were being cared for by the local programme. Patients were worked up, 
educated, introduced to a glucometer, on medication with good metabolic control. Thus 
a “prepared patient” arrived for his/her hospital appointment.  
However this level of support and early structured management was the exception 
rather than the rule. Other patients were “falling through the net” and not attending either 
setting for management leading to the development of irreversible complications 
(GP110, RGC). The quote below from a Practice Nurse illustrates the uncertainty for 
providers and patients created by “in the meantime” care and the lack of coordination 
within the system; 
“If you could say to them [patients] „look this is your diagnosis, this is what we‟re 
going to discuss and over the next 2 weeks you‟re going to meet A, B, C and then we 
have a base line of everything covered from day 1 and you know exactly where you 
are, you‟re on a springboard ready to jump. As opposed to… saying „stand on the 
spring board for about 2 months and then we‟ll jump you into that and then 2 
months later you might get called for your eyes and 2 months later you might get 
called for your feet‟, in which time they may have had a problem with their feet and 
they‟re not quite sure how they should have dealt with it…” (Nurse 104, RGC) 
While this practice was providing structured nurse-led diabetes management it was on 
the initiative of the GP rather than a formal scheme, and perhaps such initiatives 
continue to struggle with the lack of structure in the system as a whole. 
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 Boundaries & Bureaucracy: The current “palaver”  
The lack of clear boundaries and bureaucracy between settings was described by one 
GP as the current “palaver” which epitomised the consequences of uncoordinated care. 
While it was related to the multiple components of diabetes management and the 
number of disciplines involved it also surrounded simple tasks such as checking 
cholesterol; 
“…at the moment it‟s a big palaver if you check cholesterol, get it to the patient to 
bring into the hospital and it gets lost in the process lots of times and then it seems 
incredibly wasteful of effort and time and resources.” (GP106, UGC) 
Patients too got “caught up in administration and bureaucracy of the hospital system” (GP10, 
UCS). GP108 highlighted the impact of the “palaver” on patients; 
“ they spend the last precious days of their lives going around from out-patients to 
out-patients, confused as to who to believe, and in the ideal world, the GP service 
would be coordinating and making sure it doesn‟t happen too much,…then they get 
lost in the follow-up…it gets so complicated” (GP108, RGC) 
This was the only direct reference to the GPs taking responsibility for coordinating care 
between settings “in the ideal world”. This theme illustrates how the lack of coordination 
between settings led to bureaucracy around service delivery and ultimately confusion 
and wasted time for patients. 
 Avoidable Duplication 
Closely related to the palaver of navigating the health system was the potential for 
avoidable duplication. GPs providing structured care in the practice were very much 
attuned to the potential duplication of care and were actively trying to avoid it. GP112 
(RGC) felt the hospital was a duplication of care almost, given the standard and 
structure of care being provided in the practice. Thus while the consultant and nurse 
was available to them, the GP felt they didn‟t really need it in most cases. In contrast 
one Practice Nurse felt powerless against the duplication as the practice needed the 
hospital to access auxiliary services; 
“Unfortunately they still have to be seen in the hospital annually because for things 
like retinopathy screening and podiatry care, there isn‟t one single unit where you 
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could refer them…they have to go through the clinic, there‟s a bit of duplication that 
goes on there that could be avoided” (Nurse 104, RGC) 
The risk of duplication was linked to communication difficulties as the infrastructure 
was not in place to facilitate shared communication in an accurate and timely fashion. In 
this instance the responsibility for avoiding duplication was assumed by the GP and 
problem was owned by the practice however this may not always be the case.  
“one of our problems is to make sure that they don‟t have 2 annual eye tests in 
different places or…have all their bloods done a fortnight apart…Those simple sort 
of communication things but they are still difficult” (GP103, UGC)  
4.3.11.3 Mechanisms for improving coordination and integration  
As outlined in section 1, sharing or integrating care was perceived as the ideal model to 
facilitate comprehensive management of diabetes. GPs proposed a number of 
mechanisms to improve integration which would enable communication and 
coordination between the settings, namely a shared protocol and shared information 
systems. A shared protocol would address avoidable duplication and clarify the roles 
and responsibilities of each setting. A shared information system would minimize 
duplication the “palaver” in the system. 
 Developing a shared protocol 
GPs felt there was “room for” a protocol in diabetes care (GP106, UGC). There were a 
number of proposed dimensions to such a protocol and GPs drew on their experiences 
of the national protocol for antenatal care to illustrate their ideas (GP101 RSC, GP106 
UGC, GP109, RSC); 
“…the kind of protocol you have with maternity care where there would be a 
common chart held by all diabetics and that the patient would carry it from the 
hospital to the GP so it‟s clear when cholesterol was last checked…” (GP106, 
UGC) 
The protocol would provide clarity around the remit of GPs and the hospital-based 
team, answering the call for more formal boundaries of responsibility called for some 
GPs; 
“…it would be nice if it was more formal, some kind of protocol drawn up as to 
who we should send and who we shouldn‟t send” (GP110, RGC) 
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“where an integrated guidelines are drawn up where everybody knows what is going 
on…what‟s happening, whose responsibility is what and…then you would know the 
best use…the resources are best used” (GP113, USC) 
Remuneration and databases could be integrated as part of a national protocol or 
“contract” (GP101, RSC) creating a standard system for funding and providing diabetes 
care in Ireland. 
 Shared information systems 
Shared information systems were also suggested as facilitator of the coordination 
between settings (GP108, RGC) and would “make a difference” to care delivery (GP103, 
UGC). As GP106 suggests, such a system would put the patient in the centre of care; 
“…They [all health care providers involved] could feed into that…It would be kind 
of patient-focused rather than having its primary focus in hospital or a particular 
place“ (GP106, UGC) 
An internet based system whereby you could view “vacancies” online and make an 
appointment would be a vast improvement on the current letter-based referral system 
(GP105, UGC). And there was a sense that this change would be possible given the 
technology available and learning from other countries.  
“The way forward in my view would be to take these systems (hospital and GP 
systems) but get them integrated into one [software program]…and I heard of an 
experience where in Denmark, they had several systems and all of the IT developers 
of the different computer systems were hoodwinked into taking a jolly…somebody 
turned the key in the lock and left them there, on the understanding that they weren‟t 
getting out until the individual systems could talk to each other. In Ireland we only 
have two systems. Somebody needs to turn the key on those two” (GP108) 
This suggestion came from a GP who gave diabetes nurse specialists from the hospital 
access to his practice computer system to update notes and make recommendations; 
such is the current requirement for updating and sharing information between 
practitioners.  
 Building a diabetes network to facilitate integration 
Continuous dialogue when integrating settings was previously highlighted as 
characteristic of good communication required in the system (GP113, USC). Part of this 
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dialogue could be an annual meeting of all health professionals involved in diabetes care 
for patients in an area which „would be‟ beneficial, especially for a rural community. This 
in turn would “improve awareness which will improve care” (GP9).  
4.3.12 The General Practice setting as a facilitator within the system 
The General Practice setting was proposed as a facilitator of care delivery, having a 
positive effect on the health system as well as the patient. The benefits of this setting 
put forward by participants reflected the sense of the untapped potential in general 
practice (Table 29).  
“I certainly would…underline the value of primary care physicians as a resource in 
terms of managing the national diabetic problem” (GP114, p13.1) 
Table 29 Advantages of the General Practice Setting 
Advantage Quote 
Freeing up the 
hospital 
“A lot of work regarding review and monitoring can be provided in the 
general practice setting which does not need to be done in hospitals and 
that‟s the advantage of GP I think…” (GP5, UCG) 
“People from this area would have to travel to [regional town]…The 
waiting list for out-patients is already huge. There was a good while there, 
there was no diabetes specialist, it was only sort of dabbled in by the 
generalists.” (GP101, RSC) 
Continuity of 
contact 
 
“Its local, its small, it‟s not intimidating, there‟s no stigma associated like 
going to a special clinic and they see the same nurses and doctors each 
time” (GP108, RGC) 
“They see the same doctors all the time; more importantly see the same 
nurses all the time” (GP112, RGC) 
The “biggest enabler for change in general practice is that there is 
continuity of practice and care” (GP16, UCS) 
“Ongoing 
relationship” 
 “patients tend to be friends more than anything else” (GP4, UCG) 
Patient-centred 
setting 
 “they (hospital) only provide a service; it‟s not patient-friendly at all”  
(GP10, UCS)  
Patient 
preference 
 “It‟s definitely the wish of patients for local services nearby” (GP12, 
RCG) 
“A platform for 
primary care 
workers” 
“I have the premises, the computer system, I have the insurance, light, I 
even have the patients from which young doctors and diabetic nurses and 
dieticians and psychologists can work…and work as close to the patients 
home as possible” (GP108, RGC) 
4.3.13 The HSE: A Help or a Hindrance 
There was divided opinion on the role of the HSE in delivering care. Previous themes 
around the lack of coordination in the system suggested an over-bureaucratised system. 
The opinions of GPs towards the HSE centred on the concept of efficiency within the 
organisation; 
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“There‟s a big improvement in efficiency in organisation since the establishment of 
the HSE…There is a choice of three hospitals for patients and then we‟re also 
linked into Health One”. (GP13, RSC) 
This theme of the HSE as a positive change and a facilitator of care delivery emerged 
during one interview (MOM) and was not evident in the data collected from other GPs 
or by the other researcher (SMH) thus it is an important anomaly illustrating the 
different experiences of the health system across professionals, in particular locales or 
for particular conditions. This positive experience was in contrast to the view expressed 
by another rural GP where the new structures of the HSE had a negative impact as it 
now took “5 meetings to make a decision” (GP112, RGC). Furthermore the changes in the 
structure of the health system and layers of bureaucracy alluded to by GP112 were 
stifling change. This GP had witnessed a shift from a once “receptive” and flexible system 
to layers of bureaucracy;  
“You can see it now, in the quality of community care, very poor. It used to be if we 
were running a diabetic audit, we‟d ring up the North Western Health Board, you‟d 
speak to the person, not particularly medically involved but a good manager, and 
they‟d say „that‟s a good idea, send us up a letter and we‟ll push it to the whole 
[area]‟…they were good, very receptive…but it‟s gone to hell now” (GP112, RGC) 
Thus the HSE as a system could be a barrier to initiative and as a consequence a barrier 
to change. While both comments centre on efficiency, the first GP is referring to 
delivery while the second GP is referring to making changes in the system. 
4.3.14 Auxiliary Services: “Not enough of them and too hard to access” 
Emergence of Themes 
The themes in relation to support services typically emerged during discussions about 
the provision of care. Access to services and the availability of community services were 
a barrier or a „would be‟ facilitator to the provision of care. Some GPs were satisfied 
with an individual service in their area such as the dietician, eye specialist, or foot 
specialist. Services fell along a scale from good to bad or bad to worst in some cases 
reflecting the variability of availability. Thus, few GPs had access to a complete package 
of care for their patients with diabetes. Participants referred to being “lucky” to have 
access to services suggesting the availability of services was a bonus rather than the 
norm. 
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“Not enough of them and too hard to access” was how one GP summed up the situation in 
relation to support services for diabetes patients (GP108, p8.4). This statement 
encapsulates the 2 key barriers facing GPs. 
A. Lack of services in the community (not available at all or not enough) 
B. Problems accessing the services which are available 
4.3.14.1 Lack of services in the community: relying on hospital 
Support services were described as “abysmal” (GP114, USC) and “nonexistent” (PN104, 
RGC) in some areas. The lack of services in the community left GPs at a disadvantage 
to the hospital setting (GP113, USC) reiterating the theme of GPs being capable of 
providing care with the proper resources. Although GP102 was relying on the hospital 
for “finer details like eyes and feet”, and was satisfied with this arrangement, there was a 
sense that the hospital could provide what he could not therefore it was the most logical 
setting for managing diabetes. 
A number of other GPs were also relying on hospitals for access to support services 
and for some this access was the main advantage of the review visit in the hospital 
(PN104, RGC/ GP115, RSNC). This dependence was seen as one of the main barriers 
to community-based diabetes care; 
“I think that‟s the barrier to the services as a community-based thing running properly, 
because it means you have to access the acute services to get somebody in” (PN 104) 
As a result of this dependency on hospital services, the lack of coordination and its 
manifestations in the health system were also a barrier to accessing support services. For 
example when discussing access to dietetic services GP109 (RSC) referred to the 
hospital as a “fortress” and used the example to illustrate the lack of “inter-connectedness 
between services”. The reliance on the hospital also led to waiting lists for services 
hindering early intervention and management (GP106, UGC/ PN104, RGC GP115, 
RSNC). 
“I had somebody recently whose…who had very poor eyesight due to diabetes and we 
couldn‟t get a community podiatrist to see her…at all. I mean it was about 2 years 
or something they told me the list was, that she wasn‟t a priority” (GP106)  
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Outreach services facilitating care provision in rural areas 
The lack of community services was a particular challenge for the elderly, as highlighted 
by GPs from rural areas (GP15 RCS, GP9 RCS, GP109 RCS). This patient group, who 
cannot travel far, would benefit from outreach services which did not exist in their 
areas. For example one rural GP praised the provision of a dietetic outreach service 
which benefited patients in terms of time and convenience (GP110, RGC). The service 
was established by the dieticians themselves demonstrating the initiative among 
different providers with the system of diabetes care. 
4.3.14.2 “Patchy” Access: variability & vulnerability 
In addition to the lack of community services in some areas, where services were in 
place their availability was often limited, in both urban and rural areas (GP104, RGC/ 
GP105, UGC/ GP114, USC/ GP115, RSNC/GP15 RCS, GP3 RSC, GP9 RSC, GP7 
UGC, GP5 UGC, GP6 USC]. Services available to general practitioners and their 
patients ranged from good to bad. “Patchy” was a term commonly used to describe the 
availability of services in the community. This adjective reflects both the variability and 
the vulnerability which characterised services in the Irish Health System at the time. 
The variability of services fell along a scale from good to bad to worst. Some GPs were 
satisfied with a specific service such as the dietician or foot specialist in a given area. In 
particular those with access to a retinopathy screening programme were very positive 
about the level and organisation of the service (GP111, UGC/ GP112, RGC, GP8 
RCG, GP11 USNC]. Few GPs had a total package of services in the area therefore the 
availability was conceptualised as being along a scale from good to bad to worse 
reflected in the following quote; 
“The waiting lists are way too long. Now dietician isn‟t the worst. I mean I think 
foot care is probably the worst” (GP106, UGC)  
A rural based GP also referred to a scale as eyes were described as “harder” in terms of 
access compared to services for diet and feet which were both conveniently located in 
the area (GP107, RSC).  
Another feature of the services, where they did exist, was the level of vulnerability 
arising from the recruitment embargo in the health system and the risk of funding cuts 
due to the growing economic recession. This theme was reflective of the policy position 
in 2009/2010 within the government to freeze recruitment in the public sector due to 
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the economic climate. The vulnerability of services usually resulted from maternity leave 
or retirement as these health care professionals were not replaced by the HSE due to 
the recruitment embargo. This phenomenon was experienced in rural and urban areas. 
“…some things are good and some things are bad. Foot care is not particularly 
good…it‟s a bit random…dieticians were good, we had a community dietician and 
then she went on maternity leave and she wasn‟t replaced so now again it‟s a bit 
patchy at the moment” (GP111, UGC) 
Patients left “muddling through”  
The barriers to availability and access have a negative impact on patients as highlighted 
by a number of GPs. One urban-based GP referred to families “muddling through” to 
provide care for family members with diabetes (GP106, UGC) while a Practice Nurse 
based in a rural area described newly diagnosed patients being left on their own “for two 
and a half months once their diagnosis kicks in” waiting for access to a dietician to assist and 
advise on the necessary lifestyle modifications (PN104, RGC). The financial barriers for 
patients, because of insufficient services in the community, were also recognised by 
GPs. Many patients had to attend private service providers due to long waiting lists or 
the unavailability of services in the community. 
On occasion the GP was not aware of what was in place (e.g. GP115, RSNC) which is 
itself a barrier for patients. In such cases comprehensive diabetes care is dependent on 
the GP to organise a service or dependent on proactive patients showing initiative to 
seek out appropriate care; 
“The nurse checks and reminds them about taking care of their nails. Otherwise I‟ve 
nothing formally organised…its basically up to themselves…most of them do nothing 
I would suspect, some of them are probably going to a chiropodist off their own bat, 
how often I couldn‟t say” (GP110, RGC) 
4.3.14.3 “Lucky” to have access to services 
Luck appeared to be a factor which facilitated the provision of a comprehensive 
diabetes service in general practice as those who had access to services referred to their 
practices and patients as “lucky” recognising and acknowledging the unique position 
they were in (GP110 RGC, GP107 RSC). For example in reference to short waiting lists 
for auxiliary services, one participant said patients were “rather lucky…it‟s unusual” 
(GP103 UGC). 
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In some instances access to auxiliary services was an upshot of initiatives to develop 
care locally or within the practice. For example a GP from a formal scheme providing 
structured care in his practice was “in a loop with other services” but attributed this network 
to “the closure of local hospitals and the opportunity of starting this south inner city partnership” 
(GP103 UGC).  Another GP involved in a formal shared care initiative was confident 
about the way services were organised: however he appeared more detached from the 
process as services were delivered through the hospital (GP108, RGC). 
“Podiatry has to go through the hospital, eyes…I suppose, that works pretty 
much…I know others criticise it but the way that it‟s organised now, they do get 
their eyes done regularly, they do get their podiatry, I think, when necessary and its 
well organised” (GP108, RGC) 
Other practices had built up structured care in their own practice and as a result had 
local arrangements in place for patients. A Practice Nurse, who represented this 
experience, had developed a “rapport” with local foot services which she cited as a 
facilitator of care delivery as opposed to dietetics where it was more difficult to pin-
point a contact, again reflecting the variability.  
“…If ever I‟m stuck and somebody comes in…and we‟re not happy, I can ring up there 
and say „I have this patient I‟m really not happy with, will you see them as an asap‟ and 
they will. Because they know that we‟re not sending every person up there with that. And 
that is excellent because we have good rapport with them.” 
4.3.15 Resources, Time and Workload 
Emergence of Themes 
During interviews GPs discussed resources, time and workload in tandem with each 
other, reflecting the interconnection between the factors. Most GPs referred to these 
factors as barriers to optimal delivery. However there was a sense of inevitability about 
the challenges of time, workload and resources hence these factors were not the 
dominant topic of discussion during interviews. In particular GPs who had developed 
an organised structured approach care tended to gloss over these barriers or discuss 
how they overcome the challenges.  
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4.3.15.1 “People like diabetic nurses are worth their weight in gold” 
As mentioned in the previous section, the presence of a nurse emerged as a facilitator in 
the coordination and delivery of structured systematic diabetes care. This theme was 
reiterated during the latter section of the interview as having a nurse was cited as a 
resource for the practice and the patient; 
“Probably the biggest advantage really in diabetes in recent years, has been the 
diabetic nurse, she has been the single best thing to happen to diabetes from the 
management point of view.” (GP109, RSC) 
Both Practice Nurses and Diabetes Nurse Specialists (DNS) were perceived as integral 
to the delivery of care, the common feature being “somebody designated to diabetes 
management” (PN104, RGC). From various GP accounts, it appears the nurse enabled 
care in several ways. The nurse‟s role in coordinating recall and regular review was 
outlined in the 1st part of the results section. In some areas the DNS facilitated 
coordination and communication with the local hospital setting (GP8 RCG, GP7 
UCG). Improvements in quality of patient care were attributed to enhanced nurse-led 
services both in the practice and in the local hospital (GP1 UCG).  
 “We‟re lucky now, I think I‟m lucky this nurse that does this [diabetes clinics] also 
does the heart watch so this is a very easy side move for her” (GP110, RGC) 
Funding to recruit nurses as a resource for the practice was highlighted as a „would be‟ 
facilitator and current barrier particularly for single-handed practices which could not 
afford to employ another nurse (GP10, UCS, GP105 UGC, GP114, USC).  
4.3.15.2 Lack of Resources and Infrastructure in Primary Care 
Most GPs acknowledged the lack of sufficient resources to deliver optimal care 
however many did not elaborate on the point. The resource which was most challenging 
in general practice was “infrastructure” (GP107). Infrastructure related to both staff and 
premises which were often mentioned in tandem. IT structures and support were also 
singled out as insufficient for optimal care delivery. Those who had sufficient resources 
cited them as a facilitator (GP110 RGC, GP113 USC) while those without cited them as 
“limiting” factor (GP105 UGC, GP114 USC). 
“…you need staff dedicated to do that job which means you need a room for them to 
work in, you need equipment and you need access to referral centres like ophthalmologists 
and chiropodists…infrastructure. Pie in the sky I know.” (GP107, RSC) 
144 
 
More specifically, resources were cited as a barrier to the shift in diabetes care to the 
community setting. As mentioned previously GPs felt they were at a disadvantage to the 
hospital setting due to the lack of resources in primary care. GPs felt they were capable 
of providing more diabetes care in general practice but the “support” was not in place to 
enable that.  
“…until the resources…the protocols and the structure are there I‟m not going to 
unilaterally move to start doing it…There needs to be a deliberate shift” (GP113, 
USC) 
“They want us to do everything in the primary care setting which is understandable… 
as much as possible it would be nice to be supported to be able to do that but it would 
mean more staff and that inevitably brings in things that would limit staff which would 
be incentives and remuneration” (GP114, USC) 
The last quote illustrates the interplay between barriers and facilitators evident 
throughout the findings.  
4.3.15.3 Time is “always a barrier”  
Time was a thread running throughout the narratives on providing diabetes care and has 
already been referred to a number of times in this results section. The issues around 
time were two-fold; the importance of timing in diabetes management and the time 
pressures facing GPs (See Appendix XII). The former concept related to the 
importance of early intervention and timely review which has been highlighted in 
relation to waiting times for access to the specialists and for access to auxiliary services. 
The latter theme of a time barrier was an obvious issue for GPs in terms of volume of 
patients seen in their daily practice, the specific demands of providing diabetes care and 
competing demands from other patient groups. For GPs time was “always a barrier” 
(GP111, UGC) reflecting the inevitability of certain barriers. More specifically time was 
a “cost” of providing diabetes care (GP101, RSC), a sentiment echoed by other GPs 
[GPs 13 (RCS), 15 (RCS), 2 (RCS), 16 (UCS) and 11 (UnonCS)].  
“You‟ll always find time”  
However a number of participants were not held back by this barrier, particularly the 
sub-category of practices that had initiated and developed a structured approach to 
diabetes care. Their can-do attitude may have been reflective of their enthusiasm for 
diabetes care. Delegating care was one method for overcoming the time barrier. For 
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example GP6 (UCG) referred to good staff resources to deal with the time spent on 
diabetes care so it worked well in the practice. Another GP acknowledged the lack of 
time for personal engagement but delegated care to the nurse; 
“I personally would like to have more time to devote to diabetes care myself. It‟s been on 
my list of things to do for the last 2 or 3 years, to sit down with Nurse P and actually 
review with her what she „s doing” (GP110, RGC) 
Being “overstretched” was excused as due to „our‟ organisation within the practice (GP108, 
RGC) or the patient-doctor ratio in the practice (GP110, RGC). These GPs owned and 
took responsibility for the time barrier and tried to overcome as opposed to just 
bemoaning it.  
Dedicated Time: advantages & disadvantages 
A distinction has been made between dedicated time within the daily practice to deliver 
diabetes care and dedicated time to organise diabetes care. A number of single-handed 
GPs wanted dedicated time to coordinate care for patients (GP101 RSC, GP113 USC, 
GP13 RSC). This was an extra time demand in addition to provision and the use of the 
word “devote” implied a personal dedication to the task; 
“You really need to devote…an afternoon session, a day a week or a day a month or 
a day a fortnight…to try and coordinate it…its time consuming that‟s the biggest 
barrier for us” (GP101, RSC) 
The demands of organising care also include coordinating with the hospital setting as 
evidenced by one single-handed GP who did not “have time or resources to do or look for 
shared care arrangements”. 
In contrast GPs‟ opinions were divided over dedicated time to deliver care. For some 
dedicated time to deliver diabetes care to patients would be a facilitator (GP13, RCS). 
Diabetes clinics were perceived to be the “ideal” scenario (GP16, UCS, GP106 RGC) 
and preferable over hospital-based clinics (GP14 UCG). However even the „ideal‟ could 
generate problems. Clinics “may not be the best use of resources” such as space and nursing 
time. Holding special clinics during the day had implications for both the practice and 
the patient as other patients could not be seen during that time. It also placed 
restrictions on the patient with diabetes; 
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“…in an ideal world you would have [a] dedicated clinic in the practice for your 
diabetic…but then of course…diabetics have to fit their lives in as well and Thursday 
afternoon that you‟ve decided to do your clinic might not be [suitable] for the patient so I 
mean there are time constraints for the patient and the doctor” (GP106, UGC) 
4.3.15.4 Workload reaching saturation in general practice 
Workload was a growing barrier in general practice as “a huge amount more bloods are being 
done” for example. While the sheer volume of patients with diabetes and the 
“overwhelming workload with type 2 diabetics” presented a significant challenge to care 
delivery in general practice, similar to time management, some practices were tackling 
the workload effectively and efficiently. In particular planning and organisation were 
essential to managing the “heavier workload” created by managing diabetes in a systematic 
structured way (PN104, RGC). Another participant referred to “staggering care” to make it 
more manageable (GP16, UCS).  
While many GPs referred to the workload as a barrier within the practice, it is also 
system-level barrier as more and more aspects of health care were being moved to the 
community. As a setting general practice was becoming “saturated”, this could limit its 
capacity to assume primary responsibility for diabetes care. 
“I think general practice is quite willing to take on…well we always have been willing to take 
on more and more stuff that is primary care-based [and] bring it out of secondary care but 
we‟re saturated now” (GP110, RGC) 
Other factors influencing the provision of diabetes care 
Finally one of the main facilitators of optimal care delivery proposed by participants was 
the provision of education and training for health care professionals (Table 30). 
Education was seen as one way to foster interest in diabetes among the wider 
profession (GP112 RGC, GP107 RSC). However the cost of pursuing an interest was 
too high for some GPs at present. 
“I think when you‟re interested in something you will attend courses to do it so I think 
more available education would be good. Time to go and do things that are not going to 
cost you,  for me to go and take a day off means I have to get a locum and every time I 
get a locum its €400 or €500” (GP107, RSC) 
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Table 30 Other Barriers & Facilitators referred to by GPs 
B/F Factor Explanation 
F Public Health 
Policy 
 “Society needs to ban food ads, to stop the greed people are feeding 
into” (GP11, UnonCS).  
 
F Guidelines  “Now we have national guidelines, we‟ve local guidelines…we‟ve 
ICGP protocols. So I think every GP in the country knows how to 
best care for patients with diabetes” (GP103, UGC) 
 
“We‟re following the guidelines more closely trying to get people 
closer to goal. So you‟re more aware of what you should be doing not 
that you actually get it right but you‟re kind of more aiming towards 
something” (GP107, RSC) 
 
F Advances in 
medicine 
“We really have monitoring processes in place now. We also have 
medicines there that were never there before…it is a good time, to 
start a protocol because there are things that can be done at a practical 
level” (GP109, RSC) 
 
F Patient 
Awareness 
GP4 (UCG) noted that patient awareness of diabetes and their family 
history has improved in recent times and was a facilitating factor when 
providing care.  
 
B Unrealistic 
Clinical 
Targets 
GP1 (UCG) stated that the need for perfection on A1c levels was a 
barrier to satisfactory care. 
 
B Polypharmacy According to GP 6 (UCG), as it was difficult for patients to deal with 
this and difficult for GPs to communicate to patients, due to time and 
workload constraints, especially in the elderly population group.  
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4.4 Discussion 
4.4.1 Summary of Findings 
The results of this study capture the complexity and variability which characterises the 
delivery of diabetes care in Ireland. This qualitative study was conducted as a follow-up 
to the national survey of GPs to elaborate on the organisation and delivery of diabetes 
care in general practice and explore perceptions of the barriers and facilitators to 
providing optimal care in that setting. The analysis delineated four dimensions of 
diabetes care delivery. Firstly there was a continuum within the practice from “ad-hoc” to 
structured systematic care. Secondly, there was a varying balance of care between GP-
led management and hospital-led management which was influenced by the interest of 
the GP, the location of the practice, the availability of resources and the historical 
context of care. Another continuum which emerged from the data was the extent of 
sharing diabetes management between the practice and the hospital-based team. The 
relationship between the settings was synonymous with referrals. Reasons for referring 
patients to the hospital included reaching a professional threshold of expertise and the 
development of complications which required specialist input. However, participants 
also gave reasons for resisting referral of patients into the hospital including the 
apprehension of losing the patient to “the system”. The final dimension of care delivery, 
which related to a subset of interested GPs and Nurses, focused on practice 
involvement in formal local/regional initiatives to improve diabetes care or proactive 
efforts within the practice to develop a structured approach to care, categorised as 
informal initiatives.  
Previous studies have categorised factors influencing diabetes care at the level of 
patient, provider and organisation/system (180, 181). This study unpacked further 
layers of health care delivery, identifying factors relating to the relationships between 
providers and the culture underlying the health system. The main barriers to optimal 
care delivery from the general practice perspective were system-level deficiencies such 
as the lack of remuneration, insufficient services and lack of coordination between 
settings. These issues had a ripple effect throughout the system at an organisational, 
social, professional and patient level. For example the lack of remuneration for diabetes 
care created a sense of “apathy” among health care professionals but also led to out-of-
pocket costs for patients.  
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The preceding surveys of GPs (Chapter 3) and consultants suggested a lack of formal 
coordination between settings reflected in the lack of routine discharge, shared 
protocols or joint meetings (161, 170). The qualitative findings illustrate the negative 
effects of the lack of coordination in the system including the bureaucratic “palaver” 
around service delivery, the uncertainty for patients and providers of “in the meantime 
care” and “overburdened” hospital clinics. The flooded hospital system led participants to 
highlight the capacity and benefits of general practice as a setting for diabetes 
management. This potential was untapped due to the lack of infrastructure, deficient 
access to services and insufficient resources to provide high quality care. Time was 
highlighted as a significant barrier in general practice. However, some participants 
adopted a more proactive attitude towards overcoming this almost inevitable challenge.  
4.4.2 Barriers to Delivering Optimal Diabetes Care 
A number of the barriers to optimal diabetes care delivery highlighted in this study were 
brought to our attention in 2001 in national primary care strategy „Primary Care; A New 
Direction‟(182). „Inadequacies‟ in primary care in 2001 included poor primary care 
infrastructure, fragmented services, lack of availability of certain professional groups, 
poor liaison between settings and the failure to fully realise the potential of primary care 
to ease the pressure on secondary care (182). Similar barriers to diabetes care provision 
have been highlighted in a surveyed conducted in UK. The barriers identified, including 
inadequate access to auxiliary services and secondary care, were ranked with inadequate 
access to dieticians and chiropody perceived as a greater barrier in the UK than access 
to ophthalmology (164). There was a similar though unconscious rating of auxiliary 
services by participants in this study, along a scale from good to bad to worse. There 
was not an urban/rural divide in terms of access to services rather participants 
highlighted the dearth of services in primary care compared to the hospital setting. Until 
this balance is rectified, proposals to shift care to the community will not be viable. 
The results reflect the overlapping spheres of the Chronic Care Model (CCM): 
community resources and policies, the health system, the practice, the professional and 
the patient. The consequences of barriers and facilitators throughout the system are 
congruent with an underlying assumption of the CCM that different components of 
chronic illness care are interdependent. Innovation and development is unlikely to occur 
at practice level if chronic disease management is not prioritised in the health system 
(84). GPs in this study perceived the lack of financial support and encouragement as an 
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indicator of the lack of value placed on primary care chronic disease management, 
concluding that there was “no incentive to do more”.  
4.4.3 Incentivising Diabetes Care 
The lack of remuneration or financial incentives for chronic disease management was 
one of the principal barriers to providing optimal diabetes care in general practice 
according to participants in this study. However opinions were divided about the most 
desirable model of remuneration. Evidence on the best way to remunerate health care 
professionals is inconclusive and the rigorous evaluation of different payment structures 
is fraught with methodological difficulties (183). In the preceding survey over half of 
the GPs favoured a mixture of capitation grants and fee for service, while less than 25% 
supported target-driven payment as remuneration for diabetes care. The qualitative 
findings presented in this chapter revealed concerns about target-driven payment, 
including the risk of diminishing non-incentivised aspects of care and the potential for 
health care professionals to scam the system. These concerns have been raised in 
relation to the Quality Outcomes Framework (QOF) in the UK which links additional 
payment to performance and quality in general practice (184, 185). Research using QOF 
data has shown a reduction in quality among aspects of care not linked to incentives as 
well as a decline in the continuity of care (186, 187). Such unintended negative 
consequences compound the contradictory evidence base underlying the impact of pay-
for-performance structures (188). 
4.4.4 Role of personal and “vocational” incentives  
In light of the inconsistent evidence on financial incentives, Marshall and Harrison 
(2005) contend that “something more than personal financial gain is driving professional behaviour” 
(p5) (189). This proposition is supported by the results of this study which highlighted 
the activities of “keen” GPs who developed an organised approach to diabetes care, in 
the absence of adequate remuneration and in some cases at a financial loss to the 
practice. This subgroup of GPs referred to personal and “vocational” incentives including 
personal satisfaction and a professional “duty”. Internal incentives such as these are 
known as intrinsic motivation; an activity carried out because it is inherently satisfying 
as opposed to externally rewarding (190). There is evidence to suggest that intrinsic 
motivation can be “crowded out” by external rewards particularly performance-based 
rewards by diminishing self-determination and self esteem (191). This is somewhat 
similar to the concerns expressed in this study that financial incentives could corrupt 
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care and cause a ripple effect for incentivizing all chronic disease management. The self-
determination to manage other chronic illness may be undermined by the financial 
rewards received for diabetes care. However the subgroup of “keen” GPs did not 
anticipate the potential negative impact of remuneration on their own personal 
motivation. Policy-makers deciding on the ideal payment structure for healthcare should 
consider the context (183) and the alignment of values between the professional and the 
organisation (189). According to the results of this study, there is a mismatch between 
the values of the HSE and those of GPs in terms of the contribution of primary care 
and the value of chronic disease management. 
Two levels of internal incentives were identified in this study; personal incentives and 
“vocational incentives” however a framework for worker motivation proposed by Franco et 
al (2002) illuminates further distinctions in the results (192). Drawing on theories from 
economics, psychology and sociology, Franco et al identified determinants of worker 
motivation at the individual level, organisational level and cultural level. According to 
the framework, individual level determinants include goals, values, self concept (self 
efficacy & evaluation of competencies) and the experience of outcomes. In this study 
the subgroup of interested GPs‟ conveyed a sense of competence and confidence in 
their ability, referring to the feeling “that we‟ve improved the service”. Furthermore GPs 
referred to their personal experience of the complications of diabetes as an incentive to 
act and the personal value placed on preventative medicine. 
According to Franco‟s framework, organisational determinants of motivation include 
organisational structures, communication processes and organisational support such as 
adequate resources and efficient service delivery. A number of GPs emphasised 
infrastructure and resource deficits as impediments to providing optimal care although 
they acknowledged the appropriateness of the general practice setting for diabetes 
management. This suggests that organisational determinants were the dominant 
influence over individual motivation for some GPs. The success and perceived benefits 
of formal initiatives, including access to auxiliary services, illustrates how intrinsic 
motivation to improve care coupled with organisational support can lead to changes in 
the practice. However, the framework does not account for the dominance of one type 
of motivation over other, as appears to be the case for those GPs who developed care 
“off their own bat” without financial incentives. Participants suggested remuneration was 
necessary for widespread engagement in diabetes care as intrinsic incentives were 
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limited to “pockets of interest” and were insufficient to motivate all health care 
professionals. 
4.4.5 Elucidating models of care  
As suggested by one participant in this study the terms surrounding the models of care 
“mean different things to different people”. Both shared care and structured care involved 
similar features to enhance the delivery of care but the terms also had local 
connotations. Structured care was characterised by organisational and professional 
features such as patient registries and local arrangements to access services, reflecting 
some of the components of effective chronic disease management proposed by the 
Chronic Care Model (193). The allocation of tasks between the GP and the nurse which 
evidence in the data is also considered a key part of the practice delivery system (69). 
However, unique to this context, participants associated the term structured care with 
general practice-led management. In light of descriptions of structured chronic disease 
care in the literature and the participants‟ interpretation of the term, structured care 
could be considered as an organised and systematic approach adopted within the 
practice to provide diabetes care to the majority of patients.  
Formal shared care initiatives were also associated with organisational and professional 
features including shared education sessions, referral protocols and sharing the expertise 
of a Diabetes Nurse Specialist, a characteristic of formal shared care initiatives in the 
Netherlands (128). The perception of shared care, as a “good combination” of the benefits 
of primary and secondary management was in stark contrast to the unique perspective 
of shared care as a means of demoting general practice to a second best system 
delegated to by hospitals. The conflicting positive and negative views of shared care 
schemes have previously been raised in relation to sharing cancer care between primary 
care physicians and specialists (194). 
4.4.5.1 Sharing care to enhance coordination and integration 
Participants identified greater „sharing‟ of care between settings as a facilitator to 
diabetes care provision using the term interchangeably with „integrated care‟. Shared 
care arrangements and the numerous permutations (e.g. transmural care, disease 
management, integrated care pathways) have been described as mechanisms to achieve 
greater integration (171, 195). In this study „sharing‟ care combined attitudinal 
components, such as a sense of shared responsibility, and behavioural components such 
as common records and protocols for referral and discharge. Shared protocols to clarify 
153 
 
the realms of responsibility in each setting and integrated information systems could 
reduce the uncertainty of “in the meantime care”, limit “avoidable duplication” or the 
alternative of patients “falling between two stools”. These system-level interventions are in 
keeping with the WHO definition of integrated care as a concept „bringing together inputs, 
delivery, management and organisation of services related to diagnosis, treatment, care and rehabilitation 
and health promotion‟ (171). 
As opposed to either/or care, the focal point of sharing management in this study was 
two points of access for the patient combining the best of both worlds; access to and 
support from the expertise in secondary care with the balance of care in general practice 
for routine management. However, it is important to identify and highlight the unique 
opinions on the need for joint involvement. One participant perceived “no need” for 
hospital involvement while another felt the hospital was the natural setting for diabetes 
management given the availability of services and expertise. Anomalies such as these are 
often brushed over in quantitative research (196) but in this study they highlight the 
need for flexibility within a national model of care to allow for lack of interest but also 
capacity to manage the majority of patients in general practice. Originally the report 
from the Expert Advisory Group for Diabetes (2008) prescribed the number of patient 
visits required under an integrated model of care (1), however the working definition of 
the model has since been modified to allow for professional judgment and discretion. 
Integrated care now encompasses the majority of patients‟ visits taking place in general 
practice with review in the diabetes centres, the frequency of which depends on patient 
need (142). Flexibility depending on local circumstances does not negate the need for 
clarity surrounding the realms of responsibility highlighted in this study. Responsibility 
for coordinating care needs to be assigned to prevent wasteful duplication and gaps in 
care which could prove costly for the patient (197). 
4.4.6 Strengths & Weaknesses 
In this study qualitative research refers to a set of methods rather than a rival paradigm 
associated with a particular philosophical perspective (198). The Framework approach 
was a pragmatic way of analysing the data as there were pre-specified aims and 
particular information requirements to inform the establishment of a national diabetes 
register. It also facilitated analysis within a restricted time frame and the transparent 
approach to data management allowed the researchers to understand and assess the 
analysis of their colleague (175). The latter advantages of the Framework approach 
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could be framed as a criticism; is it more of a data management tool rather than a 
method of analysis? There is no single agreed method of analysing qualitative data 
which is an open and evolving process. Looking across the various methods and 
writers, there are several similarities between the coding processes of different 
approaches although different terminology are employed (178). 
Health Services Research has tried to move on from the justification or defence of 
qualitative methodology towards enhancing the quality of these methods (198). 
Triangulation is a common technique for demonstrating the rigor and quality of a study 
and in this instance triangulation of analysts was employed. Like many aspects of 
qualitative research methodology, the merits of involving more than one analyst are 
debated (199, 200). In addition to the reality of group research projects, a team of 
researchers can bring breadth and depth to the findings (22, 201) and is often 
considered an implicit form of inter-rater reliability (179). Inter-rater reliability was also 
applied explicitly in this study involving an independent researcher. Applying the term 
or concept of reliability to qualitative research is contentious in itself. Inter-rate 
reliability is seen by some as a habit of quantitative research adopted without question 
of its appropriateness (202). However the technique is appropriate in the context of 
semi-structured interviews whereby all participants are asked broadly the same questions 
in the same order with data coded at the end of the collection period. Nevertheless 
there is a risk of over-simplifying codes and themes to facilitate independent checking. 
In this study inter-rater reliability was utilised on the initial codes following the first 
wave of analysis to minimise this risk. 
The focus of this study was on the organisational and structural barriers and facilitators 
of optimal diabetes care based on the findings of the national survey of GPs. Patient-
related factors such as attitudes to diabetes and adherence have also been 
conceptualised as barriers and facilitators to care provision (181). GPs highlighted 
potential barriers and facilitators from the patient perspective including the familiarity 
of care provided in general practice and the out-of-pocket costs associated GP care 
which has been previously identified as a barrier to access (203). Further research 
should be conducted with patients to garner their views on the factors influencing 
provision and examine the similarity or disparity between the different perspectives.  
This study advances our understanding of the interaction between the barriers and 
facilitators involved in providing optimal diabetes care. Previous studies purport to 
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demonstrate relationships between barriers and facilitators however these connections 
may not necessarily emerge from the data itself and often issues are superficially 
corralled into patient, provider and system level issues. While there were differences in 
categorisation of barriers, similar challenges to diabetes management were found in 
other studies. For example a study conducted in Canada identified the lack of capacity 
for computerised recall as a physician-level barrier. While the authors of the Canadian 
study refer to the „serendipity‟ of patients returning to the practice as a barrier, a number 
of GPs in this study were purposeful in their avoidance of reminders in order to evoke a 
sense of responsibility among patients (181). There is a balance to be struck between the 
organised approach of regular recall and review and the onus on the proactive patient to 
actively manage their own illness and care. 
The barriers and facilitators identified in this study are rooted in the context and 
peculiarities of the Irish health system, such as the part played by „luck‟ in securing 
access to services in the community. However the similarity of barriers and facilitators 
identified across studies adds weight to the argument that structural and organisational 
factors influence the provision of high quality diabetes care in general practice (164, 
181, 203). There is scope for a meta-synthesis to be conducted on the barriers and 
facilitators to provision, to develop and understand the full extent of the evidence base 
(204). A number of the barriers have implications beyond diabetes care and correspond 
to issues facing the wider primary care setting (205). Consequently there is ample 
opportunity to learn from other settings and countries in terms of how to overcome 
these barriers. 
4.4.7 Conclusion 
The key ingredients of effective diabetes care highlighted in 1982, organisation and 
enthusiasm, emerged in this study of GPs‟ experiences of diabetes care provision and 
their perspectives on the barriers and facilitators to delivery. Given the policy focus on 
increasing the role of primary care in chronic disease management, there is a need to 
understand the current challenges to delivery in this setting. Reorientation of care must 
be accompanied by the reorganisation of support and resources. Internal incentives and 
enthusiasm are drivers of change for a pocket of health care professionals however this 
is not sufficient for widespread engagement of GPs in diabetes care delivery (206). 
Health systems need to invest in infrastructure to support and enable health care 
professionals to make high quality care attainable rather than aspirational. 
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Abstract 
Aim: The aim of this study was to assess the quality of structured Type 2 diabetes 
management in three primary care-led initiatives in Ireland, a bottom-up approach to 
improvement in a country with minimal incentives to promote the quality of care.  
Methods: A purposive sample of three initiatives, engaging in regular audit, participated in 
this study. Data on processes of care and intermediate outcomes were available for 3010 
adult patients with Type 2 diabetes. Results were benchmarked against the national 
guidelines for the management of Type 2 diabetes in the community, results from an audit of 
shared diabetes care in Ireland, and results from the National Diabetes Audit (NDA) for 
England (2008/2009) and the Scottish Diabetes Survey (2009).  
Results: The recording of clinical processes of care was similar to results in the UK however 
the recording of lifestyle factors was markedly lower. Recording of HbA1c, blood pressure 
and lipids exceeded 85%. Recording of retinopathy screening (71%, n=1872) was also 
comparable to England (77%) and Scotland (90%). Only 63% (n=1263) of patients had 
smoking status recorded compared to 99% of patients in Scotland while 70% had BMI 
recorded compared to 89% in England. A similar proportion of patients in Ireland and the 
UK achieved clinical targets. Thirty-five percent of patients (n=948) achieved the national 
target for HbA1c of ≤6.5% (<48mmol/mol) compared to 25% in England. Applying the 
NICE target for blood pressure (≤140/80mmHg), 54% of patients reached this target, 6% 
lower than the level of achievement among patients with Type 2 diabetes in England (60%). 
Approximately half of patients with Type 2 diabetes were categorised as obese (>30kg/m2) 
in Ireland (n=1060) and Scotland (54%).  
Conclusions: This study demonstrates what can be achieved by proactive and interested 
health professionals in the absence of national infrastructure to support high quality diabetes 
care. The quality of primary care-led diabetes management in the three initiatives studied 
appears broadly consistent with results from the UK. The challenge facing health systems is 
to establish quality assurance a responsibility for all health care professionals rather than the 
subject of special interest for a few. 
  This study has been accepted for publication in BMC Health Services Research 
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6.1 Introduction 
6.1.1 Increasing the role of primary care in diabetes management 
The persistent gap in the quality of health care has been attributed to the inability of health 
systems, which are oriented towards acute episodic care, to meet the needs of patients with 
complex chronic conditions (10). It is now widely accepted that this hospital-heavy model of 
care will not cope with the future burden of chronic disease and as a consequence health 
care systems are examining ways to reorganise services with growing emphasis on the role of 
primary care (11, 13). 
A common feature of the reorganisation of health systems in developed countries is the shift 
of chronic illness care such as diabetes management from the hospital setting to the 
community. An important proviso of this transfer is that care in the general practice setting 
is structured, planned and integrated (1). A systematic review found care in the community 
was as good as or better than hospital-based care alone in terms of mortality rates, HbA1c 
concentrations and loss of patients to follow up when it was structured with intensive 
support for GPs (231). In the qualitative study of the barriers and facilitators to optimal 
diabetes management presented in Chapter 4, GPs suggested the potential of general 
practice was stifled by the lack of resources and insufficient access to support services. 
6.1.2 Providing Structured Diabetes Care in the Community 
Structured care interventions have been described as a series of  „multifaceted disease management 
strategies‟ (p8) (133) and typically involve a combination of organisational, professional and 
patient level interventions. A systematic review of multidimensional professional and 
organisational interventions to improve the quality of diabetes care demonstrated a positive 
impact on the processes and outcomes. Combining patient education with these 
interventions and enhancing the nurses‟ role led to improvements in patient outcomes 
however outcomes beyond measures of glycaemic control tended to be neglected (14). 
Another trial of structured primary care involving diabetes registers and input from „local 
physician champions‟ had a impact on processes and outcomes of care for patients with 
Type 2 diabetes (111). Structured care can also have a positive impact on psychosocial 
outcomes as demonstrated by two studies conducted in Ireland. Significant improvements 
were identified in treatment satisfaction and well-being as well as process measures, 
following an intervention delivering structured shared diabetes care to patients with Type 2 
diabetes (138). Furthermore an observational study examining the relationship between 
models of care and quality of life, found that patients with diabetes receiving structured care 
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in general practice reported better quality of life compared to patients under a traditional or 
mixed model of care (20).  
6.1.3 Reorganising Diabetes Care in Ireland 
The adoption of a structured approach to diabetes care in general practice is the exception 
rather than the rule in Ireland. As illustrated by the survey of diabetes care in general practice 
presented in Chapter 3 of this thesis, care is often ad-hoc with limited adoption of strategies 
to enhance organisation such as patient registries or formal recall systems (170). 
Approximately half of the GPs surveyed reported using guidelines with fewer still referring 
to national guidelines for diabetes management in the community. Access to essential 
support services such as dietetics and retinopathy screening was inconsistent with multiple 
providers of services.  
Within this opportunistic system, there are a number of „islands of excellence‟ providing 
comprehensive systematic care for patients with diabetes. There are currently ten initiatives 
ranging from shared care arrangements (139), to structured care initiatives set up by GPs, to 
more recent initiatives which are mainly characterised by the appointment of a diabetes nurse 
specialist. Similar to shared care arrangements in the Netherlands (7), shared care in Ireland 
is characterised by „joint participation between hospital consultants and general practitioners in the 
planned delivery of care‟ for patients with diabetes (141). This joint participation is facilitated and 
supported by a Diabetes Nurse Specialist.  
Structured care has connotations with primary care-led diabetes management in Ireland as 
illustrated by the findings of the qualitative study of diabetes care presented in Chapter 4. 
Three initiatives pioneering a structured approach to diabetes care in the community have 
engaged interested proactive health care professionals in a bottom-up approach to improving 
the quality of care and patient outcomes. Through the dissemination of regular audit reports, 
each group has independently contributed to the evidence base for structured primary care-
led diabetes management in Ireland (137, 140, 232). The aim of this study was to profile the 
performance of this group of „champions‟ against that of the national system of diabetes care 
delivery in the UK where care provision is supported by a dedicated policy framework, 
population-based retinopathy screening, robust IT systems and a financial incentive structure 
to promote quality assurance. 
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6.1.4 Aims & Objectives 
As part of the aim to examine efforts to bridge the quality gap around diabetes care at 
practice and policy level the objective of this study was: 
1. To assess the quality of structured Type 2 diabetes management in practices with a 
special interest in diabetes, a bottom-up primary-care led approach to improvement, 
and to compare the performance to that of a national system of diabetes care (UK).  
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6.2 Methodology 
6.2.1 Design 
This cross sectional study was based on data from primary care-based initiatives across 
three regions of Ireland; the Diabetes Interest Group Cork (DIG) in the South of 
Ireland, the HSE Midland Area Diabetes Structured Care Programme and  HSE North 
East Diabetes Watch.  
6.2.2 Sample  
6.2.2.1 Practices 
A purposive sample of three primary care initiatives participated in this study. Three of 
the most well-established primary care schemes were chosen, all of which conducted 
and disseminated regular audit. There are currently 10 diabetes initiatives in Ireland, 
however most did not engage in the routine collection and analysis of audit data at the 
time. Although a purposive sample of schemes was used, within each scheme all 
practices took part in the audit (n=63). The sample represents a small proportion of the 
total number of GPs in Ireland (approx. 1%), reflecting the special interest in improving 
diabetes care.  
Participating practices were from a mixture of urban and rural areas and included single-
handed and group practices. All practices provided structured care to patients with Type 
2 diabetes in the general practice setting, which involved continuing professional 
education, incorporating guidelines, maintaining practice registers and engaging in 
regular audit and feedback. Each practice employed a Practice Nurse. Some patients 
were also attending secondary care as required. Specialist input was provided in one 
initiative by a Diabetes Nurse Specialist while the other two initiatives were coordinated 
by a Diabetes Nurse Facilitator. Practices also received administrative and 
audit/research support to manage the initiatives.  
Two of the three initiatives financially reimbursed general practices for their 
involvement in the scheme. In the Midland Area Diabetes Structured Care Programme, 
practices were reimbursed for Practice Nurse time or through participation in the Heart 
Watch Programme, the disease management programme for cardiovascular disease. GPs 
involved in Diabetes Watch were paid per patient visit and also had an annual target to 
achieve in order to receive a bonus payment. Practices involved in the third initiative, 
the Diabetes Interest Group, did not receive payment in any form for participation.  
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Prevalence 
It was not possible to calculate the prevalence of Type 2 diabetes in this sample as it is 
not mandatory in Ireland for patients to register with a single general practice; therefore 
we lack a reliable population denominator. The prevalence estimates for each region 
from the Institute of Public Health (IPH) (39), are comparable with the estimated 
national prevalence and the prevalence of Type 2 diabetes in Scotland and England 
(Figure 29).  
 
Figure 29.Estimate of population prevalence for Type 2 diabetes in adults in 2010 
6.2.2.2 Patients 
Adult patients (≤18 years old) with Type 2 diabetes who were registered with a 
participating practice were eligible for inclusion in the analysis. Type 2 diabetes was 
defined on the basis of standard clinical and blood glucose criteria (12). Patients with 
Type 1 diabetes and Pre-diabetes were excluded from the analysis.  
Due to the large number of patients enrolled in the HSE Midland Diabetes Structured 
Care Programme (>3000), a random sample was selected from each practice and 
included in the overall analysis. A sample size of 1168 patients (51%) was calculated 
using glycaemic control (HbA1c level) as the outcome measure with a confidence level 
of 95% and a difference of 2%. In a previous audit, the mean HbA1c for the total 
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sample was 7.6% and the 95% confidence interval was ± 0.11% which equates to 
~1.5%. Data were available on 989 patients with Type 2 diabetes (47.1% of total 
sample) which was 97 patients less than the determined sample size as a number of 
patients recorded on the database as current had died, left the practice or had been 
transferred to a nursing home.  
6.2.3 Data Collection 
Data collected between late 2007 to early 2009 (≤12 months in each area) were collated 
into a single dataset for analysis. All data were collected manually by practices 
themselves or by the DNS/Diabetes Nurse Facilitator (Table 35). Data sources included 
the patient‟s clinical notes (electronic and paper), letters in the clinical notes regarding 
outpatient appointments in hospitals and referrals to other services 
(chiropody/podiatry, retinopathy, dietetics etc).  
Table 35 Data Collection across the 3 Initiatives 
 HSE Midland Area 
Diabetes 
Structured 
Diabetes Interest 
Group 
Diabetes Watch 
Number of 
practices 
28 GPs 12 GPs 23 GPs 
Number of 
patients 
989 (47%) 1006  1015 
Data 
collection 
period 
Nov 08-March 09 Dec 07-May 08 Jan 08-Dec 09 
Data 
Collection 
Method 
Diabetes Clinical Nurse 
Specialists 
Diabetes Nurse 
Facilitator 
Excel datasheets 
completed by practices 
at each visit & 
submitted to Diabetes 
Nurse Facilitator 
Sample Random sample from 
each practice  
All patients registered 
with participating 
practice 
All patients who 
attended 2nd visit 
during 2008 
 
  
197 
 
As there was slight variation between the three primary care initiatives regarding the 
data collected, a comparison exercise was conducted to determine common data 
(Appendix XV). All data collected was based on the previous 12 months. Table 36 
shows details of variables common across all three initiatives.  
Table 36 Common dataset across 3 primary care-led initiatives 
Demographics Process of care Intermediate Outcome of Care 
Gender Recording of HbA1c HbA1c 
Age Recording of Blood Pressure Blood Pressure 
 Recording of Body Mass Index Body Mass Index (BMI) 
Recording of Total Cholesterol 
concentration 
Total Cholesterol concentration 
Recording of LDL Cholesterol 
concentration 
LDL Cholesterol concentration 
Recording of HDL Cholesterol 
concentration 
HDL Cholesterol concentration 
Recording of smoking status Smoking Status 
Retinopathy screening in past year  
Foot Assessment in the past year 
Treatment with statin/aspirin 
6.2.4 Comparators 
National Comparison 
The national guidelines for diabetes care in the community, “A Practical Guide to Integrated 
Type 2 Diabetes Care”, were used to define the optimal standard of care in Ireland (17). 
The guidelines set targets for the achievement of outcomes and the relevant cut-off 
points are indicated in the results section. Data were also compared to the results of the 
most recent audit of shared care in Ireland completed by the East Coast Area Diabetes 
Shared Care Programme (ECAD) (139). This enabled a comparison between two 
models of care; primary care-led structured management and shared care between GPs 
and the hospital based team. Established in 2001, the ECAD shared care scheme 
involves 11 GP practices and 3 hospitals. The most recent audit was based on data from 
261 patients with Type 2 diabetes. Data were collected from the GP practices and 
entered onto an excel spreadsheet by the GP, Practice Nurse, DNS or dietician, similar 
to data collection in the Diabetes Watch Programme. 
International Comparison 
Comparisons were drawn with the National Diabetes Audit (NDA) for England for the 
corresponding period of 2008/2009 (233). This is the largest annual audit of diabetes 
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services in the world with over 1.5 million people with diabetes included, 75% of the 
diabetic population in 2008/2009. All primary care trusts in England (n=152) 
contributed data from the majority of GP practices in England (71%, n=5920). The 
NDA 2008/2009 data are contained on the NDA “Dashboard” where data represent 
Type 1 and Type 2 diabetes combined. The published executive summary report 
contains some results stratified by type of diabetes and where available figures for Type 
2 diabetes are reported. Data from the National Diabetes Audit for Wales were excluded 
from this study as results were based on data from 31% of practices in Wales, and 
therefore were not considered representative.  
The quality of care provided by primary care initiatives in Ireland was also compared to 
results from the Scottish Diabetes Survey (234). The population level survey is 
published annually by the Scottish Diabetes Survey Monitoring Group. It collates 
nationally agreed data submitted by 14 NHS Boards incorporating both primary and 
secondary care. Diabetes registers, held by each health board, are the main source of 
data for the survey. Results from 2009 were chosen as data were stratified by type of 
diabetes allowing for direct comparison with Type 2 diabetes management. Data on 
recording and outcomes were similar across the 2008 and 2009 Scottish Diabetes 
Surveys (234). In 2009 over 220,000 people were included in the survey, of which 87.4% 
had Type 2 diabetes. 
6.2.5 Data Analysis 
Data were entered into PASW Statistics (Version 18) for coding and analysis. Standard 
descriptive statistics are used throughout the report. Categorical data are presented as 
number and percent as appropriate. Continuous data are presented with standard 
measures of central tendency and dispersion: mean, standard deviation, median, 
interquartile range (IQR; range of values between 25th and 75th percentile) and range. 
Standard parametric and non-parametric test (T-test and Mann-Whitney U test) were 
used to compare the distribution of continuous variables in independent groups. A 
number of continuous variables were classified into risk categories according to the 
targets specified in national guidelines (17). In addition HbA1c levels were broken down 
according to the risk categorisation proposed by the ICGP (235). BMI results were 
categorised according to the WHO cut-off points (236). There were missing data on a 
number of variables ranging from 6% non-recording for blood pressure to 36% for 
smoking status. Where this occurs, the figures represent the recorded data.   
199 
 
6.3 Results 
Following the collation of data from 3 primary care initiatives, data were available for 
3,010 patients with Type 2 diabetes from 63 General Practices.  
6.3.1 Characteristics of the study participants 
6.3.1.1 Age and gender 
The profile of patients in this sample was similar to that reported in the National 
Diabetes Audit for England (NDA) and the Scottish Diabetes Survey. Of the 3,010 
patients, 56.5% were male (n = 1,701) (gender unknown for 0.4% of the sample, n = 
11) comparable to Scotland where 54.6% of patients were male. This gender breakdown 
was also consistent with patients enrolled in shared care (57% male). Data on the gender 
breakdown of patients included in the NDA for England was not available. 
The mean age of patients was 65.7 years (SD=12.2) comparable to an average age of 65 
years among patients in the ECAD Shared Care Programme. Over half the patients 
were aged 65 years or over (56.5%, n=1691) compared to 70% of patients with Type 2 
diabetes in Scotland. Twenty-five percent of people included in the NDA for England 
were less than 40 years old. Figure 30 presents the age distribution of all patients 
stratified by gender. There was a statistically significant age difference between males 
and females receiving structured care (64.7 vs. 67.1, p<0.001).  
 
Figure 30 Percentage of patients in each age category by gender 
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6.3.2 Recording Processes of Care 
The recording of processes of care among practices in the shared care model was 
marginally higher than structured care practices with the exception of retinopathy 
screening (43% shared care vs. 71% structured care, n=1872). Table 37 benchmarks the 
level of process recording in structured care practices against levels in shared care 
practices and results from the UK. Process of care recording for clinical outcomes 
compared favourably to audit results in England and Scotland. However recording of 
lifestyle factors was lower. Recording of Body Mass Index (BMI) was 70.4% compared 
to 90% in Scotland and 89.2% England. Only two of the three initiatives collected 
information on the recording of smoking status. Among these practices (n=1995), 
smoking status was recorded for 63% of patients (n=1263) compared to 99% recording 
in Scotland.  
Table 37 Process of care recording 
 
Three  
Primary Care Initiatives 
Ireland 
Shared 
Care 
Scheme 
Ireland 
National 
Diabetes 
Audit 
 England † 
T1 & T2 DM 
Scottish 
Diabetes 
Survey 
T2 DM 
 % (n) 95% CI % (n) % % 
HbA1c 90.2*(2714) 89.0-91.2 95 (247) 91.7 89.9 
Blood Pressure 93.5 (2814) 92.5-94.3 96 (249) 94.1 95 
Total Cholesterol 92.2 (2776) 91.2-93.2 Fasting 
Lipids 
94 (246) 
90.3 87.7 
LDL Cholesterol 86.5 (2604) 85.2-87.7 - - 
HDL Cholesterol 84.9 (2554) 83.5-86.1 - - 
Smoking Status‡ 
(n=1995) 
63.3 (1263) 61.5-65.4 87 (228) 86.8 99.3 
BMI 70.4 (2119) 68.7-72.0 70 (182) 89.2 90.0 
Retinopathy 
screening  
71.2 (1872) 69.4-72.9 43 (111) 77.3 90.0 
Foot assessment  64.6 (1481) 62.6-66.6 84 (220) 82.9 78.8 
*4 DW pts with HbA1c = 0.1 were removed from analysis. 
 ‡Smoking Status only recorded for DIG and HSEMA  
†Data obtained from National Diabetes Audit Dashboard for England represent T1 & T2DM 
combined 
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6.3.3 Outcome Measures 
6.3.3.1 Glycaemic Control (HbA1c) 
The mean HbA1c value for the sample was 7.1% (54mmol/mol) (SD=1.3). There was 
no statistically significant difference in glycaemic control between males and females (p 
= 0.795). The mean HbA1c for patients involved in structured care was slightly higher 
than that of patients enrolled in shared care (7.1% vs. 6.8%). The mean HbA1c for 
patients with Type 2 diabetes across the 14 NHS Boards in Scotland was marginally 
higher (7.3% or 56 mmol/mol). 
Over one third of patients with Type 2 diabetes (35%, n=943) reached the national 
recommended target for HbA1c (<6.5% or <48mmol/mol), compared to 25% of 
patients in England. Table 38 illustrates the stratification of patients into three HbA1c 
risk categories. Twenty-eight percent of patients with Type 2 diabetes (n=769) were in 
the high risk category (>7.5%) compared to 36% of patients with Type 2 diabetes in 
Scotland.  
Table 38 HbA1c Risk Categories 
 Primary Care 
Initiatives 
Ireland 
National 
Diabetes Audit 
England† 
Scottish 
Diabetes 
Survey 
% (n=2718) % % 
Low Risk 
(<6.5%/<48mmol/mol) 
34.7 (943) 25.02  
 
63.8 
Medium Risk  
(6.5 – 7.5%/48-58mmol/mol) 
 37.0 (1006) 37.8 
High Risk  
(>7.5%/>58mmol/mol) 
28.3 (769) 37.2 36.1 
†Data obtained from NDA Dashboard represent Type 1 and Type 2 diabetes combined 
In the Scottish Diabetes Survey HbA1c data were categorised as <7.5, (7.5-9.0) and 
>9.0 
6.3.3.2 Blood Pressure 
Thirty-seven percent of patients (n=1025) reached the recommended target for blood 
pressure in Ireland (≤130/80mmHg). The target in the UK in 2008/09 was ≤140/80 
for patients without eye, kidney or vascular disease. Applying this target 54.4% of 
patients in the sample reached the target compared to 60.2% of patients with Type 2 
diabetes in England.  
Forty-three percent of patients (n=1209) met the current recommended target systolic 
blood of ≤130mmHg. Applying the cut-off of ≤140mmHg for systolic blood pressure 
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from the Scottish Diabetes Survey, 69% of patients in Ireland achieved this target 
compared to 74.6% of patients in Scotland. The mean systolic blood pressure for 
patients in Ireland was 136.3mmHg (SD=16.6) with no significant difference between 
males and females (p = 0.786). This was similar to the average systolic blood pressure 
recorded among patients in the ECAD Shared Care Scheme (137mmHg, n=232).  
The mean diastolic blood pressure was 77.2mmHg (SD=9.3). Again there was no 
significant difference between males and females (p = 0.373). This average was similar 
to levels recorded among patients enrolled in the shared care scheme (76mmHg, 
n=232). Seventy-two percent of patients (n=1980) reached the national recommended 
target for diastolic blood pressure of ≤80mmHg. Comparable data on diastolic blood 
pressure were not available for England or Scotland.  
6.3.3.3 Lipid Profile 
The mean total cholesterol concentration for the group was 4.2mmol/L (SD=1.0), equal 
to levels achieved in shared care practices. The mean LDL cholesterol concentration 
was 2.3mmol/L (SD=0.81) compared to 2.1mmol/L in shared care practices. The mean 
HDL cholesterol concentration was 1.2mmol/L (SD=0.36) compared to 1.3mmol/L in 
shared care practices.  
Table 39 outlines the percentage of patients in this sample achieving national target for 
blood pressure, total cholesterol, LDL cholesterol and HDL cholesterol. Using the 
Pearson chi square test, there were significant associations between gender and 
achievement of lipid targets (p<0.001). Fifty seven percent of patients from the primary 
care initiatives in Ireland achieved a NICE target for total cholesterol of <4mmol/l 
compared to 37.3% of patients in England.  
Table 39 Achievement of national targets for blood pressure and lipids among males and 
females. 
 Recommended 
Target 
Primary-Care 
Initiatives 
Males vs. 
Females (%) 
P value 
Blood 
Pressure 
≤130/80mmHg 37% (n=1025) 33.6% vs. 34.5% p=0.35 
Total 
Cholesterol 
<4.5mmol/l 64.5% 69.8% vs. 56.6%  p<0.001 
LDL <2.5mmol/l 64.2% 68.2% vs. 58.9% p<0.001 
HDL >1.0mmol/l 70.9% 62.6% vs. 82.0% p<0.001 
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6.3.3.4 Smoking Status 
Smoking status was recorded in two of the three schemes (n=1995). Just over 1 in 5 
people, who had their smoking status documented, were recorded as smokers (22.2%). 
There was no statistically significant difference between males and females (p=0.364) 
(males=22.9%, females=20.8%). A similar smoking prevalence of 18.8% was reported 
in Scotland.  
6.3.3.5 Body Mass Index (BMI) 
The mean BMI of patients was 30.8kg/m2 (SD= 6.1) which was above the national 
recommended target of ≤25kg/m2 (17). There was no statistically significant difference 
between males and females (30.6kg/m2 vs. 31.1 kg/m2, p = 0.082). A similar average 
BMI was recorded among patients enrolled in the shared care scheme (mean= 
30.4kg/m2). Fifty percent of patients with Type 2 diabetes (n=1060) in this study were 
in the obese category (>30kg/m2) compared to 54% of patients with Type 2 diabetes in 
Scotland (Figure 31). 
 
Figure 31 BMI according to the WHO classification  
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6.3.4 Prescribing medications to reduce cardiovascular risk 
Eighty-six percent of patients (n=2381) were prescribed a statin compared to 79% of 
patients enrolled in the shared care scheme (n=205). Less than 1% of patients were 
prescribed another cholesterol lowering medication (0.8%, n=23) while 79% of patients 
were prescribed aspirin (n=2363). Prescribing data were not available from the NDA for 
England or the Scottish Diabetes Survey for comparison. Prescribing data were 
stratified by age and gender and the results of this analysis are presented below. 
6.3.4.1 Statin Prescribing 
Overall 87.5% of the patients greater than 65 years old were prescribed a statin (87.8% 
M, 87.2% F). Statins appeared to be prescribed less often in females below 40 years of 
age compared to males in the same age group (43.5% vs. 76.3%), and females over 85 
years of age compared to males in the same age group (77.8% vs. 85.7%) (Figure 32).   
 
Figure 32 Prescribing of statins by age and gender 
6.3.4.2 Aspirin Prescribing 
Overall 78% of the patients greater than 65 years were prescribed aspirin (78% M and 
F). Similar to statins, aspirin appeared to be prescribed less often among females under 
the age of 40 (53.3% vs. 61%). However aspirin appeared to be prescribed less often 
among males over 85 years compared to females in the same group (61.6% vs. 75.3%) 
(Figure 33). 
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Figure 33 Prescribing of aspirin by age and gender 
6.3.5 Relationship between quality of care and financial incentives 
There were a number of significant differences between practices receiving a financial 
incentive for participation (n=2004) and practices which did not receive an incentive 
(n=1006) (Table 40). Process of care recording was higher among practices in receipt of 
a financial incentive for all outcomes with the exception of level of retinopathy 
screening and foot assessment. In both cases a substantial proportion of data were not 
recorded (NR) by non-incentivised practices (retinopathy screening=35% NR, foot 
assessment =65% NR).   
Table 40 Differences in recording of care processes of care between practices 
receiving and not receiving financial incentives 
 Practices 
receiving 
incentives 
Practices not 
receiving 
incentives 
% 
Difference 
95% CI P value 
 % (n) % (n)    
HbA1c 98.6 (1978) 73.4 (738) 25.3 22.6-28.1 p<0.001 
Blood Pressure 99.5 (1993) 81.6 (821) 17.8 15.4-20.3 p<0.001 
Total Cholesterol 99.0 (1984) 78.7 (792) 20.3 17.7-22.8 p<0.001 
LDL Cholesterol 97.1 (1946) 65.4 (658) 31.7 28.7-34.7 p<0.001 
HDL Cholesterol 97.1 (1945) 60.5 (609) 36.5 33.4-39.6 p<0.001 
Smoking Status 76.9 (761) 50% (502) 27.0 23.0-31.1 p<0.05 
BMI 86.7 (1737) 38.0 (382) 48.7 45.4-52.1 p<0.001 
Retinopathy 
screening received  
67.3 (1331)  541 (83.1) -15.8 -19.4- -12.3 p<0.001 
Foot assessment 64.1 (1242) 67.7 (239) -3.7 -8.9-1.7 p<0.05 
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There were also significant differences between the groups in terms of clinical outcomes 
(Table 41). There was a significant difference in HbA1c levels with practices receiving a 
financial incentive having a HbA1c value of 6.9% compared to 7.3% among practices 
not receiving an incentive (t=4.785, p<0.001). There was also a significant difference 
between the groups in terms of systolic blood pressure (t=2.647, p<0.01), diastolic 
blood pressure (t=3.395, p<0.01) and total cholesterol (t=3.757, p<0.000). There was 
no significant difference between the groups in terms of LDL cholesterol (p=0.66), 
HDL cholesterol levels (p=0.7) and BMI (p=0.06). Of those practices receiving an 
incentive 19% of patients were current smokers (n=146) compared to 26.7% of patients 
in practices where no financial incentive was received (n=134) (p<0.05) however 
recording of this outcome was below 65% overall. 
Table 41 Differences in clinical outcomes between practices receiving and not receiving 
a financial incentive 
 Practices receiving 
incentives 
Mean (SD) 
Practices not receiving 
incentives 
Mean (SD) 
p 
HbA1c 6.9 (1.25) 7.3 (1.4) P<0.000 
Systolic BP 135.76 (16.3) 137.57 (16.9) P<0.01 
Diastolic BP 76.8 (9.1) 78.1 (9.8) P<0.01 
Total Cholesterol 4.2 (0.99) 4.3 (1.03) P<0.001 
LDL Cholesterol 2.3 (0.81) 2.3 (0.81) P=0.66 
HDL Cholesterol 1.2 (0.37) 1.2 (0.31) P=0.7 
BMI 30.7 (6.0) 31.3 (6.3) P=0.06 
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6.4 Discussion 
6.4.1 The quality of primary care-led diabetes management 
This study has demonstrated what can be achieved by proactive and interested health 
professionals even in the absence of a national infrastructure to support diabetes 
management. There was a high level of recording of intermediate clinical outcomes such 
as HbA1c and blood pressure, comparable to results in the UK. However the recording 
of lifestyle factors such as BMI and smoking status was markedly lower. Similar 
proportions of patients in Ireland and the UK were achieving targets for HbA1c, 
cholesterol and blood pressure. Over one third of patients reached the national target 
for glycaemic control (HbA1c <6.5%) compared to one quarter of patients in the 
National Diabetes Audit for England (NDA). The proportion of patients meeting the 
NICE blood pressure target (≤140/80mmHg) was also similar to results in the National 
Diabetes Audit. However, less than half of those receiving structured care achieved the 
national recommended blood pressure target of ≤130/80mmHg. Half of all the patients 
were categorised as obese (>30kg/m2), similar to findings in Scotland. 
6.4.2 Financial Incentives and Quality Improvement  
The existence of the Quality Outcomes Framework (QOF) in the UK goes some way 
towards explaining the high level of process recording found in the National Diabetes 
Audit and the Scottish Diabetes Survey. Introduced in 2004, QOF consists of a set of 
indicators and pre-specified targets established for a number of chronic diseases 
including diabetes. General practices are financially rewarded for achieving certain levels 
of process recording and levels of control for HbA1c, blood pressure or cholesterol in 
patients registered with diabetes. There are also components relating to practice 
organisation, patient experience, additional services and access to primary care (237). 
However the proportion of patients in Ireland achieving targets for intermediate 
outcomes was similar to UK results despite the lack of a comparable national incentive 
structure to improve the quality of care. This is in keeping with the suggestion that it is 
easier to improve the recording of care, which is under the control of the health 
professional, without necessarily making a significant impact on patient outcomes (73, 
238). 
The merits of a „pay for performance‟ system such as QOF are continuously debated. A 
number of studies have demonstrated the positive impact of QOF on the achievement 
of targets since its introduction six years ago (239). However these gains appear to be 
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short-term benefits and have since reached a plateau. In addition a reduction in quality 
has been highlighted among aspects of care not linked to incentives (186). QOF has also 
been accused of subtly changing the purpose of data recording among general 
practitioners (240). However the increased investment, both financially and in terms of 
interest in primary care diabetes management, since the introduction of QOF has been 
acknowledged (241). Regardless of the arguments for or against incentivizing care, it is 
more often than not a feature of changes to models of care. Of the ten European 
countries reported to have implemented structured care programmes, seven of these are 
sustained through financial incentives (126).  
Although not comparable to the UK where QOF accounts for approximately 25% of a 
GPs income (186), two out of three initiatives involved in this study financially 
reimbursed general practices for their involvement. In this study receiving financial 
incentives was related to higher quality care. Process of care recording was significantly 
associated with whether or not practices received a financial incentive and there were 
also significant differences between the groups in terms of clinical outcomes. As 
highlighted in the qualitative study of barriers and facilitators to diabetes care, the lack 
of remuneration for chronic disease management is considered one of the main 
obstacles to optimal care. The lack of remuneration has limited the extent and scope of 
primary care initiatives in Ireland. While the latter initiative is open to participation by all 
GPs in Cork and Kerry, at present it only accounts for approximately 10% of practices 
in the region. While the lack of incentives has not stopped those with a special interest 
in diabetes in Ireland, it may be a barrier to wider engagement in quality improvement at 
primary care level in the future.  
6.4.3 Role of Special Interest 
In the absence of financial and structural incentives, primary care initiatives are ever-
more reliant on the interest and enthusiasm of general practice staff. The „special 
interest‟ concept is not unique to Ireland. The role was formalized within the National 
Health Service (NHS) Plan in 2000 (66), as part of the reconfiguration of services within 
the NHS to improve accessibility, free up specialist hospital services and reduce waiting 
times (66, 242). It is also envisaged that GPs with special interests would take referrals 
from other GPs (243). Evaluation of this policy direction is limited at present however 
the scheme has been piloted in the field of dermatology whereby a GP with a special 
interest achieved similar clinical outcomes to the hospital-based service, was more 
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accessible and preferred by patients (244) although the cost of providing the specialist 
service in general practice was higher (245). In Ireland formal specialisation is limited to 
nursing staff at present with calls for increasing numbers of Diabetes Nurse Specialists 
to facilitate the reorientation and reorganisation of diabetes care (246).   
6.4.4 Audit- a special interest activity 
Special interest is not only central to comprehensive diabetes management in the three 
primary care initiatives; it is also a driver in the pursuit of quality improvement in 
Ireland. Practices in the initiatives participate in ongoing audit and feedback on a 
voluntary basis and data collection is manual and laborious. There is a growing need for 
stable and robust IT systems such as those available in Scotland, to facilitate routine 
data capture at general practice level. In Scotland agreed core data are routinely collected 
on diabetes registers at practice level. Data entered at practice level are automatically 
uploaded onto the main repository run by the SCI-DC (Scottish Care Information 
Diabetes Collaboration) Network (234). Automated data extraction from GP software 
systems is a feasible and attainable solution in Ireland however this process is restrained 
in the absence of an agreed core dataset for diabetes care.  
6.4.5 Prescribing among patients with Type 2 diabetes 
In 2003, a population study using the national primary care prescribing database in 
Ireland found the under-prescribing of cardiovascular therapies for patients with 
diabetes in primary care (247). Less than a quarter of males (23%) and females (22%) 
with diabetes were prescribed statins. However in this study, the majority of patients 
(85%) enrolled in structured care practices were being prescribed statins. Similarly with 
aspirin approximately half of males (51%) and less than half of females (45%) with 
diabetes were prescribed aspirin compared to 79% of patients enrolled in structured care 
practices. The findings suggest intense management of cardiovascular risk factors using 
medication among practices involved in structured care. However the use of aspirin as a 
primary preventative medication for patients with diabetes is subject to ongoing debate 
(248) (249). As the diagnosis of cardiovascular risk was not recorded in the dataset it is 
not possible to comment on whether prescribing was for primary or secondary 
prevention. 
With regard to statins, there was substantially less prescribing among women below the 
age of 40 (44%) compared to other female age groups and also compared to males in 
the same age category (76%). There was also less statin prescribing among females over 
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the age of 85 (78%) compared to men in the same category (86%). The national study of 
cardiovascular therapy prescribing in diabetes demonstrated slight gender differences in 
prescribing, with less statin prescribing among females compared to males (51% vs. 
45%), however age was not taken into account (247). The gender disparity could 
indicate a missed opportunity to manage the development of complications particularly 
in the younger female age group. 
6.4.6 Comparing Models of Diabetes Care in Ireland  
The similarity of the results between the GPs providing structured care and those 
participating in the shared care scheme suggests a consistent standard of care is being 
delivered by local diabetes initiatives in Ireland. The findings also reflect the overlap and 
ambiguity detected in the literature around models of care. More often than not shared 
care initiatives foster a structured approach to care delivery, incorporating regular review 
and recall, the use of guidelines and audit and feedback (109). Thus the terms shared 
and structured are not mutually exclusive. The integrated model of care proposed for 
Ireland envisages care which is “integrated, planned, shared and structured”(1). As illustrated 
by the findings of the qualitative study with GPs presented in Chapter 4, structured care 
is associated with the primary care setting while shared care is a joint collaboration 
between GPs and the hospital-based team. Our results suggest that the underlying and 
somewhat diminishing distinction does not produce noticeably dissimilar results. The 
important factor is the structured and regular delivery of care to patients with diabetes.  
6.4.7 Isolating the Improvement Factor 
It is important to note that the essential ingredient for improving diabetes care has not 
been isolated. The evidence seems to suggest that a multifaceted approach is most 
successful. A review of quality improvement interventions by the Agency for Healthcare 
Research and Quality (AHRQ) in the U.S. did not identify one particular type of quality 
improvement (QI) strategy for improving glycaemic control or provider adherence to 
guidelines however, interventions employing more than one strategy had a greater 
chance of success (8). A more recent review of systematic reviews on diabetes care 
programmes also failed to find conclusive evidence of the critical components of such 
programmes or indeed practical guidance on design or implementation or evaluation of 
diabetes care programmes (120). The search for the single x factor in quality 
improvement may be futile as strategies are rarely introduced in isolation and 
improvement may be a result of the synergy between different approaches (114). 
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Research has now begun to look towards what are the common features of high quality 
care. One common feature among the three initiatives involved in this study is the 
involvement of a nurse who is dedicated solely to supporting the delivery of evidence 
based diabetes care in the community.  
6.4.8 Strengths and Limitations 
The complexity of evaluating multifaceted quality improvement interventions has been 
acknowledged. The use of a Randomised Controlled Trial (RCT) to evaluate a complex 
real-world intervention is not always practical for example where large scale 
implementation is already underway as is the case in Ireland (123). This study is limited 
in its comparisons by the dearth of information on the quality of diabetes care across 
Europe. The absence of an agreed core dataset for diabetes also limited the potential of 
the study as it was not possible to combine all data collected by the three initiatives. 
While data on long-term complications were available from two of the three groups, 
data collection has yet to be standardised and these outcomes are often not recorded 
consistently by all GPs involved. The overemphasis on intermediate outcomes measured 
in the short-term may underestimate the true effect of quality improvement 
interventions which have yet to be realised (118). Data on long-term outcomes will 
contribute greatly to our understanding of the full extent of the impact of structured 
care and whether benefits have been sustained. 
It should be stressed that this study is not a comparison of „like with like‟ but rather a 
benchmark of the performance of a select group of special interest practices providing 
structured care in Ireland against the standard of care observed in countries supported 
by a national diabetes management infrastructure. Furthermore the results of this study 
are not typical of diabetes care in Ireland. The lack of routine data collection in Ireland 
prohibited the inclusion of a reference group of „typical‟ practices not participating in 
formal primary care initiatives delivering structured care. It appears that elements of 
structured care may be scattered throughout Ireland as a recent survey found that half 
of the GPs reported using guidelines, engaging in routine recall or using a diabetes 
register (170). However what is absent is a consistent standard of care for all patients 
with diabetes. While the gap between shared and structured care narrows, another opens 
up between those involved in proactive quality improvement initiatives and those who 
are not.  The challenge now becomes creating a national infrastructure which supports 
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local efforts to improve quality, to avoid a situation whereby the quality of care received 
by patients is determined by geography. 
6.4.9 Conclusion 
This study which highlights what can be achieved by a group of proactive health care 
professionals working together to provide evidence based care in the community in a 
system with minimal incentives. The recording of processes of care was similar to the 
UK with the exception of recording lifestyle factors, and similar proportions of patients 
achieved clinical targets. Primary care initiatives are a viable option for health systems 
trying to tackle the growing burden of diabetes care but we cannot presume or rely on 
special interest to improve the quality of care for all patients. The challenge facing health 
systems is to establish quality assurance as a responsibility for all health care 
professionals, rather than the subject of special interest for a few. 
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8 CONCLUSION 
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8.1 Summary of Main Findings 
This thesis has examined the organisation and coordination of diabetes care in the 
community and explored the challenges to and opportunities for improving care. The 
findings illustrate a scale of service and involvement in diabetes quality improvement 
initiatives in Ireland. At the upper end of the scale there are “pockets of interest” where 
local „champions‟ have developed a structured systematic approach to diabetes care 
within general practice or in collaboration with the hospital-based team. Such initiatives 
are quality assuring care as part of provision through routine audit and feedback. 
However there is no comparative information on the quality of care being delivered in 
the remainder of the continuum, where most patients with diabetes receive care. 
The findings of this thesis highlight the „quality chasm‟ of organisation and coordination 
surrounding diabetes care. A substantial proportion of care in general practice is 
unstructured with approximately half of the GPs surveyed using a diabetes register, 
guidelines or routine recall. Almost equal proportions of practices utilised all three 
strategies as employed none of these, illustrative of the extreme ends of the scale. The 
delivery of diabetes care is further compounded by the deficient access to services and 
the lack of formal integration between settings. The qualitative follow-up study of 
diabetes care provision explored these issues in more detail. Care delivery was 
characterized by a number of continua; the extent of structure in the practice, the 
balance of care between settings, the extent of sharing between providers and division 
between informal and formal initiatives to improve care. Participants wanted greater 
„sharing‟ between providers rather than either/or care. This „sharing‟ should be reflected 
in both attitude and behaviour, with a sense of shared responsibility for patients and 
shared protocols to clarify the realms of responsibility. However they did not prescribe 
the exact workings of such „sharing‟, which depended on local interest and capacity to 
manage diabetes care in the general practice setting.  
This qualitative study also highlighted the everyday consequences for providers and 
patients of deficiencies in the health system. In particular, the lack of coordination 
between settings led to waiting times, overburdened hospitals and the uncertainty for 
patients and providers of “in the meantime” care. The lack of adequate remuneration for 
diabetes care had a similar ripple effect creating costs for patients and apathy among 
GPs. There was also a sense of inertia around quality improvement activities, 
particularly at a national level. This attitude was strongly influenced by previous 
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experiences of change in the health system. In contrast GPs spoke positively about their 
experience of change within the practice which was enabled by a practice “ethos” 
supportive of improvement, special interest and leadership. The quality of local-level 
bottom-up improvement was illustrated in the cross-sectional study of three primary 
care diabetes initiatives led by local champions. The standard of care was comparable to 
the UK in terms of the recording of clinical processes of care and achievement of 
clinical targets.  
With regard to policy efforts to improve diabetes care, this chronic disease has struggled 
to make it onto the national decision agenda. Several reports have proposed solutions to 
address the substandard service, however little tangible change has emerged. The 
Expert Advisory Group process was an instrumental case study of this cycle. The 
evolving process of action and inaction was best described by the Multiple Streams 
Theory. There was a sense of reserved optimism that a new window of opportunity is 
being prized open by the Clinical Care Programme for Diabetes which is perceived to 
have the leadership, power and mandate to implement change that was not granted to 
the Expert Advisory Group. However the development of infrastructure to deliver 
organised coordinated diabetes services will require investment of both money and 
minds.  
8.2 Interaction between evidence and context 
Quality in healthcare is not the product of one single effective strategy, nor is it entirely 
the result of the circumstances of implementation, but the interaction between the two 
(28). This idea of a „fit‟ between evidence and context proposed by Donabedian and 
borne out in evidence from systematic reviews of multifaceted quality improvement 
interventions (8), is reflected the findings of this thesis. Firstly the study of the primary 
care-led diabetes initiatives demonstrated the quality of care delivered by local 
champions implementing evidence based care in response to a need in their area. 
Results from the qualitative study of attitudes to quality improvement suggested GPs 
were sceptical, and in some cases affronted, by change imposed from above which 
carried an implicit assumption that policy makers and planners knew what was needed 
to improve care. Similarly local circumstances were two of the primary considerations of 
the EAG in making their recommendations to improve diabetes services in Ireland. 
Taking into account research and international experience, policy ideas were 
“contextualized” to “irishise” recommendations. 
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Recent research has shown how local circumstances can be used as opportunities for 
improvement. Lemmens et al (2011) have used „bottlenecks‟ in service as focal points 
for improvement in COPD care in the Netherlands with encouraging results (298). 
Bottom-up disease management programmes were developed comprising of 
interventions targeted at the bottlenecks identified in three different regions. The 
problem areas were originally identified and ranked by stakeholders in each area which 
were then used to guide the selection of appropriate strategies. For example one area 
ranked the division between primary and secondary care as a major bottleneck which 
led to the implementation of regional arrangements for referral and greater task 
delegation within and between settings. The tailored approach had a positive impact on 
processes of care, quality of life and patient experience as well as patient outcomes.  
This best fit approach to quality improvement corresponds to the classification of 
barriers as „would-be facilitators‟ by participants in the qualitative study of care 
provision. Indeed the model of barriers and facilitators outlined in this thesis illustrates 
the correspondence between problems and opportunities. Participants identified the 
coordination between settings as barrier to diabetes care, proposing shared protocols as 
a mechanism for clarifying roles of responsibility. The overburdened hospital clinics 
could be addressed by enhancing the capacity of general practice to manage a greater 
majority of diabetes care in the community, in keeping with policy proposals. Within the 
practice, the delegation of tasks between GPs and nurses emerged as a facilitator of 
structured care provision.  
Given the apathy towards national level quality improvement, a bottom-up tailored 
approach such as this, may be appropriate in the Irish context. The findings of the 
qualitative study of barriers and facilitators to improvement, revealed a distinction 
between GPs‟ positive experiences of change at a local level and their apathy towards 
national level change. The wariness of national level endeavours was echoed in the 
policy analysis as “being involved in things nationally can bring more frustration than reward.” A 
bottom-up approach, such as that employed in the Dutch study, could create a sense of 
ownership over improvement by acknowledging the challenges of diabetes management 
and utilising the experience of those delivering care. This approach would address the 
physical barriers but also the attitudinal barriers to QI as something that is imposed or 
threatening. The opportunity exists for regional Diabetes Services Implementation 
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Groups to assess the needs of patients and health care professionals in their jurisdiction 
and act accordingly. 
This is not to suggest that quality improvement should be a pick and mix of strategies 
without consideration of the evidence. The development of quality improvement 
initiatives should be underpinned by a theoretical framework, a notable absence in many 
studies (120). This would make explicit the mechanisms by which strategies are 
expected to improve outcomes. It would also guide the selection of appropriate 
indicators to evaluate the expected changes (217) (120, 298). As mentioned previously 
in this thesis, flexibility to address the needs and capacity of an area is not at odds with a 
national standard of diabetes care which all regions must meet. Local adaptation is one 
of the prevailing properties of successful dissemination of innovation (299).  
8.2.1 Culture of Quality Improvement 
Culture encompasses underlying assumptions, values, physical and behaviour 
manifestations (208). This thesis has explored the culture of quality surrounding 
diabetes care in the Irish health system. The qualitative study of GPs‟ attitudes to quality 
improvement in diabetes care gives some indication of the subculture among this 
professional group, which was characterised by a sense of wariness and apathy towards 
change in the health system compounded by previous experience. Participants did not 
prioritise improvement strategies at a population level when weighed against the 
deficiencies in the current level of service for individual patients. According to Coiera 
(2011) engaging people in change will always be a struggle when the health system is 
over-constrained, regardless of the merits of the innovation. This is an important 
observation in the context of the current economic recession with increasing pressure 
on the Irish health system to deliver more for less (207). 
According to Donabedian “the pursuit of quality depends ultimately on human will” (p138) 
(28). In the case of diabetes care in Ireland the pursuit of quality appears to depend only 
on human will. Quality improvement and subsequent quality assurance has been limited 
to a pocket of individuals in both practice and policy circles. However a culture of 
quality means that all members of staff are involved in improvement efforts, identified 
by participants in this thesis as a practice “ethos”. To embed quality improvement in the 
health care culture, GPs need to adopt a different kind of professionalism (300) known 
as civic professionalism (206). This way of thinking and doing extends the responsibility 
of the GP from the individual patient to the community as a whole, and engenders a 
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view of quality improvement as a professional obligation (206). The goal is to create the 
attitude among all professions that “everyone in healthcare has two jobs at work every day: to do 
their work and to improve their work” (p3) (35). Education and training is the foundation of 
this attitude and was identified as one of the key opportunities to develop diabetes care 
in the survey of GPs in Ireland. Part of education and training is allowing the time to try 
and test new ideas and skills however the increasing demands being placed on general 
practice has significant implications for this opportunity. 
8.3 Implications of findings 
Civic professionalism needs to be supported by the health service (300). There are a 
number of factors which can sustain quality improvement including opportunities and 
incentives for continuous improvement as well as governance arrangements for poor 
performance (300). One incentive for continuous improvement is the sharing of 
performance and experience among peers. The „early adopters‟ of structured systematic 
diabetes care could provide a valuable source of peer learning and leadership on the 
ground. Investing in this group is essential for the dissemination of quality 
improvement innovations (299). The drivers of change identified at a local level should 
be emulated at a national level. This process has begun with the appointment of a 
national clinical lead for diabetes care under the auspices of the Directorate for Quality 
and Clinical Care. 
Widespread interest and participation in quality improvement can only be expected 
when an infrastructure is put in place to support it, including IT systems for routine 
data collection and information sharing, incentives and continuing professional 
development (229), the physical manifestations of a quality culture (208). While quality 
has been at the heart of health care policy since 2001 nothing tangible has emerged to 
facilitate the evaluation and monitoring of quality. According one participant in the 
study of policy formulation to improve diabetes services; “we‟re not there yet” in Ireland. 
Yet a quality assurance infrastructure needs to be developed in tandem with proposed 
changes to the model of care delivery rather than as an after-thought. All quality 
improvement frameworks collect and utilise data to highlight deficiencies, evaluate 
needs, refine solutions and monitor outcomes. This is one of the predisposing factors to 
embedding and sustaining quality improvement in the health system (300). There is 
ample opportunity for international learning from countries such as Scotland and 
advances had been made in developing a core dataset for diabetes in Ireland however 
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progress has since stalled. Enhancing this capacity would enable health service managers 
and policy makers to evaluate change and to assure it equates to improvement.  
8.4 Conclusion 
This thesis presents a series of research on the organisation and coordination of 
diabetes care in general practice as a means of bridging the quality gap. The findings 
highlight the inconsistency and uncertainty of diabetes care in Ireland. While tangible 
investment is needed to improve the quality of diabetes care, attitudinal change is also 
required to create a culture of quality in the health system. The main barriers to optimal 
diabetes care centre on the organisation and coordination of care as a system-level with 
negative consequences for practice, providers and patients. However there are a number 
of enabling factors which could enhance care provision and promote quality 
improvement. Quality improvement initiatives need to stimulate a sense of ownership 
and interest among frontline service providers to address the local sense of inertia to 
national change. To date quality improvement in diabetes care has been largely 
dependent on “pockets” of special interest among health care professionals. The 
challenge for the Irish health system is to embed this activity as part of routine practice, 
professional responsibility and the underlying health care culture.  
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10 APPENDICES 
10.1 Appendix I: PhD Education & Training 
HRB PhD Scholars Programme in Health Services Research 
The thesis has been undertaken as a part of the HRB PhD Scholars Programme in 
Health Services Research. This four year structured programme encompassed taught 
modules such as health policy, health psychology and population health during the 1st 
year and continued training in grant writing, leadership skills and writing for publication 
during years 2-4. Additional training courses were undertaken tailored to the students 
own research which was conducted over the course of four years (Table 54). As part of 
the HRB PhD Scholars Programme a national placement was undertaken with the 
Diabetes Interest Group in Cork and the Haematology Department of Cork University 
Hospital. An international placement was completed at the Health Policy Unit of the 
London School of Hygiene & Tropical Medicine.  
Table 54 Training courses undertaken during PhD 
Year Course 
2011  Systematic Reviews for Health Sciences 
Department of Epidemiology & Public Health, UCC 
2010  Meta-synthesis: systematic review of qualitative research 
Health Technology Assessment Conference, Dublin. 
2010  Writing and Publishing Qualitative Inquiry with Janice Morse 
Dublin City University Qualitative Summer School 
2010  Integrating Qualitative and Quantitative Methods (Mixed Methods) 
Qualitative Health Research Conference, Vancouver 
2010  Grounded Theory: Using it to your advantage as a research student. 
School of Nursing and Midwifery, Trinity College Dublin 
2009  Case Study Methodology 
University of Essex Summer School in Social Science Data Analysis & 
Collection 
2009  „Creative Interviewing‟ 
Dublin City University Qualitative Summer School 
2008/09  Teaching & Learning for Graduate Students 
Department of Geology, UCC 
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Research Output & Dissemination 
Research contained in this thesis has been published in peer-reviewed journals (Table 
55) and presented at a number of national and international conferences (Table 57).  
Table 55 Peer Reviewed Publications  
Year Peer-Reviewed Journals 
Accepted S Mc Hugh1*, P Marsden2, C Brennan2, K Murphy3, C Croarkin4, J Moran3, V 
Harkins5, I. J Perry1. Counting on commitment; the quality of primary care-led 
diabetes management in a system with minimal incentives. Accepted to BMC Health 
Services Research. 
2011 O'Mullane M, Mc Hugh S, Bradley C. Informing the development of a national 
diabetes register in Ireland: a literature review of the impact of patient registration on 
diabetes care. Informatics in Primary Care. 2011; 18(3):157-68. 
2010 Mc Hugh S, Collins M, Perry IJ. Trying to Balance Quality: Can We Assume that 
Improving the Quality of Care Delivery also Improves Quality of Life? Journal of 
Clinical Metabolism & Diabetes. 2010; 1(2):35-42. 
2009 Mc Hugh S, O'Keeffe J, Fitzpatrick A, de Siún A, O'Mullane M, Perry I, et al. Diabetes 
care in Ireland: A survey of general practitioners. Primary Care Diabetes. 2009; 3 
(4):225-31. 
Table 56 Other research output 
Year Type Title 
2010 Report Murphy K, Mc Hugh S,M Kelly, Moran J. (2011) Diabetes Interest 
Group Audit Report 2009-2010. [In progress]  
2010 Report Marsden, P., Brennan, C., Mc Hugh, S., Harkins, V. (2010) Audit 
Report of the HSE Midland Diabetes Structured Care Programme. 
Department of Public Health, Health Service Executive Dublin Mid-
Leinster. 
2010 Article Murphy K, Mc Hugh S, Kelly M, Moran J. Managing Type 2 in the 
community. Diabetes Professional. 2010.  
2010 Article Mc Hugh, S. Bridging the quality gap in diabetes care. The Boolean. 
Snapshots of Doctoral Research at University College Cork. Vol .1 
(2010)  
2009 Report Murphy, K., Mc Hugh S, O‟Keeffe, J. and Moran, J. (2009). Diabetes 
Interest Group Audit Report. Dec „07- May ‟08. (unpublished) 
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Table 57 Conference Presentations over course of PhD 
Year Title  Conference 
2011 A case study of policy formulation 
in the Irish health system;  
“paper exercise” or a plan of action 
to improve diabetes care? 
Oral  Society for Social Medicine 
Annual Conference, Warwick 
Poster  Translational Health Research 
Day, UCC June 2011 
2010 “Improving the Quality of Diabetes 
Care; Exploring the GP 
perspective”. 
Oral  Society for Academic Primary 
Care, UEA Norwich July 2010.  
Poster  International Society for Quality 
& Safety in Health Care, Paris, 
Oct 2010 
 Qualitative Health Research, 
Vancouver, Oct. 2010. 
 Social Science & Medicine, 
Belfast, Sept 2010 
 Academic University 
Departments of General Practice 
Ireland Annual Scientific 
Meeting, RCSI March. 2010.   
 Translational Health Research 
Conference, UCC, June 2010. 
2010 “Diabetes services across primary 
and secondary care settings” 
Poster  Society for Academic Primary 
Care, July 2010 
 International Society for Quality 
& Safety in Health Care, Paris, 
Oct 2010 
 Academic University 
Departments of General Practice 
Ireland Annual Scientific 
Meeting, RCSI March. 2010.   
2009 “Diabetes care provision in general 
practice in Ireland” 
Oral  Society for Academic Primary 
Care, St. Andrew‟s, July 2009.  
Poster  AUDGPI Annual Scientific 
Meeting, RCSI Feb. 2009.   
 Translational Health Research 
Conference, UCC, June 2009. 
 Optimizing Diabetes 
Management in Primary Care 
(DIG, UCC & HSE) Sept. 2009 
2009 “Diabetes care in General 
Practice:  DIG- a GP initiative.” 
Poster  Translational Health Research 
Conference, UCC June 2009. 
 Optimizing Diabetes 
Management in Primary Care 
(DIG, UCC & HSE) September 
2009. [2nd prize in poster 
competition] 
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10.3 Appendix III: Literature Search Methodology 
Study Selection 
The synthesis focused on studies evaluating the effectiveness of interventions aimed at 
improving the delivery of care through structural, organisational or professional change. 
Studies were excluded if they focused solely on patient-orientated interventions (e.g. 
lifestyle interventions, self management interventions, patient education). Studies in 
which a patient-orientated component was part of a larger multidimensional 
intervention were included.  
Inclusion/Exclusion Criteria 
Types of studies  
Systematic reviews, randomised controlled trials, controlled clinical trials  
Types of participants 
Health care professionals (doctors and nurses) delivering care to adult patients with 
Type 1 or Type 2 diabetes.  
Types of outcomes 
The review focuses on measures of; 
 Health professional behaviour – process of care measures 
 Patient outcomes – objective and self-report measures 
 System performance - economic outcomes, hospital admissions. 
Search Strategy 
The following electronic databases were searched for English language articles 
published between 2000 and 2011: Medline; Cochrane Database of Systematic Reviews 
and the Clinical Trials Register; EMBASE; CINAHL and ERIC. The search strategy 
developed for MEDLINE was amended appropriately for each database. The search 
was supplemented with a search of the reference lists from relevant articles. The search 
strategy was constructed using a combination of medical subject headings (MeSH) and 
free-text terms. 
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Search Strategy for Medline (2000-2011) 
1. Diabetes Mellitus* /or Type 1 diabetes /or Type 2 diabetes  
2.  Chronic disease*/ Chronic Illness 
3.  “Health Care Quality, Access and Evaluation”* /or “Quality of Health 
Care”* /or Quality Assurance, health care/or Total Quality Management/or 
Quality Indicators, Health Care* /or “Outcome and Process Assessment 
(health care)” /or “delivery of health care” /or disease management* 
4. systematic.mp. or *Clinical Trials as topic/ or  exp Randomized Controlled 
Trial* [pt]/ or exp Controlled Clinical Trials* /or Intervention Studies /or 
Evaluation Studies/ or *Feasibility Studies/ or exp Program Evaluation* 
5. 1 OR 2 
6. [5] AND 3 AND 4 
*MeSH exploded term  Pt = publication type 
Data Extraction and Analysis 
Upon reviewing the titles and abstracts for relevance to the inclusion criteria, potentially 
relevant full-text articles were obtained. One reviewer (SMH) was responsible for all 
aspects of study selection and data abstraction. Studies were analysed qualitative and 
summarized as a narrative review. 
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10.4 Appendix IV: GP Survey 
COMMUNITY SURVEY OF THE PROVISION OF DIABETES SERVICES 
IN IRELAND 
 
Please complete all questions as fully and as accurately as you can. This should take no more than 20 
minutes. If you have any questions please contact Anna de Siún on 087 631 0667. Please return by using 
the attached FREE POST envelope to Anna de Siún, The ICGP, 4/5 Lincoln Place, Dublin 2. The questions 
should be answered on the basis of an overall practice policy rather than an individual doctor. 
Thank you for your time. 
 
The survey has been approved by the Research Ethics Committee of the Irish College of 
General Practitioners.We would be grateful if you would answer the following questions by shading the answer 
that applies (e.g. Yes No). 
 
1. ABOUT THE PRACTICE 
 
Q1. Would you describe the location of the practice that you predominantly operate out of 
as rural, urban or mixed? 
Rural Urban Mixed 
 
Q2. Do you have a practice manager? Yes No 
 
 
Q3. How many doctors are in the practice (including you)? 
 
 
A. Are all doctors in the practice involved in delivering diabetes care? Yes No 
 
 
B.  If NO, how many doctors in the practice ARE involved in delivering diabetes 
care? 
 
 
Q4. Do you have a practice nurse? Yes No 
 
Computer Systems 
 
Q5. Does your practice have a computer system? 
 
Yes CONTINUE No GO TO Q7 
 
A. If YES, which computer system do you have? (GP Mac, Dynamic GP, Health One etc.) 
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B. What is the practice computer system used for?  (Please shade all that apply). 
 
 
To maintain a register/ list of patients 
 
To issue repeat prescriptions 
 
To issue acute prescriptions other than in consultations 
(e.g. telephone or desk requests) 
 
 
To maintain continuation records of consultations 
 
To issue acute prescriptions in consultations 
 
To store reports from hospital laboratories 
 
To store reports from X-ray departments 
Yes No 
 
Yes No 
 
 
Yes No 
 
 
 
Yes No 
Yes No 
Yes No 
Yes No 
 
 
To store reports from specialists Yes No 
 
To store other reports (Please specify): Yes No 
 
 
 
 
 
 
 
To record antenatal care visits 
 
 
To record Heart Watch visits 
 
To record other forms of systematic care of patient groups 
(Please specify) 
Yes No 
 
 
Yes No 
 
Yes No 
 
 
 
 
 
 
 
To make GMS claims 
 
 
To make claims for ante-natal care 
 
 
To make other claims (Please specify): 
Yes No 
 
 
Yes No 
 
 
Yes No 
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C. Who do you receive electronic reports from? (Shade all that apply) 
 
Hospital laboratories 
 
X-ray departments 
 
Other hospital departments (Please specify): 
 
 
 
 
 
 
Consultants (Please specify): 
 
 
 
 
 
 
Others (Please specify): 
Yes No 
Yes No 
Yes No 
 
 
 
 
 
Yes No 
 
 
 
 
 
 
Yes No 
 
 
 
 
 
 
D. Are these electronic reports filed in patients' individual electronic records? 
(Shade all that apply). 
 
Automatically By Scanning Manually 
 
 
E. Is the electronic record used routinely by GPs in the practice during consultations? 
 
Yes No 
 
F. Have paper records been replaced in favour of electronic records for the following? 
 
Continuation notes of GP visits 
 
Laboratory reports 
 
X-ray reports 
 
Hospital discharge letters 
 
Out-patient referral letters 
 
Other (please specify): 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
 
 
 
 
 
 
 
G. Are you a 'paperless' practice? Yes No 
 
Q6. Is there a diabetes module on your computer system? 
 
Yes CONTINUE No GO TO Q7 Don't know GO TO Q7 
 
A. If yes, is this module used? Yes No 
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Q7. With regard to questions addressing the number of patients in 
your practice, is the data provided based on: 
 
Your best estimate 
 
 
Actual numbers from the practice IT system 
 
Q8. What is the total patient population of this practice approximately? 
 
 
 
 
 
 
A. Total Number of GMS Patients (best guess). 
 
 
B. Total number of private patients (best guess). 
 
 
 
2. DIABETES CARE DELIVERY 
 
 
 
Q9. Do you maintain a diabetes register in the practice? Yes No 
 
 
Q10. What is the estimated number of individuals known to have diabetes 
in your practice? 
Overall 
 
 
Type 1 
 
 
Type 2 
 
Q11. In 2007 how many patients were newly diagnosed with diabetes by 
your practice? 
 
Type 1 
 
 
Type 2 
 
 
Don't Know 
 
 
Q12. With regard to questions addressing the number of patients in your practice 
with diabetes, is the data provided based on: 
Your best estimate 
 
 
Actual numbers 
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Q13. Are there any professionals in your practice with a special interest in diabetes? 
(Please shade all that apply) 
 
GP Nurse Other 
 
If other please specify 
 
 
 
 
 
Q14. How many diabetic patients does the practice have in nursing homes 
/residential care? 
 
IF NONE PLEASE GO TO Q15 
 
 
A. From whom do these patients receive their medical diabetic care? i.e. reviewing HbA1c. 
 
(Please shade all that apply) 
GP from this practice
 
Yes No 
 
 
Hospital specialist service 
 
Yes No 
 
 
 
 
If other specify: 
Other 
 
Yes No 
 
 
 
 
 
 
 
B. Do you have any comments/suggestions on providing diabetic services to patients 
in nursing homes/residential care in terms of practicalities? 
 
 
 
 
 
 
 
 
Q15. With regard to questions addressing the number of patients with diabetes, 
in your practice who are living in nursing homes, is the data provided based on: 
 
Your best estimate 
 
 
 
 
Clinics 
Actual numbers from the practice IT system 
 
Q16. Does your practice hold specific clinics for diabetic patients? 
 
Yes CONTINUE No GO TO Q16b 
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A. If yes, how are these clinics led and how often are they held? 
Please shade all that apply and complete details regarding frequency of each clinic; 
 
GP Led If yes, frequency of clinic 
 
Yes No <1 Month 
 
1-3 Months 
 
4-6 Months 
 
7-12 Months 
 
>12 Months 
 
Practice Nurse Led If yes, frequency of clinic 
 
Yes No 
 
<1 Month 
 1-3 Months 
4-6 Months 
7-12 Months 
>12 Months 
 
Combined practice nurse & GP 
Yes No 
If yes, frequency of clinic 
 
<1 Month 
 
1-3 Months 
 
4-6 Months 
 
7-12 Months 
 
>12 Months 
 
Pharmaceutical nurse led 
 
Yes No 
If yes, frequency of clinic 
 
<1 Month 
 
1-3 Months 
 
4-6 Months 
 
7-12 Months 
 
>12 Months 
 
Other 
 
Yes No 
 
 
 
If other please specify: 
If yes, frequency of clinic 
 
<1 Month 
 
1-3 Months 
 
4-6 Months 
 
7-12 Months 
 
>12 Months 
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B. Other than specific diabetes clinics, when are patients with diabetes seen 
in your practice for diabetes care? (Please shade all that apply) 
 
Patient initiated appointments specifically for diabetes 
 
 
Doctor or nurse initiated appointments specifically for 
diabetes (recall for regular review). 
 
 
Opportunistic appointments (patient is being seen for 
something else other than diabetes) 
 
Other 
Yes No 
 
 
 
Yes No 
 
 
 
Yes No 
 
 
Yes No 
 
 
 
Q17. Does the practice have a formal call and recall system for reviews of a 
patient with stable Type 2 diabetes? 
 
 
Yes CONTINUE No GO TO Q19 
 
A. How often would you recall a patient with stable type 2 diabetes? 
 
Never 
 
Quarterly 
 
Semi annually 
 
Annually 
 
Other 
 
 
If other please specify:    
 
 
 
 
 
 
 
B. If yes, please indicate the proportion of patients who usually attend for their reviews? 
 
 
Proportion of Type 2 Diabetes Patients % 
 
 
Q18. With regard to questions addressing the number of patients with diabetes 
in your practice attending reviews, is the data provided based on: 
 
Your best estimate 
 
 
Actual numbers 
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Q19. As part of a routine check- up of diabetic patients which of the following would 
you do? 
 
TEST/PROCEDURE 
 
Review their medication 
 
Review of blood glucose monitoring diary 
 
Height 
Weight 
BMI 
Waist Circumference 
 
Blood Pressure 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
 
Blood Tests: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urinalysis 
Fasting Glucose 
 
 
Random Glucose 
 
HbA1c 
 
Serum creatinine 
 
Lipids Dipstick 
Microalbuminuria 
Albumin: Creatinine Ratio 
 
Dietary Review 
Smoking status Aspirin 
therapy status 
Statin therapy status 
Foot examination 
Yes No 
Yes No 
Yes No 
Yes No 
 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No
 
   If yes please give details: 
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Eye 
examination: 
Eye examination by GP 
 
 
Eye examination by a Community Opthalmic 
Physician (COP) 
 
Referral to an Opthalmic Surgeon or Medical 
Ophthalmologist 
 
 
Referral to an Optician/Optometrist 
 
 
Examination as part of a screening programme 
Yes No 
 
 
 
Yes No 
 
 
Yes No 
 
 
 
Yes No 
 
 
Yes No 
 
 
Other tests & 
procedures; 
please specify 
 
 
 
 
 
Q20. When do patients have their bloods taken for their diabetic review? 
 
Prior to Review 
 
At the time of review 
 
 
Q21. Are patients taught how to adjust their insulin treatment in the practice? 
 
Yes No 
 
Q22. Is there space in your premises for display of educational/ health promotional 
materials for diabetes in your practice? 
Yes 
 
CONTINUE No GO TO Q23 
 
 
 
A. If yes, what materials are currently available in your practice? (Shade all that apply). 
 
INFORMATION 
 
 
Posters Produced by the practice 
 
Produced by a commercial company 
Produced by Diabetes Federation of Ireland 
Produced by another organisation 
None 
 
 
Continued on the next page... 
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INFORMATION 
 
Booklets/Leaflets Produced by the practice 
 
Produced by a commercial company 
Produced by Diabetes Federation of Ireland 
Produced by another organisation 
None 
 
 
 
Videos Produced by the practice 
 
Produced by a commercial company 
Produced by Diabetes Federation of Ireland 
Produced by another organisation 
None 
 
 
 
 
Q23. Do you provide membership forms for the Diabetes Federation of Ireland? 
 
Yes No 
 
 
Q24. Do you routinely provide patients within your practice with contact details for the 
hospital based diabetes team? 
Yes No 
 
 
Q25. How do you manage a newly diagnosed (by you) Type 2 diabetic patient e.g. 
referrals, tests etc? 
 
Would you refer right away? 
Would you work up and refer right away? Would 
you manage the patient in your practice 
until the need arises for additional care? 
Yes No 
 
 
Yes No 
 
 
 
Yes No 
 
 
 
Screening 
 
Q26. Do you screen patients for diabetes in the practice? (That is people without 
symptoms of the target disorder) 
 
Yes CONTINUE No GO TO Q30 
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Q27. If yes, which factors do you consider when screening your patients for 
diabetes? 
Age Yes No 
 
Ethnic Origin 
 
Obesity 
 
Patients with Hypertension 
Yes No 
 
Yes No 
 
Yes No 
 
Family history of diabetes 
Patients with ischaemic heart disease 
Patients with peripheral vascular disease 
Patients with cerebrovascular disease 
Patients with recurrent infections 
(thrush/skin infection/recurrent UTI) 
All pregnant women 
Women with a history of gestational diabetes 
 
Patients who have had a baby >4kg 
 
If other please specify 
Yes No 
Yes No 
Yes No 
Yes No 
 
Yes No 
 
 
 
Yes No 
Yes No 
Yes No 
Yes No 
 
 
 
 
 
 
 
Q28. If yes, what tests do you use when screening your patients for diabetes? 
 
Urinalysis Yes No 
 
Random capillary glucose 
 
Fasting capillary glucose 
(using a glucose meter) 
Random venous glucose 
Fasting venous glucose 
Glucose tolerance testing in the practice 
 
Refer to hospital 
 
Yes No 
 
 
Yes No 
 
 
Yes No 
Yes No 
Yes No 
Yes No 
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Q29. How often does your practice re-screen patients with an increased risk of 
diabetes?  (Shade whichever applies) 
Never
 
 
Quarterly 
 
Bi Annually 
 
 
 
If other please specify 
Annually 
 
Other 
 
 
 
 
 
 
 
3. USE OF SERVICES 
 
 
Q30. Do you have direct access to dietician services? 
 
Yes CONTINUE No GO TO Q31 
 
 
A.  If yes, do you routinely refer your patients with diabetes to this service? 
 
Yes CONTINUE No GO TO Q31 
 
 
 
 
B. If yes, how long do these patients usually have to wait for an appointment? 
(Shade whichever applies) 
<1 Week 
 
<1 Month 
 
1-3 Months 
 
 
 
 
If other please specify 
 
 
 
 
 
 
 
Q31. Do you have direct access to chiropody services? 
4-6 Months 
 
Other 
 
Yes CONTINUE No GO TO Q32 
 
A.  If yes, do you routinely refer your patients with diabetes to this service? 
 
Yes CONTINUE No GO TO Q32 
 
 
Page 12 
347 
 
6723237325 
 
 
B.  If yes, how long do these patients usually have to wait for an appointment? 
(Shade whichever applies) 
<1 Week 
 
<1 Month 
 
1-3 Months 
 
4-6 Months 
 
 
 
If other please specify: 
Other 
 
 
 
 
 
 
 
 
Q32. Do your patients have access to a systematic population based retinal 
screening programme? (i.e. they are called and recalled on a planned basis). 
 
 
Yes CONTINUE No GO TO Q33 
 
 
A.  If yes, do you provide patient names for call and recall? Yes No 
 
 
 
Q33. Do your patients have access to ophthalmic examination by:(Shade all that apply) 
 
Community Ophthalmologists 
Community Ophthalmic Physician 
Ophthalmic surgeon 
An Optician/Optometrist 
Yes No 
Yes No 
Yes No 
Yes No 
 
 
A.  If yes, do you routinely refer your patients with diabetes to this service? 
 
Yes CONTINUE No GO TO Q34 
 
 
B. If yes, how long do these patients usually have to wait for an appointment? 
(Please shade whichever applies). 
<1 Week 
 
<1 Month 
 
1-3 Months 
 
4-6 Months 
 
Other 
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If other please specify 
 
 
 
 
 
 
 
 
 
 
Q.34 Do you refer the following patients to your local hospital based specialist team? 
(Please shade the appropriate circles) 
 
Transition to insulin in Type 2 diabetics 
 
Any child with a suspected diagnosis of 
diabetes 
Always Sometimes Rarely/Never 
 
Always Sometimes Rarely/Never 
 
Women with gestational diabetes Always Sometimes Rarely/Never 
 
 
If other please specify: 
 
 
 
 
 
 
 
 
 
 
 
Q35. If you have a patient with type 2 diabetes whom you think requires insulin, do you? 
(Please shade the appropriate circles). 
 
a). Refer to hospital. 
 
 
b). Initiate therapy in your practice. 
 
c). Initiate therapy in your practice depending on 
patient characteristics. 
Always Sometimes Rarely/Never 
 
 
Always Sometimes Rarely/Never 
 
 
 
Always Sometimes Rarely/Never 
 
 
If you initiate therapy in your practice depending on patient characteristics, please specify 
relevant patient characteristics; 
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Q36. Do you use guidelines for the care of your patients with diabetes? 
 
Yes CONTINUE No GO TO Q37 
 
 
 
A. If yes, which guidelines do you use? 
 
 
 
 
 
 
 
 
 
 
 
Q37. Does your practice have a formal shared protocol with your local hospital based 
specialist diabetes team?  
Yes No 
 
 
Q38. Has your practice ever held a joint meeting with the hospital based diabetes team? 
 
Yes No 
 
 
Q39.  Do you have regular joint meetings with the hospital based diabetes teams? 
 
 
Yes CONTINUE No GO TO Q40 
 
 
 
A.  If yes, how often are these meetings held? <1 Month 
 
1-3 Months 
 
4-6 Months 
 
7-12 Months 
 
>12 Months 
 
Other 
 
If other please specify; 
 
 
 
 
 
 
 
 
Q40. Is your practice or are any health professionals in your practice members of the 
Diabetes Federation of Ireland? 
 
Yes No 
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4. OPPORTUNITIES IN DEVELOPING DIABETES CARE 
 
 
Q41. What do you see as the principal opportunities for developing diabetes care in 
your practice? 
 
Please shade 3 from the following that you consider the most important; 
 
GP/Practice nurse training in diabetes care 
 
Access to phlebotomy services 
 
Easier access to specialist diabetic advice 
 
Access for all diabetic patients to free GP care 
 
Increased access to community services e.g. chiropody 
 
Local guidelines on diabetic care 
 
Easier access to laboratory results 
 
Other, please specify 
 
 
 
 
 
 
 
 
 
 
 
Q42. How do you think you should be remunerated for providing diabetic care? 
(Please shade 1 only) 
Grant to a practice 
 
Target driven payments 
 
Fee per patient episode 
 
Capitation grant 
 
Mixture of capitation & fee for item 
 
Q43. We welcome your insight into diabetic care and thus any comments/suggestions for 
improvements you have are appreciated whether positive/negative; 
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To allow the ICGP to follow up on non-responses, they will assign a unique ID 
number to each survey. This link will be held by the Irish College of General 
Practitioners (ICGP) and will not be passed on to the project researchers or anyone 
else involved in the project. All the information from the survey will be treated as 
strictly confidential. The final report will present aggregate anonymous data. 
 
This national survey will be followed by a qualitative study investigating the provision 
of services in more detail. If you are happy for your practice to be contacted by 
research staff for an interview or to take part in a focus group, please complete the 
section below. Alternatively you can complete and return the enclosed name and 
address card to ICGP. 
 
 
 
 
NAME: 
 
 
 
 
 
ADDRESS: 
 
 
 
 
 
 
 
 
PHONE NUMBER 
 
 
 
EMAIL ADDRESS 
 
 
 
 
Thank you for your 
time. Go raibh mile 
maith agat. 
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10.5 Appendix V: Questions contained in shortened GP Follow-Up 
Questionnaire 
 
1. How many doctors are in the practice (Q2) 
2. Do you have a practice nurse (Q4) 
3. Does you practice have a computer system (Q5) 
4. If yes which computer system 
5. Is there a diabetes module on your computer system(Q6) 
6. If yes is this module used 
7. Do you maintain a diabetes register (Q9) 
8. Are there any professionals in your practice with a special interest in diabetes 
(Q13) 
9. What is your total patient population (Q8) 
10. What is the estimated number of individuals known to have diabetes (Q10) 
11. Does your practice hold specific clinics for diabetes patients (Q16) 
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10.6 Appendix VI: GP Survey open-ended responses 
This section presents the main themes emerging from the open-ended responses 
contained in the questionnaire.  
A. Caring for patients with diabetes in nursing homes/residential care  
Respondents had the opportunity to expand on the issue of patients in nursing homes 
and residential centres. Out of the 262 respondents, 77 completed this open ended 
section (29% of sample). A distinction was made between comments on care (Table 
58a) and suggestions to enhance care (Table 59a). 
Table 58a Comments on providing diabetes care to patients in nursing comes 
Theme References  (% of respondents to 
Q) 
Unique patient group 
Protocols for providing care  
Providing care for patients in the practice  
Nurse visit nursing home 
Patients require specialised care outside 
practice 
Funding issues 
Difficulties carrying out routine blood work 
Nursing home providing care 
No electronic system, difficult to audit 
Replication of notes a big challenge 
Practice time constraints 
ICGP guidelines good for bed bound patients 
9 
7 
5 
5 
3 
3 
2 
2 
2 
1 
1 
1 
13 
10 
7 
7 
4.5 
4.5 
3 
3 
3 
1 
1 
1 
Table 59a Suggestions on providing diabetic services to patients in nursing 
homes/residential care 
Theme References  (% of respondents to Q) 
Protocol & training for nursing home staff & 
nurses 
Community diabetes nurse 
Visiting specialists needed 
GP protocols 
Training in diabetes 
Appointment of specific medical officer Diabetic 
registrar to care for nursing home patients 
Community ophthalmologist 
Diet could be managed 
Financial resources needed 
8 
5 
3 
3 
2 
2 
1 
1 
1 
1 
1 
11 
7 
4.5 
4.5 
3 
3 
1 
1 
1 
1 
1 
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Nursing home liaise with Specialist 
Portable HbA1c machine 
1 1 
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B. Using the practice computer 
To record other reports  
Regarding the storage of reports other than those listed in the questionnaire, a number 
of additional responses were elicited. Out of the 262 respondents, 110 completed this 
section (42% of sample) (Table 60a).  
Table 60a Use of Practice Computer: Storing other reports 
Sources of other reports References  (% of respondents to Q) 
Medical-legal insurance 35 32 
Practice management 20 18 
Clinical medical 17 15 
Administrative 15 14 
PMAs 11 10 
A Paperless practice 7 6 
Department of social welfare 4 4 
GP support 1 1 
To make other claims 
Respondents outlined the other claims that were recorded on the practice computer. 
Out of the 262 respondents, 67 completed this section (26% of the overall sample).  
Table 61a Use of Practice Computer: To make other claims 
Making Claims References  (% of respondents to Q) 
Vaccines 18 27 
Immunization 15 22 
Practice system 7 11 
Billing 6 9 
'Heart Watch' initiatives 5 8 
Health insurance 5 8 
Methadone treatment scheme 4 6 
STC 3 5 
Barrier to technology and registry 1 1 
Family planning 1 1 
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Palliative care claims 1 1 
State benefits claims 1 1 
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To record other forms of systematic care of patient groups 
Respondents had the opportunity to outline the other forms of systematic care that 
their practice computer was used for (Table 62a). Out of the 262 respondents, 134 
completed this section (51% of the overall respondent sample).  
Table 62a Use of Practice Computer: Recording other forms of systematic care 
Other forms of systematic care References  (% of respondents to Q) 
Diabetes care & endocrine 23 17 
Gynaecological maternity 22 16 
Clinics 16 12 
Vaccinations 16 12 
Lung asthma Respiratory 11 8 
Immunizations 6 4.5 
Postnatal and children 6 4.5 
INR 5 4 
Coagulation 5 4 
Coronary 4 3 
Particular practice protocols 4 3 
Sexual health 4 3 
Paperless practice 3 2 
Family planning 3 2 
Heart Watch 2 1 
Family history and personal info 1 1 
General observations 1 1 
Health promotion 1 1 
  
358 
 
C. Receiving electronic reports 
Respondents had the opportunity to outline the other hospital departments they 
received electronic reports from (Table 63a). Ten percent of the overall sample gave 
examples (n=25). Six percent (n=15) elaborated on receiving electronic reports from 
consultants (Table 64a). 
Table 63a Receiving electronic reports from other sources 
Other sources References  (% of respondents to Q) 
OPD 8 32 
Specific Hospitals 4 16 
Specialist medicine i.e. consultants 3 12 
GP network groups 3 12 
A&E 3 12 
Laboratories 2 8 
Do not receive electronic reports 2 8 
 
Table 64a Receiving electronic reports from consultants 
Consultants References  (% of respondents to Q) 
Receiving electronic 
correspondence 
3 20 
Receiving electronic reports 3 20 
Not offered by any consultants 2 13 
Received from Dublin hospitals 2 13 
Geriatric medicine 1 7 
Neurology 1 7 
Out-patient departments 1 7 
Patient reports 1 7 
X rays 1 7 
Replacing paper records in favour of electronic records 
Seventy respondents reported other types of records replaced in favour of electronic 
(27%) (Table 65a). 
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Table 65a Replacing paper records for electronic reports 
Theme References  (% of respondents to Q) 
Paperless practice 15 22 
Medico-legal 6 9 
Mixed paper & electronic reports 5 8 
Referral letters 4 6 
Specialist reports 4 6 
Immunisations 3 4 
Patient reports 3 4 
Personal Medical Assessments 3 4 
Accounts 2 3 
Back-up hard copies 2 3 
Hospital letters 2 3 
Maternity records 2 3 
Medical certificates 2 3 
Prescriptions 2 3 
Social welfare 2 3 
Vaccinations 2 3 
Personal injuries reports 1 1 
Receipts 1 1 
Use computer for audit 1 1 
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D. Formal call and recall system 
Of the 262 respondents, 30 provided additional comments on recalling patients for 
review and the frequency of review (11% of sample) (Table 66a). 
Table 66a Comments on recalling patients for review 
Recalling patients References  (% of respondents to Q) 
Recall for Annual review 
Recall Biannually 
As required 
Recall unstable patients 
Depends on HbA1c 
Diabetes recall system but ceased 
now 
Part of Diabetes watch programme 
Monthly recall 
New patients 
No practice standard 
OPD_diabetes clinic recall 
Practice & hospital visits 
Practice clinic not helpful 
Prescription review 
Public and private patients differ 
Recall system problems 
Review patient, not recall 
6 
3 
3 
3 
2 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
20 
10 
10 
10 
7 
3.3 
3.3 
3.3 
3.3 
3.3 
3.3 
3.3 
3.3 
3.3 
3.3 
3.3 
3.3 
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E. Routine check-up procedure 
Respondents were provided with the opportunity to expand on the details of foot 
examinations. Overall 171 respondents completed this open ended section (65% of the 
overall respondent sample).  
Table 67a Comments on foot examination & how it is conducted 
Delivering foot care to patients with diabetes References (% of respondents to 
Q) 
Part of practice clinical exam 105 61 
Provided by Chiropody service 18 11 
Occasional opportunistic check ups 12 7 
Annual check-up 12 7 
Question & answer time for patient and 
education 
8 5 
Practice nurse providing care 5 3 
Specialists visit the practice 4 2 
Diabetic clinic OPD providing foot care 3 2 
Diabetes podiatry clinic local hospital 2 1 
As part of this question GPs had the space to outline other tests and procedures they 
had performed in the practice as part of the routine check-up of patients with diabetes. 
Out of the 262 respondents, 58 completed this open ended section (22% of sample).  
Table 68a Other tests/procedures carried out in routine check-up 
Tests & Procedures References  (% of respondents to 
Q) 
Referrals to Neurologist 7 12 
Clinical and medical examinations 6 10 
Referral to Endocrine/endocrinologists 6 10 
Eye examinations 6 10 
Retinal screening 6 10 
Chiropody 5 9 
Annual review 4 7 
Optician 3 5 
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Diabetes Watch 3 5 
Mobile screening programmes 3 5 
Diabetes clinics 2 3 
Education and advice 2 3 
Retinopathy programmes 2 3 
Vaccines 2 3 
ECG 1 1 
Hospital review 1 1 
Ophthalmology 1 1 
Podiatry 1 1 
Unstructured review 1 1 
F. Professionals with a special interest in diabetes 
Of 262 respondents, 38 provided detail on individuals in the practice who had a special 
interest in diabetes care (15% of sample) (Table 69a).  
Table 69a Professionals with a special interest in diabetes  
Professionals with a special interest Total N  (%) 
Dietician 11 29 
Specialist nurse 10 26 
No professional 5 13 
Chiropodist & podiatrist services 4 11 
GP registrar 3 8 
GP in practice 2 5 
All Practice GPs 1 3 
Practice nurse 1 3 
Shared care with hospital specialist 
nurse 
1 3 
 
G. Screening 
Table 70a outlines the factors considered when screening patients for diabetes in the 
practice (19%, n=51). Respondents also elaborated on the re-screening of patients for 
diabetes (20% of the sample, n=53) (Table 71a).  
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Table 70a Additional factors considered when screening for diabetes 
 Total N  (%) 
Renal failure/problems 
Over 45 years old 
Patient requests 
Thyroid dysfunction 
Eye disease 
Fatigue 
Steroid use 
BMI 
Neurological symptoms 
PCOS 
Current medications 
Erectile dysfunction 
Haemochromotosis 
Menopause 
Liver disease 
Recurring infection 
Routine blood tests; well person check 
ups 
Visual problems 
17 
4 
4 
3 
3 
3 
3 
2 
2 
2 
1 
1 
1 
1 
1 
1 
1 
1 
32 
8 
8 
6 
6 
6 
6 
4 
4 
4 
2 
2 
2 
2 
2 
2 
2 
2 
Table 71 Rescreening patients with an increased risk of diabetes 
 Total N (%) 
Opportunistic 31 58 
Annual/Biannually 7 13 
Risk factors 6 11 
Every 2 years 4 8 
No policy or protocol 3 6 
Age dependent 1 2 
Impaired glucose tolerance 1 2 
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H. Access to diabetes related services 
A number of GPs commented on the specific waiting times for appointments with 
dieticians, chiropodists and ophthalmology services. The responses were quantified and 
combined with the frequency analysis in the results section. Remaining responses 
relating to access to dieticians (8%, n=20), chiropodists (10%, n=25) and 
ophthalmology examination (12%, n=32) were coded and are outlined in Table 71a.  
Table 72a Open-ended responses on access to services 
Dietetics N (%) Chiropody N (%) Ophthalmology N (%) 
Waiting List 16 (80) Waiting list 13 (52) Waiting List 23 (72%) 
Public vs. Private 5 (25) Public vs. Private 6 (24) Public vs. Private 6 (19) 
Community 
dietetics service 
3 (15) Other 4 (16) Access 4 (13) 
Patient factors 3 (15) Variation in 
availability 
4 (16) Inconsistent 
service 
3 (9) 
Other 1 (5) No service 3 (12) Hospital based 
(service) 
2 (6) 
Effort to reduce 
waiting list 
1 (5) Public service 3 (12) Lack of resources 2 (6) 
Heart Watch 1 (5) Diabetes Watch 2 (8) Other 2 (6) 
Hospital service 1 (5) In practice 
(service) 
1 (4)   
No replacement 1 (5)     
I. Referral to hospital based specialist team 
A number of GPs elaborated on the referral of specific patient groups to the local 
hospital based team (n=15, 6%) (Table 73a). 
Table 73a Comments on referral to the local hospital specialist 
Theme: Patient Groups N % 
Gestational 7 47 
Patients with inadequate 
control 
3 20 
Newly diagnosed patients 3 20 
Patients who are insulin 
dependent 
2 13 
Patients with Type 1 diabetes 2 13 
Patients with complications 2 13 
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J. Characteristics considered when initiating insulin  
Of the total sample, 34 GPs offered examples of characteristics considered when deciding to 
initiate insulin therapy in practice (13%, n=34). The emergent themes are outlined in Table 74a  
Table 74a Characteristics considered when initiating insulin 
Patient factors N  % 
Understanding 12  35 
Stability 8  24 
Compliance 7  21 
Motivation 6  18 
Ability to administer 6  18 
Age 6  18 
Education 5  15 
Other 5  15 
Complications 4  12 
Co-morbidities 3  9 
Ability to monitor 3  9 
Support 3  9 
Eye sight 3  9 
Medication 3  9 
Confidence 2  6 
Reluctance to go to hospital 2  6 
Able to attend practice 2  6 
Advice from DNS 2  6 
Knowledge 2  6 
Access to hospital 1  3 
Ethnicity 1  3 
Co-operation 1  3 
K. Regular meetings with the hospital based team 
Eleven respondents offered comments on local arrangements with the hospital team or lack 
thereof (4%). Table 75a outlines the themes emerging from GPs opinions on contact with local 
hospitals. 
Table 75a Comments regarding contact with the local hospital based team 
Theme N % 
Link between practice & 
hospital 
5 45 
No contact 4 36 
Lack of resources 2 18 
Information sharing 2 18 
Informal arrangement 2 18 
Engagement with specialist 
nurse 
2 18 
Waiting list 1 9 
Reduced services (hospital) 1 9 
Lack of interest 1 9 
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L. Principle opportunities for developing diabetes care. 
When asked to choose the principal opportunities for developing diabetes care, almost 20% of 
GPs offered additional comments (18%, n=46) (Table 76a). 
Table 76a Themes on the principal opportunities to develop care 
Theme References % of Total References 
Shared care 11 24 
Dietician Access 8 18 
Protocols 7 16 
Remuneration 7 16 
Ophthalmology 5 11 
Resources 5 11 
Dedicated nurse 4 9 
Positive feedback 4 9 
Hospital services 3 7 
Screening 3 7 
Podiatry 2 4 
Time 2 4 
Patient Education 1 2 
M. Development of Diabetes Care 
Respondents were asked for suggestions on ways to improve diabetes care in Ireland. Most 
elaborated on issues raised in the previous questions thus there is substantial overlap in the 
themes (n=93) (Table 77a). 
Table 77a Comments/suggestions for improvements to diabetes 
Theme References % of Total References 
Incentives 27 29 
Shared Care 24 26 
Lack of Resources 20 22 
Community Services 20 22 
Secondary Care 18 19 
Workload 15 16 
Time 14 15 
Balance between primary & secondary care 13 14 
Clinics 11 12 
Local Initiatives 11 12 
Nursing staff 9 10 
Positive aspects of care delivery 9 10 
Support/help 9 10 
Manpower 8 9 
Technology 7 8 
Training/education 6 7 
Enthusiasm/Interest 5 5 
Funding 5 5 
Practicalities of delivering care 4 4 
Prevention 4 4 
Referrals 4 4 
Specialist care 4 4 
Patient behaviour/attitudes 3 3 
Patient education 3 3 
Recall/review 2 2 
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10.7 Appendix VII: Ethical Approval for GP Survey 
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10.8 Appendix VIII: Topic Guide for Qualitative Study 
 
Diabetes Care Delivery; Barriers & Facilitators 
Objectives of Interview 
1. To explore GPs perspective on delivering diabetes care at present. 
2. To elucidate models of care; practice procedures, links with secondary care, use 
of services. 
3. To determine barriers and facilitators to delivering optimal diabetes care 
4. To explore previous experiences of change within the health system 
5. To assess attitudes to quality improvement, in particular attitudes to developing 
a national diabetes register and conducting audit. 
Introduction (Script Sheet) 
o Introduce the National Diabetes Register Project (information sheet) 
o Confidentiality; the use of quotations (consent form) 
o Recording and timing  
Overview of Interview Topics 
 Current care organisation 
 
 Changes/Improvements that have been made 
 
 How can care be improved? 
 
 Establishing a register 
 
 Ideal scenario  
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1. Current Situation 
 
Get GPs talking about their experiences… 
 How do you currently manage your patients with diabetes? 
 Diabetes management relative to other illnesses in general practice 
[Scale of problem, time taken to manage, workload; particular challenges of 
diabetes relative to other problems at GP level] 
 How care is organised (model: involvement in shared  care schemes etc) 
[Feasibility, why does it (not) work?] 
 Balance of care across settings (ownership)... 
 Advantages/disadvantages of the GP setting  
2. Change 
Explore attitudes to change at a local and national level (may not necessarily 
be improvement) 
 What, if anything, has changed in the how care is delivered in your 
practice/locally/nationally?   
 Dealing with barriers to change in care delivery 
 Facilitators/necessary conditions 
 Sustaining change/improvement 
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3. Delivering Diabetes Care: Barriers & Facilitators 
→ Explore barriers and facilitators → Introduce CHECKLIST? 
 Check List - derived from GP survey 
Factors Influencing Diabetes Care Facilitators Barriers 
Incentives    
Remuneration   
Shared care2   
Secondary care services   
Specialist community services   
Resources   
Time   
Workload   
Additional factors   
4. Diabetes Register 
 Establishing a register: current use of a register & its maintenance  
 Setting up a national register: what are the issues 
[IT, shared care, pathways of information, data extraction, coding, indicators] 
 Advantages of regional vs. national register 
5. FUTURE DEVELOPMENT 
 Wish-list for delivering care to patients with diabetes (ideal world) 
 How should care be delivered…? 
 What needs to change? (attitudes) 
 Thoughts for the future of diabetes care… 
 
                                                          
2 For our information- prompt interviewee regarding the concept of sharing, sharing information etc. 
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10.9 Appendix IX: Prompt (modified checklist) used in interview 
Factors influencing the delivery of care 
Based on your experience, please indicate how the following factors promote and/ or inhibit efforts to 
provide and improve care. 
 Incentives 
 Remuneration 
 Shared care arrangements 
 Secondary care services 
 Specialist community services 
 Resources 
 Time 
 Workload 
 Additional factors.... 
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10.10 Appendix X: Invitation Letter for Qualitative Study 
 
 
 
 
Dear Dr X 
 
Re: Qualitative study of diabetes care delivery in general practice 
We are contacting you as part of a Health Research Board (HRB) funded project that 
is preparing the groundwork for the development of a National Diabetes Register in 
Ireland.  
You may recall completing a survey on diabetes care during the summer of 2008, 
administered through the ICGP. Upon completing the survey you provided your 
contact details to indicate willingness to be contacted regarding a qualitative follow-up 
study. We would value the opportunity to discuss your experience of delivering 
diabetes care and to discuss the barriers and facilitators to improving the quality of 
care. We envisage that this research will inform future planning of diabetes services in 
your area and on a national level.  
The interview will last approximately 20 minutes. We appreciate that you are very busy. 
Therefore, the researcher will arrange to visit your practice at a time that is most 
convenient to you. We will contact you shortly to see if you would like to be involved 
in this study and arrange a suitable time for the interview. If you decide to take part we 
will forward you an outline of the topic guide prior to the interview. We hope that you 
can find the time to participate. Any identifiable information will be kept confidential 
and only anonymous data will be reported. A summary of the findings will also be 
provided to each GP for his/her own information. You are free to withdraw from the 
study at any time. 
If you require any further information regarding this project please contact Monica 
O‟Mullane on 021-4205254 (email m.omullane@ucc.ie) or Sheena McHugh on 021-
4205253 (email s.mchugh@ucc.ie).  
 
Yours sincerely 
Professor Colin Bradley 
University College Cork  
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10.11 Appendix XI: Consent form &Information Sheet for 
Qualitative study 
 
CONSENT FORM 
Title of Study: Qualitative Study of Diabetes Care Delivery in General Practice. 
Consent of Research Participant: 
I   of      agree to participate in the 
research study outlined by_______________. The researcher has explained the 
objectives of the study to me and I understand its purpose. I understand that this study 
is for the advancement of health care and I am free to withdraw at any time. 
 
 I give permission for my interview with    to be tape-recorded  
 
 I understand that anonymity will be ensured in the write-up of the results by 
disguising my identity.          
 
 I understand that anonymous extracts/quotes from the interview may be used in 
the thesis and any subsequent publications.      
 
 I agree to quotation/publication of anonymous extracts from my data  
 
Signature of research participant:_________________ Date: _________________  
Signature of Witness: __________________________ Date: _________________ 
 
I confirm that I have explained to _______________________________ the purpose and 
nature of this investigation and the risks involved. 
Signature of researcher: ______________________ Date: _________________ 
A qualitative study of diabetes care delivery in general practice 
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INFORMATION SHEET 
Many thanks for agreeing to take part in an interview for the qualitative study of 
diabetes care delivery in general practice. Before giving written consent it is important 
for you to be aware of what will be involved. Please take the time to read the following 
information and ask me if there is anything that is not clear or you would like further 
detail. 
What is this study for? 
This study is part of a programme of work being undertaken by the National Diabetes 
Register Project and funded by the Health Research Board (HRB). The project is 
exploring key issues that need to be understood before a national diabetes register can 
be successfully implemented. This proposed register would be used to drive forward 
improvements in the quality of diabetes care in Ireland. This qualitative study will lead 
to a better understanding of diabetes management in general practice and the barriers 
and facilitators to improving the quality of care.  
What is involved? 
The interview will last approximately 25 minutes. If it is agreeable with you, the 
interview will be recorded by the researcher 
What about confidentiality? 
All information obtained during the study will be strictly confidential. All identifiable 
information will be removed from interview transcripts and a study ID number will be 
assigned to your tapes and transcripts to maintain anonymity. Participants will be given 
the opportunity to review the transcripts and tapes will be destroyed after recordings 
have been validated by the participant. Only investigators named on this information 
sheet will have access to the data and it will be stored securely for 5 years after 
completion of the study. 
What will happen with the results of this study? 
The findings of this study will be written up for the HRB report and subsequent 
publications. The results will also be compiled and submitted as part of a PhD thesis. In 
all cases only anonymous extracts or quotes will be reported. Copies of the findings will 
be made available to participants. 
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Who has reviewed this study? 
The proposal for this research was reviewed by (the ethics committee of the Irish College of 
General Practitioners).  
If you decide to take part you will be given this information sheet to keep for your own 
records and be asked to sign a consent form. You are free to withdraw at any time. If 
you have any concerns after the interview, please do not hesitate to contact the 
researchers who will do their best to answer your questions. 
Thank you for taking the time to read this information. 
Lead Investigators: Prof. Colin Bradley (UCC), Dr Velma Harkins (Midlands Structured 
Diabetes Care Programme), Dr Sean Dinneen (NUIG), Prof Ivan Perry (UCC)  
Contact for further information 
Monica O‟Mullane 
Dept. of General Practice 
University College Cork 
Tel: 021-4205254 
Email: m.omullane@ucc.ie 
Sheena Mc Hugh 
Dept. of Epidemiology & Public Health 
University College Cork 
Tel: 021-4205253 
Email: s.mchugh@ucc.ie 
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10.12 Appendix XII: Use of Memos in Analysis 
Memos were written throughout the study but were most informative during the 
analysis phase. Included here are a number of examples of memo writing and how they 
informed the development and refinement of themes. The examples are based on a 
typology of recommended categories to reflect on (178). The early memos (Example 1) 
are free-flowing and suggestive. These are followed by examples of how memos led to 
the development and refinement of themes (Example 2 and 3).  
Example 1: Early Memos written on individual transcripts: 
 Reflection on personal connection and ethical dilemma raised by study; 
“Luck”> GP103 talks about being lucky to have good relationship with hospital, lucky 
to receive care close by (p4). Shouldn‟t this be standard rather than luck? Do other GPs 
feel lucky or cheated even? (18.02.10) 
“Luck implies almost a passive role by the GP when this is not really the case for 
GP103 (involved in setting up a shared and then structured care programme). Do you 
make your own luck? Is some care down to circumstance i.e. what GP you get, where 
you live even within the one city? Mentions proximity of services vs. contrast to 
distance facing patients of GP101 
→Death by geography has been mentioned in the Irish health system before in relation 
to relocation of cancer services in the North West (home). Not necessarily death for 
diabetes patients but perhaps quality of care determined by geography? Some patients 
don‟t know how good it could be…Should they know the ideal standard of care if they 
are not receiving it.. 
 Emergent patterns in data 
Register> GP103- I mentioned patient identifier not the GP, would they have 
considered this an issue otherwise? Vague responses to register questions. Note as you 
go along- did GPs have more questions than answers about register? (18.02.10)- Theme 
in itself 
 Emergent dichotomy between themes 
Recall> GP115 – Overlap with other GPs=reliant on patient to come back when 
appropriate, tries to avoid reminders (p3). This raises the idea that reminders take away 
from personal responsibility. Is there a danger that too much structure and support has 
a negative impact as patients become complacent and it reduces personal responsibility? 
But then this GP goes on to suggest that if she had a nurse she could have reminders, 
so is the barrier 1) personal attitude to responsibility for chronic illness 2) organisational 
issue of manpower, time etc. Different strategies would be required to tackle different 
barriers. 
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 Contrast between themes 
Level of detail on provision of care> Nurse 104> Initial thought after reading 
transcript; emphasis on patient, paraphrasing patients, familiarity suggests regular 
contact and close relationship. Emphasis on support of GP i.e. supporting her work in 
clinics. Gives much more detail on the process of care and how it is delivered compared 
to GP102 for example – reflects engagement and involvement in provision. →Note: 
models may reflect the involvement of GP/Nurse in care delivery- how much do they 
know about it? (21.02.10) 
←Unfamiliar with patient hurdles > GP115 – GP seems unfamiliar with hurdles 
facing patients e.g. doesn‟t know about chiropody services, presumes probably correctly 
that the hospital clinics are massive (p5). Model of care diagram is quite empty 
compared to others. I would have to question some GPs closeness to the delivery 
process. Lack of GP awareness could be a barrier for the patient and a barrier to better 
care. 
 Use of Language 
Heart Watch > GP106- Note language around Heart Watch is flexible = “framework”, 
“type”. A management programme as a guide or foundation rather than an enforced 
rigid structure (p4) (25.02.10) 
Emergent theme: tentative attitude towards improvement initiative 
Benefits of a register > 107> p9- Very unsure of benefits. Similar to other GPs 
vagueness and hesitation. Not proposing any benefits rather saying if reason/benefit 
then yes GP would support.  
Reason + benefit = necessary conditions for buy-in.    IF→THEN conditional 
statement 
I propose planning services using a register; GP took opposite negative view of taking 
services away. Why? Past experience with surgical services, burned before. Suspicious? 
Antonym of allocation = take away, withhold. Synonym for „take away‟ = downgrade, 
term used by the HSE. 
 Problems with study (data collection) and its role in the response of GP 
“Nature of General Practice” < GP114 – This could be a main theme. GP talks about 
chaotic nature of practice, previously had to cancel interview when I was in the practice 
because of an emergency. It has both advantages and disadvantages as a setting – it can 
be a barrier or a facilitator. GP as a setting emerging from the data, not on the prompt 
list. It is an environmental/cultural factor maybe; the culture of general practice to deal 
with all ailments. 
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 Emergent or related existing theory 
Role of audit > GP108> seems to suggest audit is part of moral role of GP. What is a 
“real doctor”, should audit be part of competencies? Look up literature around attitudes 
to audit and professionalism (29.03.10). 
 My research question  
Checklist > GP105 speaks mostly in the conditional tense, doesn‟t give me a sense of 
what his barriers are in reality. There is a mixed approach to the checklist. GP105 
offered barriers and facilitators for each factor e.g. barriers to shared care are lack of 
communication systems. Other GPs have suggested which factors act as barriers or 
facilitators e.g. services are a barrier because they are hard to access. The latter approach 
addresses my research question „what are the barriers and facilitators to providing care‟ 
rather than what are the barriers and facilitators to x, y and z. Perhaps change the 
checklist to a prompt… (27.03.10) 
 Social context of interviews and themes 
Financial context of interviews> GP112> refers to McCarthy report. He is 
discussing the feasibility of tendering for services. Is that like commissioning in the UK? 
The Mc Carthy report proposes to put out to tender services for GMS patients 
(dismantling the current contract) and introducing competition between GPs. The IMO 
are against this proposal. (20.04.10) 
 Final report of study & an emergent distinction 
Organising themes> Barriers to Quality of care (availability of services) vs. Barriers to 
Quality Improvement (incentives, attitudes to audit and registration). Is this a real 
distinction? Although there is overlap the attitudes to registration reflect broader 
concerns and scepticism of the GPs towards initiatives. Is it a necessary distinction? 
Provision and quality improvement/quality assurance should ideally go hand in hand 
but this is not always the case. Services may not be provided by the system (recruitment 
freeze) but there may still be efforts to reorganize practice for example.  
Example 2: Memos used to development of themes 
Memo: Nurse as a key ingredient (facilitator) for delivering optimal 
diabetes care in a structured way. 
The nurse‟s role is central to adopting a structured approach to diabetes care in general 
practice i.e. organizing and delivering systematic and regular care to patients. The role of 
the nurse was intertwined throughout GP accounts of how care is delivered and the 
division of labour within the practice. Even those GPs who did not have a nurse in the 
practice noted the absence and suggested ways in which having a nurse could advance 
care.  
→Theme=Presence of nurse facilitates the provision of structured regular diabetes care 
379 
 
Instances from memos on individual transcripts 
 14.02.10. GP101> Impact of not having practice nurse 
The GP spoke about having changed nurses. The previous nurse had experience of 
running the Heart Watch programme in the practice. When this nurse left diabetes care 
“came back to an ad hoc thing” = regressed suggested a nurse is central to maintaining 
organisation and improving. The Practice Nurse was central to making Heart Watch 
programme work as it was problematic. When she left they “opted out”.  There appears 
to be a continuum of support for the GP from none to expert.  
 21.02.10> Nurse 104> Life before the nurse 
 Before PN it wasn‟t physically possible to develop a structured approach to diabetes 
but when the PN joined it facilitated change. The GP had own idea of what they 
wanted ≈plan is not always feasible until right/necessary factors are in place. This 
elaborates the role of the nurse to facilitating change also. [Note: Distinction between 
practical or physical barriers and attitudinal barriers.] 
Emergent theme 
 30/04/10 > After grouping the individual codes together under „Provision of Care‟, 
it was evident that the nurse was central within a number of provision codes (recall 
and the division of labour). For example the presence or absence of the nurse seems 
to facilitate regular recall. Furthermore the role was cited explicitly as a resource by 
some participants when discussing the barriers and facilitators to care provision. 
There was a sense from the accounts that something‟s are impossible or more 
difficult without a nurse.  
 It felt contradictory to separate out the presence of the nurse as a facilitator given 
how the role was interwoven through GPs accounts. To reflect this thread of the 
nurse enabling delivery, I will highlight the areas where the nurse enables care as I 
go along and include the nurse‟s role as a feature of structured care.  
Memo 3: Time 
Drafted 29.04.10: following analysis of each interview looking across emergent themes. 
 Time emerges in a number of contexts– importance of time in diabetes 
management 
Memos on individual GPs: 
21.02.10> Nurse 104: Emphasizes timing throughout> how long everything takes, 
waiting time etc. Refers to time patient is left on his/her own dealing with illness 
waiting for services (p3) [Time]. Diagnosis “kicks in” and thus is an important time 
point for patient and for intervention, clock starts for management once patient is 
diagnosed. Diagnosis is a window of opportunity to lay down foundation of 
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management – services etc [Timing]. Emphasizes that she refers immediately as she 
knows they will be waiting a while. 
03.03.10> GP107- time pressures of Heart Watch. Cause and effect of time demands. 
Nurses time to do programme→ GP doing bloods→ pressure on practice→ sick 
patients waiting 
Other GPs talked about getting patients early, stopping progression of illness (GP103) 
before development of complications, again reemphasizing early intervention [Timing]. 
GPs talked about the burden of diabetes management in terms of practice time taken to 
do full review etc. Time is an investment for the GP (Nurse 104). This was also 
mentioned in relation to setting up a register and conducting audit – time to provide 
care and time to organize care. [Time]. Competing time demands: cervical cancer 
screening being rolled out at that time. GP101 referred to his nurse being caught up 
with that but hoped to move on to diabetes. (“The next big thing”) 
Emerging distinction: Significance of timing vs. Lack of time 
 
Timing is more of a thread or undercurrent than a specific theme reflected in the quotes 
on how care is delivered. Time or lack of is a specific barrier to delivery and 
improvement. 
BARRIER 
Time to deliver: 
clinics, reviews, 
competing demands in 
practice 
Time to organise: 
audit, set up register, 
barrier to quality 
improvement more 
generally. 
Time 
Thread running 
through provision and 
delivery of care 
Early Intervention 
vs. Waiting Times: 
diagnosing patients, 
referral to services & 
time waiting for those, 
waiting for specialist 
input. 
Timing 
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10.13 Appendix XIII: Sample of triangulation between team of 
analysts 
 Models of Care 
Team Meeting: 30.06.10 with CB 
SMH suggested models of care ranged between structured approach (register and recall 
etc) to ad hoc and opportunistic. This is a dimension in itself. Rather than a 
preconception of structured to shared care, shared care is not the ultimate model but 
rather an aspect or feature of the ideal. MOM had another distinction between formal 
care with structure (i.e. in a formal initiative) and informal structured care (not in an 
initiative but doing it off their own bat). CB recommended that we conceptualise it in a 
different way, that there are two types of structured care and then disjointed or ad hoc 
care at the other end. SMH agreed with the distinction and had also differentiated 
formal and informal (independent) initiatives.  (Diagram prepared by MOM); 
Structured care             Structured care  
 
 
Ad hoc, opportunistic, disjointed care> 
Correspondence 08.07.10 
CB suggested the two pronged approach was right but that it should be on its side and 
that the distinction was more between hospital-led structured care and primary care led 
structured care. A third prong was also suggested; „shared care‟ in which both hospital 
and primary care provide structured care with a degree of coordination between them. 
Correspondence 21.07.10 
SMH put together a diagram based on these suggestions and developments to capture 
the different care arrangements emerging. It is based on MOMs two prongs but taking 
into account CB‟s distinction between hospital and GP-led care. SMH had 2 instances 
of hospital-led care which was somewhat structured in the practice. One instance was a 
formal shared care programme so I would consider „shared care initiatives‟ as hospital-
led but also structured at GP level. This is distinct from GP-led care which is shared 
(informal, not a shared care scheme in the traditional sense we know in Ireland). GP111 
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is floating on the diagram because this GP is ad hoc but becoming more structured yet 
still not really sharing care with the hospital. Sharing encompassed those who spoke 
about sharing with the hospital, those with informal arrangements & communication 
(e.g. GP107 and GP101). SMH did not count simple referral as sharing hence there is a 
group of ad-hoc GPs with ambiguous links to the hospital. It was agreed that this 
model capture the layers of delivery and the different guises of diabetes care in Ireland.  
 Breaking down the relationship with Hospital 
Team Meeting: 30.06.10 with CB 
Although it was originally conceived as part of the provision or model of diabetes care 
(a preconception perhaps), SMH began to delineate this category by looked at 
relationship in terms of types of patients being referred to hospital, how the access to 
hospital is, etc. This constitutes the model of care/care pathway between the hospital 
and the GP. While the model of care is an aspect of the relationship with the hospital, 
the broader issue is one of interfacing between settings which can be a challenge with or 
without a care pathway in place. Thus a sub-theme has emerged of 'lack of coordination 
or integration between settings.' Even where communication is good between settings 
and typically positive relationships, there's still a problem of coordination i.e. risk of 
people falling through the net, duplication etc. 
 lack of coordination is a barrier  
 Consequences of lack of coordination: duplication etc. (examples, patients sent 
from pillar to post) 
  suggestions for greater integration (e.g. Could be shared care model like the 
ante-natal one with shared care cards)- SMH has termed these mechanisms for 
integrating settings 
CB suggested that this group of categories be re-named 'Primary Care and Secondary 
Care Interface Issues'  
 Absence of Barriers ≠ Facilitator  
Analyst Meeting: 22.09.2010 
SMH questioned MOM‟s theme of the lack of incentives as a facilitator and would 
argue that just because something is not a barrier for a GP does not automatically make 
it a facilitator. A facilitator is something which assists the GP to provide optimal care.  
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The argument was based on the view of a GP in her group; “…there were no barriers, there 
were just no incentives.” (GP112, P5.3). While money was not a particular barrier for this 
GP there were no particular incentives in terms of recognition or additional resources 
to establish a systematic structured approach to diabetes care. Upon reflection the 
attitude expresses by some GPs in MOM‟s interviews was that additional remuneration 
was not necessarily warranted as diabetes care as part of their job. It was decided to 
categorise these opinions under the theme of „General Practice is a business so how important 
is money?  
 Unique insight into the practice ethos.  
Analyst Correspondence 25.09.10 
During the analysis a theme of trust and teamwork emerged from practices that had 
made a change to the way they managed diabetes care. It was particularly evident in an 
interview with a Practice Nurse who gave the impression that she did not want to take 
all the credit for the advances in the practice and conveyed the team effort in her story. 
Indeed the GP had been invited to take part but passed the invitation on to the nurse 
who responded to the letter. The theme was further echoed by GP108 in his 
discussions of visiting Diabetes Nurse Specialists to his practice to run clinics. While 
this theme did not emerge from MOM‟s analysis it was supported by the narrative of 
SMH‟s participants [“If you‟re not supported in setting up specialized time to do it you 
can‟t take it on your own bat to get off and do it” (Nurse 104, p8.1)] and thus was 
included in the final results.  
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10.14 Appendix XIV: Ethical Approval for Qualitative Research 
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10.15 Appendix XV: Comparison of Audit Data  
  
Data recorded 
Midlands DIG Diabetes 
Watch 
Patient Details 
 GP √ √ √ 
 Patient Number √ √ √ 
Sex √ √ √ 
 DOB √ √ √ 
 Classification of DM √ √ X 
DM control √ √ X 
 Year of diagnosis √ √ X 
Date of Enrolment √ Audit Date X 
Lifestyle 
Smoking Status (Y/N) √ √ X 
 Alcohol (Units/wk) √ √ X 
Physical Activity(Min/wk) X √ X 
Measurements 
 HbA1c √ √ √ 
 Serum Creatinine √ √ X 
Proteinuria √ √ X 
Microalbumin √ √ X 
Total Cholesterol √ √ √ 
HDL √ √ √ 
LDL √ √ √ 
Triglycerides √ √ X 
 BMI √ √ √ 
Weight X √ √ 
Height X √ √ 
Waist Circumference X X √ 
 Systolic BP √ √ √ 
Diastolic BP √ √ √ 
Screening/Complications 
Seen Ophthalmologist/ √(past 18 mnths) - X 
Retinopathy Screening - √(Where) X 
Retinopathy present √ √ X 
Laser Treatment √ √ X 
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Chiropodist/Podiatrist past yr 
√ √ X 
Foot Assessment recorded √ √ X 
Risk Classification of Foot √ √ X 
  
Dietician past yr 
√  √(Where) X 
  OPD visits with 
DM 
√ √  X 
(number of, (Y/N, 
Where, 
Other) 
incl CVD)   
  
Renal OPD/Clinic 
√ √ X 
  Hospital 
Admissions 
√ √ X 
Diabetes related √ √ X 
Cause e.g. DKA √ √ X 
  Complications √ √ X 
  Amputations √ √ X 
Microvascular √ √ X 
Macrovascular/ 
CVD Events 
√ √ CVS Risk 
Hypoglycaemic 
Events 
√ X X 
 Prescribing Medication X √ √ 
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10.16 Appendix XVI: Policy Study Invitation Letter, Consent & 
Information Sheet 
 
Re: Study of the Diabetes Policy Process 
Dear            , 
I am contacting you to invite you to participate in a study of the policy formulation 
process in the Irish health setting. My name is Sheena Mc Hugh and I am a PhD 
student funded by the Health Research Board as part of their PhD Scholarship 
Programme in Health Services Research. Together with Professor Ivan Perry (UCC), 
Professor Colin Bradley (UCC) and Prof. Ruairi Brugha (RCSI), I am interested in 
examining how policy is developed in Ireland and wish to use the Expert Advisory 
Group Report on diabetes care as an instrumental case study.  I would value your 
opinion and experience of diabetes care in Ireland and the policy process. I envisage 
that this study will inform future policy formulation for chronic illness and health 
services and build on a foundation for policy analysis in the Irish health system.  
Please find enclosed an information sheet outlining the details of the study and two 
consent forms (personal copy and researcher copy). If you agree to participate, the 
interview will last approximately 45 minutes. You will be forwarded an outline of the 
topic guide prior to the interview. While diabetes policy will be employed as a case 
study, the focus of my research will be the policy process therefore your views and 
opinions will be presented to protect your anonymity. Any identifiable information will 
be removed from interview transcripts and your responses will be anonymised. 
Participation is voluntary and you are free to withdraw from the study at any time. 
I appreciate that you are very busy so I would arrange to meet you at a time and 
location most convenient to you. If you are interested in taking part please return the 
consent form enclosed and I will contact you to arrange a suitable time to conduct the 
interview. I hope that you can find the time to participate. If you require any further 
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information regarding this project please contact Sheena Mc Hugh on 021-420-5253 
(s.mchugh@ucc.ie). 
Yours sincerely 
Ms. Sheena Mc Hugh 
Prof. Ivan Perry  
Prof. Ruairi Brugha  
Prof. Colin Bradley  
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Participant Information Sheet 
Research Project: 
 
 
Investigator Directing Research: Professor Ivan J. Perry Phone: 021 490 1589 
You are being invited to participate in a research study conducted within the 
Department of Epidemiology & Public Health in University College Cork. This leaflet 
provides information about the study so that you can make an informed decision about 
whether or not you wish to participate. Please feel free to ask any questions you may 
have at any point.  
Your participation is strictly voluntary and you may withdraw at any time without 
having to give a reason. Non-participation or withdrawal will be treated as a confidential 
action with no consequences for you.  
What is this study for? 
The purpose of this study is to understand the policy formulation process in the Irish 
health context, thereby informing future policy formulation in other areas as well as 
highlighting barriers and facilitators to this stage of the policy process. The study aims 
to examine the formulation process behind the development of the Expert Advisory 
Group Report on the management of diabetes in Ireland. It also aims to examine the 
explanatory value of alternative theories to explain the policy process.  
Who is organising and funding the study? 
The study is funded by the Health Research Board (HRB). It is being conducted as part 
of a programme of work for a doctoral thesis by Sheena Mc Hugh a HRB PhD Scholar 
in Health Services Research at University College Cork. The study and thesis are being 
supervised by Professor Ivan Perry (UCC), Professor Colin Bradley (UCC) and 
Professor Ruairi Brugha (Royal College of Surgeons in Ireland).  
 
 
An analysis of the policy formulation process to improve diabetes 
care in Ireland 
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How will the study be conducted? 
The study will commence in August 2011 and the interviews are expected to conclude 
in November 2011. A pilot interview will be conducted to test the suitability of the 
topic guide. It is anticipated that between 20 and 25 participants will be interviewed.  
What is involved? 
You can select a suitable time, date and location for the interview and the interviewer 
will travel to you. The interview will last approximately for 45 minutes. If it is agreeable 
with you, the interview will be audio-recorded by the researcher to assist with 
transcription. Tapes will be destroyed following transcription. 
You are permitted and will be given an opportunity to review and edit the transcript 
from your interview. If you request to review your transcript, we will contact you when 
the transcripts are ready to be reviewed whereupon you will be given a 3 month period 
within which you can request edits. If you agree, the researcher may telephone you to 
clarify any points from the interview. 
What about confidentiality? 
All interviewee responses will be anonymised. Any identifiable information will be 
removed from interview transcripts and a study ID number will be assigned to your 
tapes and transcripts to maintain anonymity. This ID number will be stored securely 
and separately from the identification code key. Details from the consent forms will also 
be stored securely by the study researcher in UCC. The data will be kept electronically 
on the secure UCC server and will be password protected. Only investigators named on 
this information sheet will have access to the data. In accordance with the Data 
Protection Act the interview data transcripts will be kept for 7 years after which time 
they will be deleted.  
What are the benefits of taking part? 
The study aims to build knowledge around the formulation stage of the policy process 
using diabetes policy as a case study. This should inform the future development of 
policy in this area and be relevant to policy making for other chronic diseases. It will 
also benefit the future policy process for health services nationally and internationally.  
What will happen with the results of this study? 
The findings of this study will be part of a doctoral thesis in Health Services Research 
which will be submitted to University College Cork. The results may also be drafted for 
publication in a peer-reviewed journal or report. In all cases only anonymous extracts or 
quotes will be reported with identifiable information removed. Copies of the findings 
will be made available to participants. 
Who has reviewed this study? 
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The proposal for this research was reviewed and granted approval by the Clinical 
Research Ethics Committee, University College Cork.  
Statement of consent 
If you agree to take part we would appreciate it if you could confirm by returning the 
consent form by email or in the pre-paid envelope. Thank you.  
Contact for further information 
If you have any concerns after the interview, please do not hesitate to contact us: 
Sheena Mc Hugh:   Tel: 021 420 5252  Email: s.mchugh@ucc.ie 
Prof. Ivan Perry:   Tel: 021 490 1589  Email: i.perry@ucc.ie  
Prof. Colin Bradley  Tel: 021 490 1547  Email: c.bradley@ucc.ie 
Prof. Ruairi Brugha:  Tel: 01 402 2434    Email: rbrugha@rcsi.ie 
Thank you for taking the time to read this information. 
 
Ms. Sheena Mc Hugh 
Prof. Ivan Perry 
Prof. Ruairi Brugha 
Prof. Colin Bradley 
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CONSENT FOR PARTICIPATION IN RESEARCH PROTOCOL 
SECTION A  
Protocol Number:     Participant Name:         
Title of Protocol: 
 
 
Investigator Directing Research: Prof. Ivan J. Perry   Phone: 021 490 1589 
Nominated Researcher: Sheena Mc Hugh   Phone: 021 420 5253 
You are being asked to participate in an interview, as part of a research study. The 
research team at University College Cork, supported by Professor Ruairí Brugha from 
the Royal College of Surgeons in Ireland, is undertaking an analysis of diabetes policy 
formulation processes. In order to decide whether or not you want to be a part of this 
research study, you should understand enough about its risks and benefits to make an 
informed judgment. This process is known as informed consent. This consent form 
gives detailed information about the research study, and you will be given an 
opportunity to ask questions about it. Once you understand the study, you will be asked 
to sign this form if you wish to participate. 
SECTION B 
I. NATURE AND DURATION OF THE STUDY: 
 The purpose of this study is to examine how policy is formulated in Ireland using 
the Expert Advisory Group Report for Diabetes as a case study. The research will 
be conducted by Sheena Mc Hugh, a PhD student based in University College 
Cork. You are invited to take part in an interview with Sheena to explore issues 
relating to the development of the policy over time.  
II. POTENTIAL RISKS AND BENEFITS: 
The interview will be an opportunity for you to share your experience and opinion 
on the development of policy for diabetes care in Ireland. There is minimal risk 
attached to taking part. Your identity will be kept confidential at all times and only 
anonymised data will be reported.  
III. POSSIBLE ALTERNATIVES: 
An analysis of the policy formulation process to improve diabetes care in 
Ireland. 
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 Your participation in the study is entirely voluntary and you are free to withdraw at 
any time without having to give a reason and without any personal consequence.   
SECTION C:  
AGREEMENT TO CONSENT: Please tick the appropriate answer: 
                   Yes      No 
I confirm that the research project and the interview associated     
with it have been fully explained to me.       
     
I have read and understood the attached        
Participant Information Sheet dated 16/08/10 and have had  
an opportunity to ask questions concerning any and all aspects  
of the project, to which I have had satisfactory answers.  
 
I am aware that participation is voluntary and that I may withdraw     
my consent at any time without having to give a reason. I am aware  
that my decision not to participate or to withdraw will not have  
any personal consequences for me.  
 
Confidentiality of records concerning my involvement in this project     
will be maintained in an appropriate manner. When required by law,  
the records of this research may be reviewed by government agencies  
and sponsors of the research. 
 
I understand that the sponsors and investigators have such insurance     
as is required by law in the event of injury resulting from this research. 
 
I have received a copy of this consent form and       
the participant information sheet for my records.   
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I, the undersigned, hereby consent to being a participant in the above described project 
conducted at the University College Cork.  I understand that if I have any questions 
concerning this research, I can contact the researcher listed above.  If I have further 
queries concerning my rights in connection with the research, I can contact the Clinical 
Research Ethics Committee of the Cork Teaching Hospitals, Lancaster Hall, 6 Little 
Hanover Street, Cork. After reading the entire consent form, if you have no further 
questions about giving consent, please sign where indicated. 
 
        
Participant Signature  Name in Block Capitals   Date  
 
SHEENA MC HUGH 
 
Researcher Signature   Name in Block Capitals   Date 
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10.17 Appendix XVII: Topic Guide for Policy Study 
TOPIC GUIDE 
PARTICIPANT & EAG 
 
Your position now & then 
How did you get involved (Who asked you) 
Who decided EAGs & why?  
What led up to EAGs? Why now? 
Why diabetes? 
Were there particular challenges for diabetes then 
MEMEBERSHIP 
 
Other members selected 
Remit for group, brief * 
Your role within group (did it change) 
Your objectives/priorities 
Your expectations for the group 
DEVELOPING 
POLICY 
 
Objectives from the outset… 
How were priorities identified- who brought them to 
table 
What issues were to the forefront, most occupied with? 
How recommendations developed (…prompt) 
 ALTERNATIVES 
 
Alternative solutions discussed: sharing ideas? 
How were alternatives evaluated 
Why disregard them 
Topics of confusion or disagreement 
How were differences of opinion handled? (consensus) 
Was there bargaining involved? In what way… 
CONTENT 
+ EVIDENCE 
Existing/ available evidence or Efforts to 
produce/gather evidence 
Types of evidence drawn on: expertise, international, 
research 
How did presentations inform report? Was info used? 
SUB-GROUP Tell me about that…Why that subgroup/topic 
(Integrated care, how was that model developed?) 
Bringing ideas to the larger group for 
discussion/agreement?  
FINALISING REPORT Any crisis points in the process? 
How did the approval process work with the HSE?- 
request changes? 
RELATIONSHIPS How did people get on working together 
Some more influential than others 
Leaders who stand out 
Partnerships within group 
People resisting/enabling 
Other B & F 
CONTEXT Key milestones/crises in diabetes  
Previous efforts – was this process different, 
adv/disadv of this attempt 
 
Influence of other policies, changes in HSE… 
Financial implications/ Economic situation 
Current resources: staff, skills, organisation. 
Media Role? 
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IMPLEMENTATION What was the expectation once recommendations were 
agreed?  
Reaction of diabetes community: widely accepted? 
Critical factors for implementation 
 
Should the content differ? What could have been done 
differently 
Balance of goals & priorities 
Use of EAGs for policy making 
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10.18 Appendix XVIII: Ethical Approval for Policy Study 
 
 
